[
  {
    "title": "Effectiveness and safety of sofosbuvir/velpatasvir ± ribavirin vs glecaprevir/pibrentasvir in genotype 3 hepatitis C virus infected patients",
    "url": "https://ejhp.bmj.com/content/27/e1/e41",
    "authors": "Luis Margusino-Framiñán, Purificación Cid-Silva, Sandra Rotea-Salvo, Álvaro Mena-de-Cea, Francisco Suárez-López, Pilar Vázquez-Rodríguez, Manuel Delgado-Blanco, Ana Isabel Sanclaudio-Luhia, Isabel Martín-Herranz, Ángeles Castro-Iglesias",
    "institution": "Pharmacy Service, Universitary Hospital of A Coruña, A Coruña, Spain. Division of Clinical Virology, Biomedical Research Institute of A Coruña (INIBIC), Universitary Hospital of A Coruña (CHUAC), Sergas, University of A Coruña (UDC), A Coruña, Spain. Infectious Diseases Unit. Internal Medicine Service, Universitary Hospital of A Coruña (CHUAC), A Coruña, Spain. Hepatology Unit, Digestive System Service, University Hospital of A Coruña (CHUAC), A Coruña, Spain. Information Systems Department, University Hospital of A Coruña, A Coruña, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-002060",
    "filters": {
      "actSubs": ["Sofosbuvir / Velpatasvir", "Sofosbuvir", "Velpatasvir", "Ribavirin", "Glecaprevir / Pibrentasvir", "Glecaprevir", "Pibrentasvir"],
      "indication": ["Hepatitis C Genotype 3", "Liver Fibrosis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Fisher’s Exact Test", "Mann-Whitney U Test", "Real-Time Polymerase Chain Reaction"],
      "studyLength": ["1 year - 2 years"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Evaluation of the stability of vancomycin solutions at concentrations used in clinical services",
    "url": "https://ejhp.bmj.com/content/27/e1/e87",
    "authors": "Morgane Masse, Stéphanie Genay, Anthony Martin Mena, Natacha Carta, Damien Lannoy, Christine Barthélémy, Bertrand Décaudin, Pascal Odou",
    "institution": "Univ. Lille, CHU Lille, ULR 7365–GRITA–Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-002076",
    "filters": {
      "actSubs": ["Vancomycin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)", "Mann-Whitney U Test"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Long-term stability of ready-to-use norepinephrine solution at 0.2 and 0.5 mg/mL",
    "url": "https://ejhp.bmj.com/content/27/e1/e93",
    "authors": "Sixtine Gilliot, Morgane Masse, Stéphanie Genay, Damien Lannoy, Christine Barthélémy, Bertrand Décaudin, Pascal Odou",
    "institution": "EA 7365–GRITA–Groupe de Recherche sur les formes Injectables et les Technologies Associées, University of Lille, CHU Lille, F-59000 Lille, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-002146",
    "filters": {
      "actSubs": ["Norepinephrine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography Reversed-Phase (RP-HPLC)", "Cochran Test"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Cost efficacy analysis of abiraterone in newly diagnosed high risk metastatic castration sensitive prostate cancer",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A4.1",
    "authors": "A Soares, A Alcobia",
    "institution": "Hospital Garcia De Orta, Pharmacy Department, Almada, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.8",
    "filters": {
      "actSubs": ["Abiraterone"],
      "indication": ["Prostate Cancer (Metastatic Castration Sensitive)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Application of a time slot model in oncology: delivery planning and process optimisation",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A8.2",
    "authors": "C Bertino, M Di Gerardo, A Pirrone, E Dalla Fontana, G Caravella, A Spagnuolo, R Cursano",
    "institution": "Università Degli Studi Di Milano, Scienze Farmaceutiche-Scuola Di Specializzazione Farmacia Ospedaliera, Milano, Italy. Asst Melegnano Martesana, Farmacia, Vizzolo Predabissi, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.18",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": ["pharmacoeconomy"],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Envisioning sustainability in personalised medicine: Fondo AIFA 5% and the Italian example",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A7.2",
    "authors": "F Bocchio, M Tizzoni, M Calvi, A Di Benedetto",
    "institution": "Fondazione Irccs Policlinico San Matteo Pavia, Uoc Farmacia, Pavia, Italy. Universita’ Degli Studi Di Milano, Scuola Di Specializzazione in Farmacia Ospedaliera, Pavia, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.16",
    "filters": {
      "actSubs": ["Venetoclax", "Eltrombopag", "Pembrolizumab", "Ruxolitinib", "Blinatumomab", "Trabectedina", "Cenegermin"],
      "indication": ["Leukaemia (Acute Myeloid)", "Lymphoma (Mantle Cell)", "Pure Red Cell Aplasia", "Lymphoma (Hodgkin)", "Lymphoma (non-Hodgkin)", "Myeloproliferative Neoplasm (BCR/JAK2-Rearranged)", "Leukaemia (Acute Lymphoblastic)", "Graft Versus Host Disease", "Ovarian Carcinoma", "Ovarian Serous Adenocarcinoma", "Neurotrophic Keratitis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["10 - 50"],
      "criteriaMethod": [],
      "studyLength": ["1 year - 2 years"],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Smartphone applications for patients diagnosed with genitourinary tumours: analysis of the quality using the mobile application rating scale",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A6.1",
    "authors": "MÁ Amor, R Collado-Borrell, V Escudero-Vilaplana, A Ribed-Sánchez, A Melgarejo-Ortuño, FJ García-Moreno, S García-Sánchez, Á Narrillos-Moraza, P Ruiz-Briones, A Herranz-Alonso, M Sanjurjo-Sáez",
    "institution": "Servicio De Farmacia, Hospital General Universitario Gregorio Marañón, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.13",
    "filters": {
      "actSubs": [],
      "indication": ["Genitourinary Cancers", "Prostate Cancer", "Cervical Cancer", "Testicular Cancer", "Ovarian Carcinoma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study", "Observational Study", "Descriptive Study"],
      "setting": [],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Mobile Application Rating Scale (MARS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": ["mobileVR"],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Biological drugs for the treatment of moderate and severe plaque psoriasis: a cost analysis and an application of a correlation analysis to investigate cost effectiveness",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A1.2",
    "authors": "N Sagaria, D Mengato, I Corbucci, G Felluga, G Morandell, A Tavella",
    "institution": "School of Hospital Pharmacy, Department of Pharmaceutical Sciences University of Padova, Padova, Italy. Bolzano General Hospital, Hospital Pharmacy Department, Bolzano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.2",
    "filters": {
      "actSubs": ["Adalimumab", "Infliximab", "Guselkumab"],
      "indication": ["Psoriasis (Moderate to Severe Plaque)"],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Psoriasis Area and Severity Index (PASI)", "Correlation Analysis"],
      "studyLength": ["3 months - 5 months"],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Economic comparison of therapeutic alternatives for firstline treatment of multiple myeloma",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A2.2",
    "authors": "MD Gil-Sierra, S Fenix-Caballero, MDP Briceño-Casado, M Dominguez-Cantero, EJ Alegre-Del Rey",
    "institution": "Hospital Universitario De Puerto Real, Pharmacy, Puerto Real, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.4",
    "filters": {
      "actSubs": ["Daratumumab", "Lenalidomide", "Bortezomib", "Thalidomide", "Melphalan", "Prednisone", "Dexamethasone"],
      "indication": ["Multiple Myeloma (Newly Diagnosed)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "ABC-VEN crosstab analysis: a decision making system for anticancer medicines",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A2.3",
    "authors": "M Fragiadaki, E Rinaki, M Petrongonas, L Tzimis",
    "institution": "Chania General Hospital, Pharmacy, 73300-Chania, Greece",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.5",
    "filters": {
      "actSubs": ["Daratumumab", "Trastuzumab emtansine", "Pantoprazole"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Haematology", "Oncology", "Chemotherapy"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["ABC/Pareto Analysis"],
      "studyLength": ["5 months - 1 year"],
      "country": ["Greece"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Can rivaroxaban become cost saving compared with vitamin K antagonists in the treatment of patients with non-valvular atrial fibrillation in France?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A1.1",
    "authors": "S Robert, F Vincent, S Vengadessane",
    "institution": "Chru Nancy, Pharmacy, Vandoeuvre Les Nancy, France. Hospices Civils De Lyon, Pharmacie, Lyon, France. Université Paris Descartes, Faculté De Pharmacie De Paris, Paris, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.1",
    "filters": {
      "actSubs": ["Rivaroxaban"],
      "indication": ["Nonvalvular Atrial Fibrillation"],
      "statedClass": ["Vitamin K Antagonists", "Novel Oral Anticoagulants"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Cost effectiveness analysis of patient self-administration of medication during hospitalisation in a cardiology unit",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A6.2",
    "authors": "CA Sørensen, A De Thurah, M Lisby, C Olesen, SB Sørensen, U Enemark",
    "institution": "Hospital Pharmacy Central Denmark Region, Clinical Pharmacy-Randers Regional Hospital, Randers Nø, Denmark. Randers Regional Hospital, Medical Department-Cardiology Unit, Randers Nø, Denmark. Aarhus University, Clinical Medicine, Aarhus, Denmark. Aarhus University Hospital, Rheumatology, Aarhus, Denmark. Aarhus University Hospital, Research Centre of Emergency Medicine, Aarhus, Denmark. Hospital Pharmacy Central Denmark Region, Clinical Pharmacy-Aarhus University Hospital, Aarhus, Denmark. Aarhus University, Public Health, Aarhus, Denmark",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.14",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Cardiology"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Denmark"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": ["selfMedication"],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Evaluation of bispectral index monitoring in general anaesthesia through a health technology assessment method: a possible introduction in clinical practice in an Italian hospital?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A7.1",
    "authors": "E Guido, ME Borghesi, A Saccardi",
    "institution": "University of Milan, Specialisation School in Hospital Pharmacy, Milan, Italy. Asst Carlo Poma-Mantova, Hospital Pharmacy, Mantova, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.15",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": ["preopMedication"],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "National reporting system for drug shortages: classification and trends in reported causes from 2015 to 2018",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A5.2",
    "authors": "A Benhabib, P Maison",
    "institution": "French National Agency for Medicines and Health Products Safety, Health Products Survey, Saint-Denis, France. Strasbourg Faculty of Pharmacy, Hospital Pharmacy, Strasbourg, France. Ea 7379- Paris Est Creteil University Upec and Chic Hospital, Epidemiology Department, Créteil, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.12",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Study of the use of intravenous immunoglobulins during the fourth quarter of 2018 and analysis of its off-label use",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A2.1",
    "authors": "S Izquierdo Muñoz, A Pariente Junquera, A De Frutos Soto",
    "institution": "Hospital Clínico Universitario De Valladolid, Farmacia Hospitalaria, Valladolid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.3",
    "filters": {
      "actSubs": [],
      "indication": ["Demyelinating Neuropathies", "Myasthenia Gravis", "Myopathy", "Encephalitis", "Encephalomyelitis", "Morvan Syndrome", "Paraneoplastic Syndrome", "Refractory Atopic Dermatitis", "Paraneoplastic Dermatomyositis", "Scleroderma", "Antisynthetase Syndrome"],
      "statedClass": ["Intravenous Immunoglobulins (IVIg)"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Effectiveness evaluation of high cost drugs for advanced non-small-cell lung cancer: real world evidence, compliance with clinical practice guidelines and economic evaluation",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A3.1",
    "authors": "A Isoardo, E Grande, MM Ferrero, C Fruttero",
    "institution": "Ao S Croce E Carle, SC Farmacia Ospedaliera, Cuneo, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.6",
    "filters": {
      "actSubs": ["Pemetrexed", "Erlotinib", "Gefitinib", "Afatinib", "Osimertinib", "Crizotinib", "Pembrolizumab", "Nivolumab"],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Kaplan-Meier Method"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "New cancer drug approvals in Portugal",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A3.2",
    "authors": "A Alcobia, A Soares",
    "institution": "Hospital Garcia De Orta, Pharmacy Department, Almada, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.7",
    "filters": {
      "actSubs": ["Midostaurin", "Olaparib", "Brentuksimab vedotin", "Vedotin", "Pomalidomide", "Durvalumab", "Venetoclax", "Ixazomib", "Alectinib", "Atezolizumab", "Cabozantinib"],
      "indication": ["Refractory Cancer", "Metastatic Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Budget impact analysis of a natalizumab extended interval dosing regimen",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A4.2",
    "authors": "E Pierobon, A Mastrogiacomo, F Capano, D Ielo",
    "institution": "AOU San Luigi Gonzaga, Pharmacy, Turin, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.9",
    "filters": {
      "actSubs": ["Natalizumab"],
      "indication": ["Progressive Multifocal Leukoencephalopathy", "Multiple Sclerosis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["501 - 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Introduction of rituximab biosimilar: an opportunity to improve health system efficiency?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A4.3",
    "authors": "C Panciroli, L Cervi, D Mazza, G Mangoni, M Dall’aglio, F Ruggiero, ML Medaglia",
    "institution": "Asst Grande Ospedale Metropolitano Niguarda, SC Farmacia, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.10",
    "filters": {
      "actSubs": ["Rituximab"],
      "indication": [],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": ["vigilance"],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Assessment of asthma diagnosed population eligible for new monoclonal antibody therapy and related cost in the Veneto region",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A5.1",
    "authors": "L Degli Esposti, V Perrone, D Sangiorgi, AM Menti, M Andretta",
    "institution": "Clicon SRL-Health-Economics and Outcomes Research, Clicon SRL-Health-Economics and Outcomes Research, Ravenna, Italy. Uoc Hta-Azienda Zero-Regione Veneto, Uoc Hta-Azienda Zero-Regione Veneto, Padova, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.11",
    "filters": {
      "actSubs": ["Theophylline"],
      "indication": ["Asthma (Severe Refractory)"],
      "statedClass": ["Monoclonal Antibodies", "Inhaled Corticosteroids", "Long-Acting β Adrenoceptor Agonists", "Antileukotriene Agents", "Anticholinergics", "Systemic Corticosteroids"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": [],
      "ward": [],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Impact of supply problems in a hospital pharmacy service",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A8.1",
    "authors": "B Zarate, Á Pieras López, R Menárguez Blanc, A Iglesias Carbajo, C Álvarez Asteinza, A Lozano Blazquez, Á Arias-Martinez, I Maray Mateos, MD Macía Rivas, CL Fernández Laguna",
    "institution": "Hospital Universitario Central De Asturias, Pharmacy, Oviedo, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.17",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Hospital pharmacists aged <45 years: an employment status and job satisfaction survey in Italy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A9.1",
    "authors": "SE Campbell Davies, G Bagaglini, F Brera",
    "institution": "Italian Society of Hospital Pharmacy Sifo, Young Pharmacists, Milano, Italy. Italian Society of Hospital Pharmacy Sifo, Young Pharmacists, Roma, Italy. Italian Society of Hospital Pharmacy Sifo, Young Pharmacists, San Donà Di Piave, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.19",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": ["youngPharma"],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Implementation of home delivery and telepharmacy systems in a third level hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A9.2",
    "authors": "J Cordero-Ramos, Ú Baños-Roldán, JA Fernandez-González-Caballos, C Castillo-Martin, EM Delgado-Cuesta",
    "institution": "Hospital Universitario Virgen Macarena, Hospital Pharmacy, Seville, Spain. Hospital Universitario Virgen Macarena, Primary Care Pharmacy Department, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.20",
    "filters": {
      "actSubs": [],
      "indication": ["Multiple Sclerosis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Outpatient Clinic"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": ["telepharmacy"],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": ["delivery"],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Improvement in an antimicrobial stewardship programme after implementing a screening alert system",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A10.1",
    "authors": "E Tevar, MJ Castillo Méndez, A Ferrer Machín, ML Padilla Salazar, L Abella Vázquez, J Ode Febles, K Álvarez Tosco, M Hayek Peraza, MÁ Ocaña Gómez, J Merino Alonso",
    "institution": "Hospital Nuestra Señora De La Candelaria, Pharmacy Service, Santa Cruz De Tenerife, Spain. Hospital Nuestra Señora De La Candelaria, Computer Department, Santa Cruz De Tenerife, Spain. Hospital Nuestra Señora De La Candelaria, Internal Medicine, Santa Cruz De Tenerife, Spain. Hospital Nuestra Señora De La Candelaria, Microbiology Service, Santa Cruz De Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.21",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Quasi-Experimental Design"],
      "setting": ["Hospital"],
      "ward": ["Cardiology", "Vascular Surgery", "General Surgery", "Geriatrics", "Internal Medicine", "Neurology", "Traumatology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Economic impact of the introduction of lamivudine plus dolutegravir bitherapy in HIV naive patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A10.2",
    "authors": "L Cantarelli, J Gonzalez Garcia, B Del Rosario Garcia, J Ramos Rodriguez, F Gutierrez Nicolas, J Garcia Cairos, S Garcia Gil, GJ Nazco Casariego",
    "institution": "Complejo Hospitalario Universitario De Canarias, Pharmacy, Santa Cruz De Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.22",
    "filters": {
      "actSubs": ["Dolutegravir", "Abacavir", "Lamivudine", "Emtricitabine", "Tenofovir", "Raltegravir"],
      "indication": ["HIV (Treatment-Naive)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Efficiency of precision dosing with intravenous immunoglobulins in patients with haematological malignancies",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A11.1",
    "authors": "M Dominguez Cantero, FJ Salmeron-Navas, EM Barreiro-Fernandez, C Moreno-Ramos, MP Briceño-Casado",
    "institution": "Hospital Universitario Puerto Real, Servicio De Farmacia, Cadiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.23",
    "filters": {
      "actSubs": ["Intravenous Immunoglobulin (IVIg)"],
      "indication": ["Hematologic Malignancy", "Immunodeficiency", "Autoimmune Hemolytic Anemia", "Idiopathic Thrombocytopenic Purpura"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Economic analysis of osimertinib in previously untreated EGFR mutant advanced non-small cell lung cancer",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A11.2",
    "authors": "A Ferrer Machín, LG José Arístides, JA Martín Conde, T Betancor García, M Vera Cabrera, S Hernández Rojas, I González García, K Álvarez Tosco, J Merino Alonso",
    "institution": "Hospital Pharmacist, Pharmacy Service, Santa Cruz De Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.24",
    "filters": {
      "actSubs": ["Osimertinib", "Afatinib", "Gefitinib", "Erlotinib"],
      "indication": ["Non-Small Cell Lung Cancer (EGFR-Mutated)"],
      "statedClass": ["Tyrosine Kinase Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Assessment of regorafenib, ramucirumab and cabozantinib as secondline therapy in hepatocarcinoma and alfa-fetoprotein value ≥400 ng/mL",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A12.1",
    "authors": "M Camean-Castillo, S Fenix-Caballero, FJ Salmeron-Navas, M Dominguez-Cantero, JM Borrero-Rubio",
    "institution": "Hospital Universitario Puerto Real, Pharmacy, Puerto Real, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.25",
    "filters": {
      "actSubs": ["Regorafenib", "Ramucirumab", "Cabozantinib", "Sorafenib"],
      "indication": ["Hepatocarcinoma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Meta-Analysis"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Bucher's Method", "Shakespeare Method"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Out of supply of chemotherapy injectable medicines over 9 months: patient impact",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A12.2",
    "authors": "F Charbonneau, Y Brasleret, MA Zilavec, C Naine, J Grimaux, G Svrcek",
    "institution": "Soissons Hospital Centre, Pharmacy Unit, Soissons, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.26",
    "filters": {
      "actSubs": ["Bleomycin", "Mitomycin C", "Docetaxel"],
      "indication": ["Ovarian Carcinoma", "Bladder Cancer", "Squamous Cell Carcinoma of the Rectum", "Prostate Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Impact of French experiment for incentivising etanercept biosimilar use after 10 months",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A12.3",
    "authors": "P Paubel, A Degrassat-Théas, F Bocquet",
    "institution": "Faculté De Pharmacie De Paris, Institut Droit Et Santé- Inserm Umr S 1145, Paris, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.27",
    "filters": {
      "actSubs": ["Etanercept"],
      "indication": [],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital", "Community Pharmacy"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Cost minimisation study of the biological treatment of inflammatory bowel disease: ustekinumab versus vedolizumab",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A13.1",
    "authors": "L Cantarelli, F Gutierrez Nicolas, B Del Rosario Garcia, J Ramos Rodriguez, J Garcia Cairos, JA Morales Barrios, S Garcia Gil, GA Gonzalez De La Fuente, J Gonzalez Garcia, GJ Nazco Casariego",
    "institution": "Complejo Hospitalario Universitario De Canarias, Pharmacy, Santa Cruz De Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.28",
    "filters": {
      "actSubs": ["Ustekinumab", "Vedolizumab"],
      "indication": ["Inflammatory Bowel Disease"],
      "statedClass": ["Tumor Necrosis Factor (TNF) Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": ["pharmacoeconomy"],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Economic impact of switching the administration route of tocilizumab in polyarticular juvenile idiopathic arthritis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A13.2",
    "authors": "M Rodriguez Reyes, F Bossacoma Busquets, M Sanchez Celma, J Arrojo Suarez, A Comes Escoda, C Latre Gorbe, E Iglesias Jimenez, J Anton Lopez",
    "institution": "Hospital Clinic Barcelona, Pharmacy, Barcelona, Spain. Hospital Sant Joan De Déu/Fundació Salut Empordà, Pharmacy, Esplugues De Llobregat, Spain. Hospital Sant Joan De Déu, Pharmacy, Esplugues De Llobregat, Spain. Hospital Sant Joan De Déu, Paediatrics, Esplugues De Llobregat, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.29",
    "filters": {
      "actSubs": ["Tocilizumab"],
      "indication": ["Polyarticular Juvenile Idiopathic Arthritis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Trans-interface gain share programme for biosimilar infliximab",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A14.1",
    "authors": "C Mc Gann, S Cullen, B Love, J Carr",
    "institution": "Connolly Hospital, Pharmacy Department, Blanchardstown, Ireland",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.30",
    "filters": {
      "actSubs": ["Infliximab", "Vedolizumab"],
      "indication": [],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Rheumatology", "Gastroenterology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["5 months - 1 year"],
      "country": ["Ireland"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Cost minimisation study in severe asthma treatment",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A14.2",
    "authors": "J Ramos Rodríguez, S García Gil, L Cantarelli, J González García, C Romero Delgado, J García Cairós, G Calzado Gómez, GA González De La Fuente, B Del Rosario García, GJ Nazco Casariego, F Gutiérrez Nicolás",
    "institution": "Hospital Universitario De Canarias, Pharmacy, San Cristóbal De La Laguna, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.31",
    "filters": {
      "actSubs": ["Omalizumab"],
      "indication": ["Severe Asthma (IgE-Mediated)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Pneumology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Application of the ABC analysis method for optimising the stock management of medical devices in common use",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A15.1",
    "authors": "M Belhouari, N Nchinech, H Attjioui, N Bouhlala, B Elouadghiri, J Lamsaouri",
    "institution": "Mohammed V Military Training Hospital, Pharmacy, Rabat, Morocco. Mohammed V University-Faculty of Medicine and Pharmacy of Rabat, Chis, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.32",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Universal Kits", "Sterile Gloves", "Infusers", "Plaster Strips", "Guedel Cannulas", "Y Fittings"],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["ABC/Pareto Analysis"],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Evaluating the methodological quality of pivotal clinical trial publications for orphan drugs authorised in 2018. Are they reliable?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A15.2",
    "authors": "R Iglesias Gómez, F Luna, J Moya Sola, M Tordera Baviera, MJ Company Albir, T Palanques Pastor, I Beltran Garcia, JL Poveda Andres",
    "institution": "Hospital Universitario Y Politécnico La Fe De Valencia, Servicio De Farmacia, Valencia, Spain. Hospital General De Agudos Carlos G. Durand, Servicio De Farmacia, Buenos Aires, Argentina",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.33",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain", "Argentina"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": ["orphan"],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Cost of stockout. A growing problem",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A16.1",
    "authors": "G Rodriguez Torne, MJ Sanchez Cuenca, F Burgos Sierra, C Fernandez Oropesa",
    "institution": "Hospital De Baza, Pharmacy Service, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.34",
    "filters": {
      "actSubs": ["Piperacillin / Tazobactam", "Docetaxel", "Paclitaxel", "Levothyroxine (IV)"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Future distribution models for paid pharmaceuticals: the patient’s perspective",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A16.2",
    "authors": "C Olesen, MN Pedersen, MS Wellner",
    "institution": "Hospital Pharmacy Central Denmark Region, Clinical Pharmacy-Aarhus, Aarhus C, Denmark. Hospital Pharmacy Central Denmark Region, Department of for Paid Pharmaceuticals, Aarhus C, Denmark",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.35",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Denmark"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": ["telepharmacy"],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": ["delivery"],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Impact of the implementation of the falsified medicines directive at the Lisbon Portuguese Institute of Oncology (FG, EPE)",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A16.3",
    "authors": "AC Franco, A Gouveia",
    "institution": "Lisbon Portuguese Institute of Oncology Francisco Gentil Epe, Hospitalar Pharmacy, Lisbon, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.36",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": ["falsified"],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Four year study of drugs shortages in two public hospitals",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A17.1",
    "authors": "A Decoene, S Traore, A Pruvost, I Walbecq, P Mazaud",
    "institution": "Ch De Dunkerque, Pharmacy, Dunkerque, France. Chu De Lille, Pharmacy, Lille, France. Ch De Valenciennes, Pharmacy, Valenciennes, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.37",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Student's T-test"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Four years of shortages regarding the anatomic, therapeutic and chemical classification",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A17.2",
    "authors": "A Decoene, S Traore, I Walbecq, P Mazaud",
    "institution": "Ch De Dunkerque, Pharmacy, Dunkerque, France. Chu De Lille, Pharmacy, Lille, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.38",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Cephalosporins"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Impact of medicine shortages on an outpatient clinic of a general hospital ",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A18.1",
    "authors": "I Puértolas Tena, M Comet Bernad, C Moncín Torres",
    "institution": "Hospital Royo Villanova, Servicio De Farmacia, Zaragoza, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.39",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Outpatient Clinic"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Survey of drug shortages in Hungarian hospitals",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A18.2",
    "authors": "RG Vida, S Sebők, B Nyaka, J Hornyák, L Botz",
    "institution": "University of Pécs Faculty of Pharmacy, Department of Pharmaceutics and Central Clinical Pharmacy, Pécs, Hungary. Semmelweis University, University Pharmacy Department of Pharmacy Administration, Budapest, Hungary",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.40",
    "filters": {
      "actSubs": ["Digoxin", "Sodium Ferric Gluconate", "Phytomenadione", "Immunoglobulin", "Idarubicin", "Amoxicillin / Clavulanic acid"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Hungary"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": ["selection"],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Drug shortages and drug unavailability: analysis from an Italian hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A19.1",
    "authors": "A Zovi, C Inserra, M Piacenza, V Stefania",
    "institution": "Asst Fatebenefratelli Sacco-L Sacco Hospital, Pharmacy, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.41",
    "filters": {
      "actSubs": ["Ampicillin", "Ceftazidime", "Midazolam", "Oxacillin", "Ferrous gluconate", "Glutathione", "Piperacillin / Tazobactam", "Lysine acetylsalicylate", "Hydrocortisone", "Suxamethonium", "Cefepime", "Methylprednisolone", "Heparin", "Atracurium", "Mupirocin", "Chlorphenamine", "Alprostadil", "Etilefrine", "Diazepam", "Lorazepam", "Fructose", "Labetalol", "Danazol", "Sodium nitroprusside"],
      "indication": [],
      "statedClass": ["Antibiotics", "Non-Steroidal Anti-Inflammatory Drugs", "Benzodiazepines", "Antihypertensives", "Dietetics", "Anaesthetics", "Urological Drugs", "Antihistamines", "Adrenergic Drugs"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "How much does falsified medicines directive actually costs? Detailed cost evaluation of serialisation in a representative sample of Hungarian hospital pharmacies",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A19.2",
    "authors": "A Fittler, K Richter, P Vajda, Z Bodrogi, RG Vida, R Bella, S Kovács, A Zemplényi, L Botz",
    "institution": "University of Pécs, Department of Pharmaceutics and Central Clinical Pharmacy, Pécs, Hungary. Szent Borbála Hospital, Department of Pharmacy, Tatabánya, Hungary. University of Pécs, Department of Pharmacoeconomics, Pécs, Hungary",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.42",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Hungary"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": ["falsified"],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Shortages of medicines in hospital: results of a survey on the perception of health workers in the wards VSV real world",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A20.1",
    "authors": "A Zovi, UM Musazzi, F Cilurzo, P Minghetti",
    "institution": "Asst Fatebenefratelli Sacco-L Sacco Hospital, Pharmacy, Milan, Italy. University of Milan, Department of Pharmaceutical Sciences, Milano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.43",
    "filters": {
      "actSubs": ["Danazol", "Ceftazidime", "Oxacillin", "Lysine acetylsalicylate"],
      "indication": [],
      "statedClass": ["Antibiotics", "Corticosteroids", "Gastroprotectors", "Antihypertensives", "Benzodiazepines", "Psychostimulants", "Nutritional Agents", "Antihistamines", "Blood Products", "Biologicals"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": ["selection"],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Application of hazard vulnerability analysis to evaluate the risk level of medicine shortages",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A20.2",
    "authors": "E Di Martino, D Vinci Leonardi, R Giammona, A Provenzani, P Polidori",
    "institution": "Università Degli Studi Di Palermo, Stebicef, Palermo, Italy. Università Degli Studi Di Messina, Chimica-Biologia-Farmacia-Scienze Ambientali, Messina, Italy. Irccs Ismett, Clinical Pharmacy, Palermo, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.44",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Hazard Vulnerability Analysis"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Management of drug shortages",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A20.3",
    "authors": "MI Bernias Domínguez, M Mañes Sevilla, B Martin Cruz, B Santiago Gallego, I Escribano Valenciano, C Moriel Sánchez",
    "institution": "Hospital Universitario De Móstoles, Hospital Pharmacy, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.45",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Antimetabolites", "Corticosteroids", "Antiarrhythmics", "Antipsychotics"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Economic impact of drug shortages",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A21.1",
    "authors": "C Aparicio Carreño, Y Labeaga Beramendi, B Rodriguez, B Fernández González, A Gándara Ande, FJ Barbazán Vázquez, C Martínez-Múgica Barbosa, C Durán Román",
    "institution": "Cabueñes Hospital University, Pharmacy, Gijón, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.46",
    "filters": {
      "actSubs": ["Piperacillin / Tazobactam", "Alprostadil", "Dexchlorpheniramine", "Magnesium sulphate", "Clorazepate dipotassium", "Metoclopramide", "Sodium chloride", "Doxycycline", "Isoniazid / Pyrazinamide / Rifampicin", "BCG Vaccine (Tice strain)"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Descriptive Study"],
      "setting": ["Hospital", "Community Pharmacy"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Referencing a midline: how to make a choice?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A21.2",
    "authors": "P Behague, M Debailleul, L Lampe, N Garnier, V Colas, M Raoult, F Cathelineau, N Guenault, V Leclercq, C Canevet, E Floret",
    "institution": "Hôpital Saint Philibert, Service Pharmacie, Lomme, France. Hôpital Saint Philibert, Equipe Opérationnelle D’hygiène, Lomme, France. Hôpital Saint Philibert, Service D’anesthésie, Lomme, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.47",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Midlines"],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": ["youngPharma"],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Compatibility and stability assessment of a sodium glycerophosphate formulation mixed in bags for neonatal total parenteral nutrition",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A22.1",
    "authors": "A Isoardo, E Grande, MM Ferrero, M Viglione, B Rolando, R Fruttero, C Fruttero",
    "institution": "Ao S Croce E Carle, SC Farmacia Ospedaliera, Cuneo, Italy. Università Degli Studi Di Torino, Dipartimento Di Scienza E Tecnologia Del Farmaco, Torino, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.48",
    "filters": {
      "actSubs": ["Sodium glycerophosphate"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": ["incompatibilities"],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Microbiological stability test of 15% topical resorcinol for quality control",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A22.2",
    "authors": "J Cordero-Ramos, M Delgado-Valverde, V Merino-Bohórquez, C Castillo-Martin, FJ Falcón-Rodríguez, M Cameán-Fernández",
    "institution": "Hospital Universitario Virgen Macarena, Hospital Pharmacy, Seville, Spain. Hospital Universitario Virgen Macarena, Microbiology Department, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.49",
    "filters": {
      "actSubs": ["Resorcinol"],
      "indication": ["Hidradenitis suppurativa"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Terlipressin pH stability for continuous infusion",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A23.1",
    "authors": "A Castro Balado, J González-López, S Blanco-Dorado, EJ Bandín-Vilar, L García-Quintanilla, I Varela-Rey, M Busto Iglesias, M González-Barcia, I Zarra-Ferro",
    "institution": "Complejo Hospitalario Universitario De Santiago De Compostela, Hospital Pharmacist Service, Santiago De Compostela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.50",
    "filters": {
      "actSubs": ["Terlipressin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Physicochemical stability of cefepime in polypropylene syringes and in elastomeric devices",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A23.2",
    "authors": "E D’huart, H Zenier, J Vigneron, A Charmillon, B Demore",
    "institution": "University Hospital of Nancy, Pharmacy Department, Vandoeuvre Lès Nancy, France. University Hospital of Nancy, Infectious and Tropical Diseases Department, Vandoeuvre Lès Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.51",
    "filters": {
      "actSubs": ["Cefepime"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Polypropylene Syringes", "Elastomeric Devices"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Physicochemical stability of cefazolin in polypropylene syringes and in elastomeric devices",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A24.1",
    "authors": "E D’huart, N Sobalak, J Vigneron, A Charmillon, B Demore",
    "institution": "University Hospital of Nancy, Pharmacy Department, Vandoeuvre Lès Nancy, France. University Hospital of Nancy, Infectious and Tropical Diseases Department, Vandoeuvre Lès Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.52",
    "filters": {
      "actSubs": ["Cefazolin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Polypropylene Syringes", "Elastomeric Devices"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Physicochemical stability of aztreonam in polypropylene syringes at high concentration for intensive care units",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A24.2",
    "authors": "YE Nisse, J Vigneron, F Blaise, E D’huart, A Charmillon, B Demoré",
    "institution": "Chru Nancy, Pharmacy, Vandoeuvre-Lès-Nancy, France. Chru Nancy, Infectious Diseases Department, Vandoeuvre-Lès-Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.53",
    "filters": {
      "actSubs": ["Aztreonam"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Polypropylene Syringes"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Levofloxacin 0.05% eye drops: a case study",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A24.3",
    "authors": "M Martín Marqués, A De Dios López, J Del Estal Jiménez, PA López Broseta, MÁ Roch Ventura, A Sanjuan Belda, S Jornet Montaña, E Esteve Pitarch, M Vuelta Arce, M Mendoza Aguilera, L Canadell Vilarrasa",
    "institution": "Hospital Universitari Joan Xxiii, Pharmacy, Tarragona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.54",
    "filters": {
      "actSubs": ["Levofloxacin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": ["Neonatal Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Intravenous perfusion of ceftolozane–tazobactam using elastomeric infusion pumps",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A25.1",
    "authors": "S Rotea, M García, B Feal, C Fernández, V Giménez, I Martín",
    "institution": "Hospital Pharmacy, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.55",
    "filters": {
      "actSubs": ["Ceftolozane / Tazobactam"],
      "indication": ["Pneumonia (Hospital Acquired)", "Severe Abdominal Infection", "Urinary Infection (Severe)"],
      "statedClass": [],
      "typeOfMedical": ["Elastomeric Infusion Pumps"],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Home Care Unit"],
      "numPatients": ["Less than 10"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": ["homeCare"],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Treatment of recurrent otomycosis with local application of a compounded formulation of voriconazole ear drops: case series",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A25.2",
    "authors": "L Carrasco Piernavieja, E Zhan Zhou, M Dominguez Bachiller, AM Martín De Rosales Cabrera, MS Marcos Salazar, M Perez Encinas",
    "institution": "Hospital Universitario Fundación Alcorcón, Hospital Pharmacy, Alcorcón, Spain. Hospital Universitario Fundación Alcorcón, Otorhinolaryngology, Alcorcón, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.56",
    "filters": {
      "actSubs": ["Voriconazole"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)", "STATA", "McNemar Test"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Evaluation of the production accuracy and error rate in the automated compounding of cytotoxic preparations by a robot",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A26.1",
    "authors": "BR Kujau, J Raffaelli, C Klaas",
    "institution": "Universitätsklinikum Münster, Zentrale Einrichtung Apotheke, Münster, Germany. Loccioni Deutschland Gmbh, Humancare, Calw, Germany",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.57",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["More than 1000"],
      "criteriaMethod": [],
      "studyLength": ["5 months - 1 year"],
      "country": ["Germany"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Closed system transfer device based on air filtration: the drug vapour challenge",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A26.2",
    "authors": "G Levin",
    "institution": "Simplivia Healthcare, Research and Development, Hod Hasharon, Israel",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.58",
    "filters": {
      "actSubs": ["Cyclophosphamide", "Florourasil (5-FU)"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Closed System Drug-Transfer Device (CSTD)", "Vial Adaptors"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Liquid Chromatography Tandem - Mass Spectrometry (LC–MS/MS)"],
      "studyLength": [],
      "country": ["Israel"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Management of non-administered chemotherapy preparation: an opportunity to minimise drug waste in oncology pharmacy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A27.1",
    "authors": "A El Assil, C Adade, R Issa, H Bechar, A Zedou, A Fassi Fihri, Y Rahali",
    "institution": "Mohamed V University-Faculty of Medecine and Pharmacy, Department of Pharmacy, Rabat, Morocco. National Institute of Oncology-Ibn Sina University Hospital, Department of Pharmacy, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.59",
    "filters": {
      "actSubs": ["Docetaxel"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Centralised Cytotoxic Preparation Unit"],
      "numPatients": [],
      "numPrescriptions": ["51 - 100"],
      "criteriaMethod": [],
      "studyLength": ["5 months - 1 year"],
      "country": ["Morocco"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": ["vigilance"],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": ["incompatibilities"],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Comparative biophysical stability study of ziv-aflibercept (Zaltrap, opened vials) stored at 4°C and room temperature for 2 weeks",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A27.2",
    "authors": "J Hermosilla Fernández, A Salmeron García, J Cabeza, N Navas",
    "institution": "Biomedical Research Institute Ibs Granada, Analytical Chemistry-Science Faculty-University of Granada, Granada, Spain. Biomedical Research Institute Ibs Granada, Clinical Pharmacy-San Cecilio University Hospital, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.60",
    "filters": {
      "actSubs": ["Ziv-Aflibercept"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Dynamic Light Scattering", "Size-Exclusion Chromatography (SEC)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Use of cabazitaxel and reduction of waste: the potential of drug day",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A28.1",
    "authors": "L Gasperoni, M Nardelli, A Caraffa, A Colicchio, M Mancini",
    "institution": "Azienda Ospedaliera Ospedali Riuniti Marche Nord, Uoc Farmacia, Pesaro, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.61",
    "filters": {
      "actSubs": ["Cabazitaxel"],
      "indication": ["Prostate Cancer (Metastatic Castration Resistant)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Short term stability of diluted solutions of the monoclonal antibody daratumumab",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A28.2",
    "authors": "G Mangoni, F Selmin, L Camuffo, L Cancanelli, M Piccoli, M Rivano, L Cervi, F Cilurzo, P Minghetti",
    "institution": "Università Degli Studi Di Milano, School of Specialisation in Hospital Pharmacy, Milano, Italy. Università Degli Studi Di Milano, Department of Pharmaceutical Sciences, Milano, Italy. Asst Grande Ospedale Metropolitano Niguarda, SC Farmacia, Milano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.62",
    "filters": {
      "actSubs": ["Daratumumab"],
      "indication": ["Multiple Myeloma"],
      "statedClass": [],
      "typeOfMedical": ["Low Density Polyethylene (LDPE) Bags"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Size Exclusion Chromatography - High Performance Liquid Chromatography (SEC-HPLC)", "Dynamic Light Scattering", "Nanoparticle Tracking Analysis (NTA)"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Stability of compounded nivolumab solution after pneumatic system transportation",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A29.1",
    "authors": "L Camuffo, F Selmin, F Vasile, M Rivano, M Piccoli, G Mangoni, L Cancanelli, M Fazio, F Cilurzo, P Minghetti",
    "institution": "University of Milan, School in Hospital Pharmacy, Milan, Italy. Humanitas Research Hospital, Pharmacy, Rozzano, Italy. University of Milan, Department of Pharmaceutical Sciences, Milan, Italy. San Raffaele Hospital, Pharmacy, Milan, Italy. University of Milan, Department of Chemistry, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.63",
    "filters": {
      "actSubs": ["Nivolumab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Dynamic Light Scattering", "Nuclear Magnetic Resonance", "Size Exclusion Chromatography - High Performance Liquid Chromatography (SEC-HPLC)"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Increasing pharmacy productivity by expanding the role of the intravenous compounding robot in a comprehensive cancer centre",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A29.2",
    "authors": "M Capilli, M Federici, T Comandone, G Maffeis, F Foglio, L Omini, F Enrico",
    "institution": "University of Turin, Drug Science and Technology-School of Specialisation in Hospital Pharmacy, Turin, Italy. Loccioni, Angeli Di Rosora, Ancona, Italy. University of Turin, Drug Science and Technology, Turin, Italy. Fpo Irccs Candiolo, Hospital Pharmacy, Candiolo, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.64",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Mitomycin C stability according to pH and temperature conditions",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A29.3",
    "authors": "G Miralles Andreu, I Truyols García, M Pomares Bernabeu, L Soriano Irigaray, L Peral Ballester, A Navarro Ruiz",
    "institution": "Hospital General Universitario De Elche, Hospital Pharmacy Department, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.65",
    "filters": {
      "actSubs": ["Mitomycin C"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "In use physicochemical and microbiological stability of diluted solutions of the monoclonal antibody nivolumab",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A30.1",
    "authors": "M Rivano, F Selmin, L Camuffo, L Cancanelli, G Mangoni, MA Piccoli, G Longobardo, F Cilurzo, P Minghetti",
    "institution": "University of Milan, School of Hospital Pharmacy, Milan, Italy. University of Milan, Department of Pharmaceutical Sciences, Milan, Italy. Irccs San Raffaele, Pharmacy, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.66",
    "filters": {
      "actSubs": ["Nivolumab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Dynamic Light Scattering", "Size Exclusion Chromatography - High Performance Liquid Chromatography (SEC-HPLC)", "Gel Electrophoresis"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": ["flatDoses"],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Physicochemical stability of 25 mg/mL pemetrexed diarginine in partially used vials and 3 and 12 mg/mL diluted in dextrose 5% in polyolefin bag",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A30.2",
    "authors": "YE Nisse, J Vigneron, N Sobalak, B Demoré",
    "institution": "Chru Nancy, Pharmacy, Vandoeuvre-Lès-Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.67",
    "filters": {
      "actSubs": ["Pemetrexed"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Storage of nivolumab pembrolizumab and daratumumab for 14 days after compounding in the hospital pharmacy: a microbiological stability study",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A31.1",
    "authors": "L Cancanelli, F Selmin, L Camuffo, G Mangoni, M Piccoli, M Rivano, F Cilurzo, P Minghetti",
    "institution": "Università Degli Studi Di Milano, Department of Pharmaceutical Sciences, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.68",
    "filters": {
      "actSubs": ["Nivolumab", "Pembrolizumab", "Daratumumab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Particulate quality of a controlled atmosphere area. Compliance with good manufacturing practices at rest and during activity, highlighting factors impacting on contamination",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A31.2",
    "authors": "M Pottier, M Naveau, A Villain, G Strobbe, I Sakji, F Feutry, G Marliot",
    "institution": "Centre Oscar Lambret, Pharmacy, Lille, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.69",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Development and validation of a discriminative method for anthracyclines used in oncology by visible spectrometer",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A32.1",
    "authors": "CA Adade, A El Orche, H Attjioui, A Cheikh, H Mefetah, M El Karbane, M Bouatia",
    "institution": "Mohamed V University-Faculty of Medicine and Pharmacy, Analytical Chemistry Laboratory, Rabat, Morocco. University of Sultan Moulay Slimane Beni-Mellal, Faculty of Science and Technology, Beni-Mellal, Morocco. Abulcasis University of Health Sciences, Faculty of Pharmacy, Rabat, Morocco. Paediatric Hospital, Pharmacy, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.70",
    "filters": {
      "actSubs": ["Daunorubicin", "Doxorubicin", "Epirubicin"],
      "indication": [],
      "statedClass": ["Anthracyclines"],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": ["Paediatric Haematology – Oncology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Partial Least Squares Discriminant Analysis (PLS-DA)", "Ultraviolet – Visible Spectrophotometry"],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "The effects of freeze–thaw cycling on the stability of the adalimumab biosimilar SB5",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A32.2",
    "authors": "H Ebbers, J Kim, J Yun, D Park, SJ Hwang, SJ Park",
    "institution": "Biogen International GmbH, Scientific Affairs, Baar, Switzerland. Samsung Bioepis Co Ltd, Qc Group, Incheon, Korea South",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.71",
    "filters": {
      "actSubs": ["Adalimumab"],
      "indication": [],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": ["Prefilled Syringes"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Size Exclusion Chromatography - High Performance Liquid Chromatography (SEC-HPLC)", "Capillary Electrophoresis - Sodium Dodecyl Sulfate (CE-SDS) (non-reducing)", "Fluorescence Resonance Energy Transfer (FRET)"],
      "studyLength": [],
      "country": ["Switzerland", "South Korea"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": ["coldChain"],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Magistral formulation for a patient with multiple food allergy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A33.1",
    "authors": "Y Jiménez López, E Pérez Cano, M Merino Almazán, R Claramunt García, MI Sierra Torres, I Caba Porras",
    "institution": "Hospital Universitario De Jaén, Pharmacy Service, Jaén, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.72",
    "filters": {
      "actSubs": ["Iron", "Zinc", "Sirolimus"],
      "indication": ["Multiple Food Allergy (MFA)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Formulation and galenic characterisation of a tacrolimus adhesive gel for treatment of ulcerative proctitis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A33.2",
    "authors": "MF Pérez Almagro, C Perelló Alomar, MM Santandreu Estelrich, M Ortiz González, M Gómez Zamora, E Rodríguez Campos, B García García, FJ Cámara Aguilera, O Delgado Sánchez",
    "institution": "Hospital Universitario Son Espases, Hospital Pharmacy, Palma De Mallorca, Spain. Hospital Universitario Son Espases, Laboratory Medicine Department, Palma De Mallorca, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.73",
    "filters": {
      "actSubs": ["Tacrolimus"],
      "indication": ["Ulcerative Proctitis"],
      "statedClass": [],
      "typeOfMedical": ["Luer-Lock Syringes", "Rectal Cannulas"],
      "studyDesign": [],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Long term stability of a ready to use topical anaesthetic gel kit",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A34.1",
    "authors": "E Dijkers, H Polonini, A Ferreira, C Zander",
    "institution": "Global Innovation Project Manager, Fagron Bv, Rotterdam, The Netherlands. Ortofarma Analytical Services, Ortofarma Analytical Services, Matias Barbosa, Brazil. Fagron Inc, Fagron Inc, Saint Paul, USA",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.74",
    "filters": {
      "actSubs": ["Lidocaine hydrochloride", "Epinephrine bitartrate", "Tetracaine hydrochloride", "Sodium metabisulfite"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Prefilled Syringes"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High-Performance Liquid Chromatography - Ultraviolet (HPLC-UV)"],
      "studyLength": [],
      "country": ["Netherlands", "Brazil", "USA"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Compounding an oral liquid formulation of diazepam alcohol free",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A34.2",
    "authors": "R Barbosa, A Capela, C Sampaio, S Fraga, T Soares, J Campos, D Ferreira, P Costa, L Bighinati",
    "institution": "Centro Hospitalar E Universitário São João- Epe, Pharmacy, Oporto, Portugal. Faculdade De Farmácia Da Universidade Do Porto, Ucibio- Requimte-Pharmaceutical Tecnology, Oporto, Portugal. Universitá Degli Studi Di Modena E Reggio Emilia, Chimica E Tecnologia Farmaceutiche, Modena, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.75",
    "filters": {
      "actSubs": ["Diazepam"],
      "indication": ["Epilepsy"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["Portugal", "Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Paediatric drug resistant epilepsy: nitrazepam 1 mg/mL solutions to avoid clinical therapeutic error",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A35.1",
    "authors": "MA Berardi, GB Ortenzi, V Moretti, E Adresciani, AMF Garzone, S Cappanera, C Polidori, A Pompilio",
    "institution": "Università Degli Studi Di Camerino ‘Scuola Di Scienze Del Farmaco E Dei Prodotti Della Salute’, Facoltà Di Farmacia, Camerino, Italy. Ospedali Riuniti Di Ancona, Sod Farmacia Pediatrica Ospedale Pediatrico G Salesi, Ancona, Italy. Ospedali Riuniti Ancona, Sod Neuropsichiatria Infantile, Ancona, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.76",
    "filters": {
      "actSubs": ["Nitrazepam", "Levetiracetam", "Clobazam", "Topiramate"],
      "indication": ["Epilepsy (Drug-Resistant)", "Lennox–Gastaut Syndrome"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["International League Against Epilepsy Criteria", "High-Performance Liquid Chromatography - Ultraviolet (HPLC-UV)", "Triple Quadrupole Mass Spectrometer (QqQ MS)"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Analytical method validation to carry out physicochemical stability studies of methadone oral solutions",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A35.2",
    "authors": "EA Álvaro Alonso, MP Lorenzo García, FJ Rupérez Pascualena, A Aguilar Ros, P Tejedor Prado, A Lázaro Cebas, I Cañamares Orbis, S Esteban Casado, A Such Díaz, I Escobar Rodríguez",
    "institution": "Hospital Universitario Infanta Leonor, Pharmacy, Madrid, Spain. Universidad Ceu San Pablo, Pharmacy, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.77",
    "filters": {
      "actSubs": ["Methadone"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High-Performance Liquid Chromatography - Ultraviolet (HPLC-UV)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Current state of the anti-infective ophthalmic compounding formulation in pharmacy services: a national survey",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A36.1",
    "authors": "A Castro Balado, L Garcia-Quintanilla, C Mondelo-García, M González-Barcia, I Zarra-Ferro, A Fernández-Ferreiro",
    "institution": "Complejo Hospitalario Universitario De Santiago De Compostela, Hospital Pharmacist Service, Santiago De Compostela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.78",
    "filters": {
      "actSubs": ["Vancomycin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Autologous tissue adhesive in ophthalmological surgery",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A36.2",
    "authors": "S Berisa, M Medina Persinal, N Vazquez, M Chacon, J Merayo-Lloves, A Meana, L Fernandez-Vega Cueto-Felgueroso",
    "institution": "Instituto Oftalmológico Fernández Vega, Farmacia, Oviedo, Spain. Instituto Oftalmológico Fernández-Vega, Advanced Therapies and Regenerative Medicine, Oviedo, Spain. Instituto Universitario Fernández Vega, Advanced Therapies and Regenerative Medicine, Oviedo, Spain. Instituto Universitario Fernández Vega, Ophthalmology, Oviedo, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.79",
    "filters": {
      "actSubs": ["Human fibrinogen / Human thrombin"],
      "indication": [],
      "statedClass": ["Autologous Fibrin Tissue Adhesive"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Intracameral and intrastromal voriconazole administration in fusarium keratitis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A37.1",
    "authors": "S Gutiérrez Palomo, IM Moreno Escudero, A Rochina Astorga, A Quesada Asencio, L Peral Ballester, A Navarro Ruiz",
    "institution": "Hospital General Universitario De Elche, Pharmacy, Elche, Spain. Hospital General Universitario De Elche, Ophthalmology, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.80",
    "filters": {
      "actSubs": ["Voriconazole"],
      "indication": ["Fusarium Keratitis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Content uniformity of extemporaneous compounded suspensions",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A37.2",
    "authors": "E Dijkers, H Polonini, A Ferreira",
    "institution": "Global Innovation Project Manager, Fagron Bv, Rotterdam, The Netherlands. Ortofarma Analytical Services, Ortofarma Analytical Services, Matias Barbosa, Brazil",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.81",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Oral Liquid Vehicle Range"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High-Performance Liquid Chromatography - Ultraviolet (HPLC-UV)"],
      "studyLength": [],
      "country": ["Netherlands", "Brazil"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "93% oxygen self-production: experience in an Italian hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A38.1",
    "authors": "M Lecis, E Viglione, S Strobino, G Ceravolo",
    "institution": "Asl To3, Hospital Pharmacy, Rivoli, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.82",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Randomized Controlled Trial"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Case study: development of an ointment according to the Pharmaceutical Inspection Convention guideline",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A38.2",
    "authors": "L Pascual Masiá, E Rizkallal, M Machetti, C Lacasa, MI Calvo, F Martínez-Galán",
    "institution": "University of Navarra, Department of Pharmaceutical Technology and Chemistry, Pamplona, Spain. University of Navarra, Pharmacy Services-Clínica Universitaria De Navarra, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.83",
    "filters": {
      "actSubs": ["Phenylephrine hydrochloride", "Lidocaine hydrochloride", "Hydrocortisone"],
      "indication": ["Haemorrhoid"],
      "statedClass": ["Vasoconstrictors", "Local Anaesthetics", "Glucocorticoids"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Laboratory", "Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Sterility of single use vials when accessed using a closed system transfer device",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A39.1",
    "authors": "JA Schoenenberger Arnaiz, M Nevot-Blanc, A Moroba-Estor, M Gonzalez-Garcia, M Martinez-Sogues, M Gilabert-Sotoca",
    "institution": "Hospital Universitari Arnau De Vilanova, Pharmacy, Lleida, Spain. Hospital Universitari Santa Maria, Pharmacy, Lleida, Spain. Irblleida, Clinical Trials, Lleida, Spain. Hospital Universitari Arnau De Vilanova, Microbiology, Lleida, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.84",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Single Use Vials", "Closed System Drug-Transfer Device (CSTD)"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Physicochemical stability of the bevacizumab biosimilar, ABP 215, in intravenous bags after preparation and storage",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A39.2",
    "authors": "J Seckute, I Castellanos, S Bane",
    "institution": "Amgen, Process Development, Cambridge, Massachusetts, USA",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.85",
    "filters": {
      "actSubs": ["Bevacizumab"],
      "indication": [],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Size-Exclusion Chromatography (SEC)", "Capillary Electrophoresis", "Cation Exchange Chromatography", "Subvisible Particle Testing"],
      "studyLength": [],
      "country": ["USA"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Optimisation of mixing an oral powder mixture of codeine prepared in the hospital pharmacy for filling into hard capsules",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A40.1",
    "authors": "L Bouz, S Klovrzová, L Matysová",
    "institution": "Institute for Clinical and Experimental Medicine, Hospital Pharmacy, Prague, Czech Republic. Charles University-Faculty of Pharmacy, Department of Analytical Chemistry, Hradec Králové, Czech Republic",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.86",
    "filters": {
      "actSubs": ["Codeine"],
      "indication": ["Diarrhoea (Chronic)", "Irritable Bowel Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Spectrophotometry", "Relative Standard Deviation (RSD)"],
      "studyLength": [],
      "country": ["Czech Republic"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Galenic validation of a dexamethasone 0.01% mouthwash solution to prevent everolimus related stomatitis ",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A40.2",
    "authors": "J Vicente Valor, JL Herrero Revuelta, MS Pernia López, A Herranz Alonso, M Sanjurjo Sáez",
    "institution": "Gregorio Marañón University General Hospital, Pharmacy Service, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.87",
    "filters": {
      "actSubs": ["Everolimus", "Dexamethasone"],
      "indication": ["Stomatitis", "Breast Cancer (HR Positive / HER2 Negative Metastatic)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Surface contamination with cytotoxic drugs in European hospital wards",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A41.1",
    "authors": "E Korczowska, H Jankowiak-Gracz, M Crul, J Tuerk, D Arnold, K Meier",
    "institution": "University Hospital of Lord’s Transfiguration, Hospital Pharmacy, Poznan, Poland. Amsterdam University Medical Centre, Department of Clinical Pharmacology and Pharmacy, Amsterdam, The Netherlands. Institute of Energy and Environmental Technology, Iuta, Duisburg, Germany. Department of Medical Oncology, Klinik Für Tumorbiologie, Freiburg, Germany. Institute For Applied Healthcare Sciences, Ifahs, Hamburg, Germany",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.88",
    "filters": {
      "actSubs": ["Cyclophosphamide", "Florourasil (5-FU)", "Paclitaxel", "Gemcitabine"],
      "indication": [],
      "statedClass": ["Platinum Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Liquid Chromatography Tandem - Mass Spectrometry (LC–MS/MS)", "Inductively Coupled Plasma Mass Spectrometry (ICP-MS)"],
      "studyLength": [],
      "country": ["Poland", "Netherlands", "Germany"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "The significance of pharmacy preparation in paediatrics: making individual therapies for critically ill children possible",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A41.2",
    "authors": "B Verdino, K Nemec",
    "institution": "Donauspital, Hospital Pharmacy, Vienna, Austria",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.89",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Neonatal Intensive Care", "Paediatric Intensive Care"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Austria"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Hazardous drugs: impact of measures for safe handling",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A42.1",
    "authors": "S Buendía-Bravo, C Gastalver-Martin, AM Iglesias-Bolaños, C Capilla-Montes, T Cruz-Cruz",
    "institution": "Hospital Universitario Del Sureste, Pharmacy, Arganda Del Rey, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.90",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": ["selection"],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "In use physicochemical stability of pembrolizumab under the dilution condition required for use in a day hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A42.2",
    "authors": "M Piccoli, F Selmin, G Mangoni, L Camuffo, L Cancanelli, M Rivano, C Jemos, F Cilurzo, E Omodeo Salè",
    "institution": "Università Degli Studi Di Milano, Pharmaceutical Sciences, Milano, Italy. Istituto Europeo Di Oncologia, Hospital Pharmacy, Milano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.91",
    "filters": {
      "actSubs": ["Pembrolizumab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Polyolefin Infusion Bags"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Dynamic Light Scattering", "Size Exclusion Chromatography - High Performance Liquid Chromatography (SEC-HPLC)", "Nanoparticle Tracking Analysis (NTA)"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": ["flatDoses"],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Impact of the preparation of a clinical solution of rituximab 1.0 mg/mL on the particulates (aggregation) measured by dynamic light scattering: sodium chloride and glucose concentration, and agitation effect",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A43.1",
    "authors": "N Natalia-Iglesias, J Hermosilla, J Exposito, A Salmerón-Garcia, J Cabeza",
    "institution": "Science Faculty-Institute for Biomedical Research-University of Granada, Analytical Chemistry, Granada, Spain. San Cecilio University Hospital/Institute for Biomedical Research, Clinical Pharmacy, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.92",
    "filters": {
      "actSubs": ["Rituximab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Dynamic Light Scattering"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Parenteral nutrition admixtures: review of the microbiological sampling plan",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A43.2",
    "authors": "C Sampaio, A Capela, R Barbosa, S Fraga, T Soares, M Ribeiro, C Teixeira",
    "institution": "Centro Hospitalar Universitário São João, Pharmacy, 4200–319 Porto, Portugal. Centro Hospitalar Universitário São João, Clinical Pathology, 4200–319 Porto, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.93",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Study of the Trigon depot allergy test (triamcinolone and excipients: carboxymethylcellulose, polysorbate 80) developed in the pharmacy department",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A44.1",
    "authors": "P Pacheco, N Manresa-Ramón, MA Meroño-Saura, MÁ Carvajal-Sánchez, S Clavijos-Bautista, TM Rodríguez-Martínez, C Fernández-Zamora, J Ibañez-Caturla, AM Mora-González",
    "institution": "Hospital General Universitario Morales Meseguer, Pharmacy, Murcia, Spain. Hospital General Universitario Morales Meseguer, Allergology, Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.94",
    "filters": {
      "actSubs": ["Triamcinolone", "Docetaxel"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Importance of non-sterile formulation in a paediatric hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A44.2",
    "authors": "D Gavrus Ion, JM Català Foguet, M Sanchez Celma, JA Cuartero Lozano, M Villaronga Flaqué, R Farre Riba, F Bossacoma Busquets",
    "institution": "Hospital Sant Joan De Déu, Pharmacy, Esplugues De Llobregat, Spain. Hospital Sant Joan De Déu/Fundació Salut Empordà, Pharmacy, Esplugues De Llobregat, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.95",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Digestive System and Metabolism Drugs", "Blood and Haematopoietic Derivatives", "Cardiovascular Drugs", "Dermatological Drugs", "Hormonal Drugs", "Anti-Infective Drugs", "Antineoplastics and Immunomodulators", "Musculoskeletal System Drugs", "Nervous System Drugs", "Antiparasitics", "Respiratory System Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Imipenem–cilastatin fortified eye drops for the treatment of corneal ulcers caused by contact lenses: development and characterisation",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A45.1",
    "authors": "P Pacheco, N Manresa-Ramón, MÁ Carvajal-Sánchez, T Rodríguez-Martínez, MA Meroño-Saura, S Clavijos-Bautista, C Fernández-Zamora, J Ibañez-Caturla",
    "institution": "Hospital General Universitario Morales Meseguer, Pharmacy, Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.96",
    "filters": {
      "actSubs": ["Imipenem / Cilastatin"],
      "indication": ["Corneal Ulcer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": ["Emergency Department", "Ophthalmology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Importance of compounding in the paediatric hospital pharmacy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A45.2",
    "authors": "JM Català Foguet, D Gavrus Ion, M Sánchez Celma, M Villaronga Flaqué, R Farré Riba, F Bossacoma Busquets",
    "institution": "Hospital Sant Joan De Déu, Pharmacy, Esplugues De Llobregat, Spain. Hospital Sant Joan De Déu/Fundació Salut Empordà, Pharmacy, Esplugues De Llobregat, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.97",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Circuit to prepare and condition oral hazardous medicines",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A46.1",
    "authors": "A Benito Reyes, C Otero Villalustre, D Dorta Vera, D Fernández Vera, MÁ Perez Cruz, J Montoya Matellanes, E Dolz Bubbi, M Lobardero Pin",
    "institution": "Complejo Hospitalario Universitario Insular Materno Infantil, Pharmacy, Las Palmas De Gran Canaria, Spain. Hospital Universitario Araba Sede Txagorritxu, Pharmacy, Alava, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.98",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],  
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Hazardous medicines in a paediatric hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A46.2",
    "authors": "D Gavrus Ion, JM Català Foguet, A Diaz Cambron, MA Romo Murillo, J Vinent Genestar, R Farré Riba, F Bossacoma Busquets",
    "institution": "Hospital Sant Joan De Déu, Pharmacy Department, Esplugues Del Llobregat Barcelona, Spain. Hospital Sant Joan De Déu/Fundació Salut Empordà, Pharmacy Department, Esplugues Del Llobregat Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.99",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Impact of serialisation on reception of medicines and activity smoothing",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A47.1",
    "authors": "P Lacassagne",
    "institution": "Intern in Pharmacy, 31270, Cugnaux, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.100",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Sodium benzoate suspension in non-ketotic hyperglycinaemia: a case report",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A47.2",
    "authors": "S Inmaculada, F Valiente Borrego, M Muros, N Lucas, MA Sarabia, MA Rodriguez, J Ramos, I Alarcon",
    "institution": "Hospital De La Vega Lorenzo Guirao, Pharmacy, Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.101",
    "filters": {
      "actSubs": ["Sodium benzoate"],
      "indication": ["Nonketotic Hyperglycinemia"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": ["orphan"],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Magistral formulation of 10% sucralfate enemas in proctitis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A37.2",
    "authors": "A Gascón Villacampa, M Pio, M Marin, N Alzueta, D Perez, M Castresana",
    "institution": "Hospital Reina Sofia- Tudela, Pharmacy, Tudela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.82",
    "filters": {
      "actSubs": ["Sucralfate"],
      "indication": ["Proctitis", "Prostate Cancer", "Rectal Neoplasia", "Endometrial Neoplasia", "Iron Deficiency Anemia", "Diarrhoea"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["Less than 10"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Preliminary results on the use of oral rehydration solution in the form of gelato for rehydration of children with acute gastroenteritis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A38.1",
    "authors": "G Zvigule Neidere, A Barzdina, G Laizane, I Sviestina, K Gross",
    "institution": "Riga Stradins University, Paediatrics, Riga, Latvia. Riga Stradins University, Anaesthesiology and Intensive Care, Riga, Latvia. Children’s Clinical University Hospital, Infectology, Riga, Latvia. Children’s Clinical University Hospital, Pharmacy, Riga, Latvia. Riga Technical University, Faculty of Materials Science and Applied Chemistry, Riga, Latvia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.83",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Latvia"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Weight-lowering pseudoephedrine-based prescriptions: monitoring patient feedback after update of national price list of medicines and magistral preparation",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A38.2",
    "authors": "A Pirrone, V Marangon, AA Nisic, F Panzeri, L Cavallo, AL Manfredi, G Palmieri, MG Pizzonia, M Avantaggiato",
    "institution": "Universita Degli Studi di Milano, Scienze Farmaceutiche – Scuola di Specializzazione in Farmacia Ospedaliera, Milano, Italy. ATS Brianza, Pharmacy Service, Monza, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.84",
    "filters": {
      "actSubs": ["Pseudoephedrine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Community Pharmacy"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": ["More than 1000"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "What happens when insulin aspart is diluted in dextrose?",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A38.3",
    "authors": "LH Préta, H Henry, M Masse, N Carta, M Kouach, C Foulon, JF Goossens, D Lannoy, S Genay, B Decaudin, P Odou",
    "institution": "Université de Lille, EA 7365 – Grita – Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille, France. Université de Lille- Chu de Lille, EA 7365 – Grita – Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.85",
    "filters": {
      "actSubs": ["Insulin Aspart"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High-Performance Liquid Chromatography - Ultraviolet (HPLC-UV)", "High Performance Liquid Chromatography - Mass Spectrometry Detection (HPLC-MS)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Stability study of a 10% sodium benzoate oral solution",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A39.1",
    "authors": "A Castro Balado, A Bayón Fernández, I Adán Barrientos, JM Giráldez Montero, I Varela Rey, A Fernández Ferreiro, M González Barcia, I Zarra Ferro",
    "institution": "Clinical University Hospital Santiago de Compostela Sergas, Hospital Pharmacy Department, Santiago de Compostela, Spain. Faculty of Pharmacy- University of Santiago de Compostela USC, Pharmacy and Pharmaceutical Technology Department, Santiago de Compostela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.86",
    "filters": {
      "actSubs": ["Sodium benzoate"],
      "indication": ["Urea Cycle Defects (UCD)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Spectrophotometry"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Analysis of the regimens established at the pharmacy service for total parenteral nutrition and the use of glutamine as a source of nitrogen",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A39.2",
    "authors": "O Montero Pérez, P Selvi Sabater, A Peláez Bejarano, D Yáñez Feria, E Sánchez Gómez",
    "institution": "Hospital Juan Ramón Jiménez, Pharmacy Service, Huelva, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.87",
    "filters": {
      "actSubs": ["Glutamine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Critical Care Unit"],
      "numPatients": [],
      "numPrescriptions": ["More than 1000"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Implementation and quality control of a 5% fructose and 10% glycerol sterile solution for digestive endoscopy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A40.1",
    "authors": "M Roche, D Lannoy, C Nassar, F Bourdon, C Berneron, J Branche, P Odou",
    "institution": "CHRU Lille, Pharmacie, Lille Cedex, France. CHRU Lille, Maladies de L’Appareil Digestif, Lille Cedex, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.88",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High-Performance Liquid Chromatography - Ultraviolet (HPLC-UV)", "Kinetic Chromogenic Method", "Light Obscuration"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Physicochemical stability of norepinephrine bitartrate in polypropylene syringes at high concentrations for intensive care units",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A40.2",
    "authors": "E D’Huart, J Vigneron, B Demoré",
    "institution": "University Hospital of Nancy, Pharmacy, Vandoeuvre Lès Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.89",
    "filters": {
      "actSubs": ["Norepinephrine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Polypropylene Syringes"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)", "Spectrophotometry"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Successful treatment of hamartoma in child syndrome after 30 months with topical administration of simvastatin/cholesterol cream: a case report",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A41.1",
    "authors": "H Crametz, D Lannoy, B Catteau, V Foulon, C Nassar, M Roche, P Odou",
    "institution": "CHRU Lille, Pharmacie, Lille Cedex, France. CHRU Lille, Dermatologie, Lille Cedex, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.90",
    "filters": {
      "actSubs": ["Simvastatin / Cholesterol (TFSC)"],
      "indication": ["Epidermical Hamartoma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Stability of chlorhexidine 0.05% eye drops compounding drug",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A41.2",
    "authors": "S Berisa, L Macia, A Fernández, FJ Otero, X García",
    "institution": "Instituto Oftalmológico Fernández Vega, Pharmacy, Oviedo, Spain. Santiago de Compostela University, Pharmacy, Santiago de Compostela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.91",
    "filters": {
      "actSubs": ["Chlorhexidine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": ["preopMedication"],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Effectiveness of 3% topical imiquimod in off-label use for oral florida papillomatosis: a case report",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A42.1",
    "authors": "L Rendón de Lope, P Ruiz Huertas, C Donoso-Rengifo, M Murillo Izquierdo, C Castillo Martin, J Cordero Ramos, MD Alvarado Fernandez, M Fernandez Gonzalez, ML Moya Martin",
    "institution": "Hospital Universitario Virgen Macarena, Pharmacy, Seville, Spain. Hospital Universitario Virgen Macarena, Oral and Maxilofacial Surgery, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.92",
    "filters": {
      "actSubs": ["Imiquimod"],
      "indication": ["Papillomatosis (Oral Florid)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Topical cidofovir compounding cream for the treatment of disseminated infection by molluscum contagiosum",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A42.2",
    "authors": "R Barbosa, M Vieira, P Carinha, C Lisboa, N Gomes, M Costa-Silva",
    "institution": "Centro Hospitalar e Universitário São João- Epe, Pharmacy, Oporto, Portugal. Centro Hospitalar e Universitário São João- Epe, Dermatology Service, Oporto, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.93",
    "filters": {
      "actSubs": ["Cidofovir"],
      "indication": ["Molluscum Contagiosum", "Erythroderma (Severe)"],
      "statedClass": [],
      "typeOfMedical": ["Luer-Lock Syringes"],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Portugal"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Feedback from a feasibility study of allergy test preparations in day hospitalisation",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A42.3",
    "authors": "A Leleux, S Tombelle, F Danicourt",
    "institution": "Dunkerque Hospital Center, Pharmacy, Dunkerque, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.94",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Antibiotics", "Analgesics", "Local Anaesthetics", "Iodinated Contrast Products", "Non-Steroidal Anti-Inflammatory Drugs"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Dermatology", "Paediatrics", "Pneumology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Stability of 1 mg/ml and 4 mg/ml hydrocortisone solium succinate solutions in 0.9% sodium chloride and 5% glucose",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A43.1",
    "authors": "K Mihovec, R Roškar, &Zcaron; Temova Rakuša, EE Gaal",
    "institution": "UKC Ljubljana, Pharmacy, Ljubljana, Slovenia. University of Ljubljana- Faculty of Pharmacy, Biopharmaceutics and Pharmacokinetics, Ljubljana, Slovenia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.95",
    "filters": {
      "actSubs": ["Hydrocortisone"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["Slovenia"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Physicochemical stability of cefotaxime in polypropylene syringes at high concentrations for intensive care units",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A43.2",
    "authors": "E D’Huart, J Vigneron, F Blaise, A Charmillon, B Demoré",
    "institution": "University Hospital of Nancy, Pharmacy, Vandoeuvre Lès Nancy, France. University Hospital of Nancy, Infectious and Tropical Diseases Service, Vandoeuvre Lès Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.96",
    "filters": {
      "actSubs": ["Cefotaxime"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Polypropylene Syringes"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Physicochemical stability of vancomycin hydrochloride in polypropylene syringes at high concentrations for intensive care units",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A44.1",
    "authors": "E D’Huart, J Vigneron, A Charmillon, B Demoré",
    "institution": "University Hospital of Nancy, Pharmacy, Vandoeuvre Lès Nancy, France. University Hospital of Nancy, Infectious and Tropical Diseases Service, Vandoeuvre Lès Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.97",
    "filters": {
      "actSubs": ["Vancomycin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Polypropylene Syringes"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Physical compatibility of intravenous anti-infective drugs with medications commonly used in intensive care units",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A44.2",
    "authors": "E D’Huart, J Vigneron, B Demoré",
    "institution": "University Hospital of Nancy, Pharmacy, Vandoeuvre Lès Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.98",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Anti-Infective Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Observational Study", "Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Ultraviolet – Visible Spectrophotometry", "Turbidimetry"],
      "studyLength": ["Less than 3 months"],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": ["incompatibilities"],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Implementation of quality control of paediatric cytotoxic drug preparations: pilot trial with etoposide",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A45.1",
    "authors": "M Alami Chentoufi, I Bennani, M Benabbes, S Bennis, L Yachi, M Bouatia",
    "institution": "Mohamed V University, Faculty of Medicine and Pharmacy, Rabat, Morocco. Mohamed V University- Faculty of Medicine and Pharmacy, IBN Sina Hospital University Centre- Paediatric Hospital, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.99",
    "filters": {
      "actSubs": ["Etoposide"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Ultraviolet – Visible Spectrophotometry"],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Risk management of cross-contamination of paediatric anti-cancer preparations using failure mode and effects criticality analysis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A45.2",
    "authors": "M Alami Chentoufi, M Benabbes, S Bennis, L Yachi, I Bennani, A Cheikh, H Meftah, M Bouatia",
    "institution": "Mohamed V University, Faculty of Medicine and Pharmacy, Rabat, Morocco. Abulcasis University, Faculty of Pharmacy, Rabat, Morocco. Paediatric Hospital, IBN Sina Hospital University Centre, Rabat, Morocco. IBN Sina Hospital University Centre- Paediatric Hospital, University Mohamed V- Faculty of Pharmacy, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.100",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Failure Mode, Effects and Criticality Analysis (FMECA)"],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Nivolumab weight-based dosing vs flat dose economic analysis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A45.3",
    "authors": "C Bianconi, G Gandini, G Zanotti, M Dall’Ara, E Sterzi, R Barbazza, P Marini",
    "institution": "Azienda Ospedaliera Universitaria Integrata Verona, Hospital Pharmacy, Verona, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.101",
    "filters": {
      "actSubs": ["Nivolumab"],
      "indication": ["Melanoma", "Renal Cell Cancer", "Non-Small Cell Lung Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": ["flatDoses"],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Impact of a centralised intravenous additive service in patients and healthcare workers risk reduction",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A46.1",
    "authors": "Á Marcos Fendián, A Sancho Artés, P Llopis Salvia, M Climente Martí",
    "institution": "Hospital Universitario Doctor Peset, Pharmacy, Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.102",
    "filters": {
      "actSubs": ["Valproic acid"],
      "indication": [],
      "statedClass": ["Antibiotics", "Antiepileptics", "Analgesics", "Proton-Pump Inhibitors", "Corticosteroids"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Centralised Intravenous Additive Service"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": ["nutrition"],
      "highRisk": ["highRisk"],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Preliminary microbiological study of injectable chemotherapy dose-banding",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A46.2",
    "authors": "G Dozias, C Lambert, H Hugerot, B Rey-Rubio, C Loeuillet, N Mugnier, V Cogulet",
    "institution": "CHRU Brest, Pharmacy, Brest, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.103",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Turbidimetry"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": ["flatDoses"],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "A risk analysis method to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients’ safety",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A47.1",
    "authors": "B Marzal Alfaro, CG Rodríguez-González, V Escudero-Vilaplana, JL Revuelta-Herrero, S Ibáñez-Garcia, E García Martín, E González-Haba, I Iglesias-Peinado, A Herranz, M Sanjurjo-Saez",
    "institution": "Hospital General Universitario Gregorio Marañon, Pharmacy, Madrid, Spain. College of Pharmacy- Complutense University, Pharmacology Department, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.104",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Comparative Risk Assessment", "Failure Mode, Effects and Criticality Analysis (FMECA)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "The validation of control method: the gravimetric analysis in cytotoxic drug preparation",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A47.2",
    "authors": "L Nicolas, C Blanc, C Fercocq, L Baillet, R Linossier, JL Pons",
    "institution": "Centre Hospitalier Victor Dupouy, Pharmacy, Argenteuil, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.105",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Gravimetric Analysis"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Optimisation of compounding organisation after implementing a robotic system for automated preparation of oncologic drugs",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A48.1",
    "authors": "P Silimbani, M Tontini, L Moriconi, D Paolucci, M Federici, C Masini",
    "institution": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRST IRCCS, Oncology Pharmacy Unit, Meldola FC, Italy. Loccioni, Loccioni Humancare, Moie di Maiolati- Ancona AN, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.106",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "What is the best chemical decontamination solution for conventional anti-neoplastic drugs in a hospital compounding unit?",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A48.2",
    "authors": "N Simon, P Odou, B Decaudin, P Bonnabry, S Fleury-Souverain",
    "institution": "CHRU de Lille, Institut de Pharmacie, Lille Cedex, France. Hopitaux Universitaires de Geneve, Pharmacie, Geneve, Switzerland",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.107",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France", "Switzerland"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Productivity analysis of an automated compounding system for intravenous chemotherapy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A49.1",
    "authors": "AC Riestra, MJ Tames, O Olariaga, G Cajaraville",
    "institution": "Onkologikoa, Pharmacy, San Sebastián, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.108",
    "filters": {
      "actSubs": ["Paclitaxel"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Dose-banding gemcitabine and standardisation of chemotherapy protocols production",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A49.2",
    "authors": "C Tirone, S Bertoli, M Galassi, C Della Costanza, V Ladisa",
    "institution": "Fondazione Irccs Istituto Nazionale dei Tumori, Pharmacy, Milano, Italy. Universita’ Degli Studi di Milano, School of Hospital Pharmacy, Milano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.109",
    "filters": {
      "actSubs": ["Gemcitabine", "Bevacizumab", "Carboplatinum", "Cisplatinum", "Dacarbazine", "Docetaxel", "Oxaliplatinum"],
      "indication": ["Ovarian Carcinoma", "Cervical Cancer", "Endometrial Neoplasia", "Breast Cancer", "Non-Small Cell Lung Cancer", "Mesothelioma", "Biliopancreatic Cancer", "Uterine Leiomyosarcoma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Gynaecology", "Oncology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": ["flatDoses"],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Quality of gemcitabine ready to administer preparations",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A50.1",
    "authors": "R Trittler, H Reinhardt, MJ Hug",
    "institution": "University Medical Centre, Pharmacy, Freiburg, Germany. University Medical Centre, Haematology, Freiburg, Germany. University Medical Centre, Apotheke, Freiburg, Germany",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.110",
    "filters": {
      "actSubs": ["Gemcitabine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography with Diode-Array Detection (HPLC-DAD)", "Liquid Chromatography Mass Spectrometry (LC-MS)"],
      "studyLength": [],
      "country": ["Germany"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": ["flatDoses"],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Physical, chemical and microbiological stability of sirolimus 0.4% in topical formulations",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A50.2",
    "authors": "C Cortell, MA Martinez, C Molina, AC Cercos, M Climente, V Merino",
    "institution": "Hospital Doctor Peset, Pharmacy, Valencia, Spain. Universidad de Valencia, Pharmaceutical Technology, Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.111",
    "filters": {
      "actSubs": ["Sirolimus"],
      "indication": ["Facial Angiofibroma", "Tuberous Sclerosis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High-Performance Liquid Chromatography - Ultraviolet (HPLC-UV)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "The transition from the use of bupivacaine to ropivacaine in the delivery room, in order to achieve a better analgesic effect",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A51.1",
    "authors": "S Hadad, A Ataba, P Abecassis",
    "institution": "Rambam – Health Care Campus, Pharmaceutical Services – Pharmacy Director, Haifa, Israel. Rambam Medical Centre, Pharmacy Department, Haifa, Israel. Rambam Medical Centre, Anaesthesiolgy Department, Haifa, Israel",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.112",
    "filters": {
      "actSubs": ["Ropivacaine", "Bupivacaine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Israel"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": ["preopMedication"],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Low-dose morphine solution for spinal anaesthesia – ready to use to improve patient safety in drug therapy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A51.2",
    "authors": "K Lämmle, A Kirchhoff, P Hoffmann, S Amann",
    "institution": "München Klinik, Hospital Pharmacy, München, Germany. München Klinik, Klinik für Anästhesiologie- Operative Intensivmedizin und Schmerztherapie, München, Germany",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.113",
    "filters": {
      "actSubs": ["Morphine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography Reversed-Phase (RP-HPLC)"],
      "studyLength": [],
      "country": ["Germany"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": ["preopMedication"],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Labelling without strength for a pharmaceutical preparation used in a blinded dosage adjustment of clozapine",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A51.3",
    "authors": "C Giraudeau, J Jost, M Strumia, G Arnaud, P Brosset, V Ratsimbazafy",
    "institution": "Dupuytren University Hospital, Pharmacy, 87000 Limoges, France. Mother and Child Hospital, Paediatry, 87000 Limoges, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.114",
    "filters": {
      "actSubs": ["Clozapine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Imipenem-fortified eye drops for the treatment of bacterial keratitis: development and characterisation",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A52.1",
    "authors": "A Castro Balado, X García Otero, I Zarra Ferro, M González Barcia, FJ Otero Espinar, A Fernández Ferreiro",
    "institution": "Clinical University Hospital Santiago de Compostela Sergas, Hospital Pharmacy Department, Santiago de Compostela, Spain. Health Research Institute of Santiago de Compostela Idis, Clinical Pharmacology Group, Santiago Compostela, Spain. Faculty of Pharmacy- University of Santiago de Compostela USC, Pharmacology- Pharmacy and Pharmaceutical Technology Department, Santiago de Compostela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.115",
    "filters": {
      "actSubs": ["Imipenem"],
      "indication": ["Bacterial Keratitis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Spectrophotometry"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Galenic formulations for ophtalmologists: new formulations, prescribing pathways and patient information",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A52.2",
    "authors": "S Manzini, F Gradellini, C Polidori, G Borciani, L Fares",
    "institution": "Azienda Unità Sanitaria Locale – Irccs di Reggio Emilia, Hospital Pharmacy, Reggio Emilia, Italy. University of Camerino, Pharmacology, Camerino, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.116",
    "filters": {
      "actSubs": ["Amphotericin", "Cyclosporine", "Chlorhexidine", "Fluconazole", "Mitomycin C", "Tacrolimus", "Tobramycin", "Vancomycin", "Voriconazole"],
      "indication": [],
      "statedClass": ["Antibiotics", "Antimycotics", "Immune-Suppressors", "Immune-Modulators", "Oncologic Drugs"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Comparison of metabolite levels in serum and tears: implications for the dilution of autologous-serum-eye-drops",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A53.1",
    "authors": "D Wandel, C Steuer, JP Sigle, L Bernasconi, R Egger",
    "institution": "Kantonsspital Aarau, Pharmacy, Aarau, Switzerland. Kantonsspital Aarau, Clinical Chemistry and Clinical Immunology, Aarau, Switzerland. Stiftung Blutspende, SRK Aargau-Solothurn, Aarau, Switzerland",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.117",
    "filters": {
      "actSubs": [],
      "indication": ["Dry Eye Syndrome"],
      "statedClass": ["Autologous Serum Eye Drops"],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Liquid Chromatography Tandem - Mass Spectrometry (LC–MS/MS)"],
      "studyLength": [],
      "country": ["Switzerland"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Development of virtual drug information centre for pharmacy compounding area",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A53.2",
    "authors": "JA Montero Delgado, A Ferrer Machín, M Vera Cabrera, MC Jordán de Luna, L Díaz Díaz, I González García, MA Navarro Dávila, R Mesa Exposito, E Tevar Alfonso, MÁ Ocaña Gomez, FJ Merino Alonso",
    "institution": "Hospital Universitario Nuestra Señora de Candelaria, Hospital Pharmacy Department, Santa Cruz de Tenerife, Spain. Instituto Catalán de Oncología, Pharmacy Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.118",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": ["mobileVR"],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Stability study of (99MTC)dotatoc and (68GA)dotatoc in syringes",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A54.2",
    "authors": "S Chaïb, F Hallouard, C Darcissac, P Chennell, V Sautou, M Fraysse",
    "institution": "Groupe Hospitalier Sud-Hospices Civils de Lyon, Unité de Radiopharmacie- Service de Pharmacie, Pierre-Bénite, France. Université de Clermont Auvergne – CHU Clermont-Ferrand, CNRS- Sigma Clermont- ICCF, Clermont-Ferrand, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.120",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Nuclear Medicine"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": ["radiopharmaceuticals"],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Health hazards of raw materials used in the compounding of pharmaceuticals formulations",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A55.1",
    "authors": "EA Álvaro Alonso, P Tejedor Prado, E Izquierdo Garcia, A Such Diaz, A Lazaro Cebas, S Esteban Casado, I Cañamares Orbis, C Esteban Alba, A Santiago Perez, I Escobar Rodriguez",
    "institution": "Hospital Universitario Infanta Leonor, Pharmacy, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.121",
    "filters": {
      "actSubs": ["Atenolol", "Budesonide", "Diltiazem", "Spironolactone", "Phenobarbital", "Furosemide", "Phenol", "Boric Acid", "Dexamethasone", "Disodium tetraborate", "Triamcinolone", "Clobetasol", "Captoril"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Automation of parenteral nutrition compounding: results of gravimetric quality control before and after its implementation",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A55.2",
    "authors": "R Barbosa, S Nogueira, T Soares, S Fraga, A Silva, P Carinha",
    "institution": "Centro Hospitalar e Universitário São João- EPE, Pharmacy, Oporto, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.122",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Gravimetric Analysis"],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "A science- and risk-based strategy to qualify sterilised prefilled syringes as primary packaging material in a hospital pharmacy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A56.1",
    "authors": "K Beld, A Kuiper, S Van Berkel, H Robben, R Wijnsma, K Taxis, E Frijlink",
    "institution": "ISALA Hospital, Clinical Pharmacy, Zwolle, The Netherlands. University of Groningen, Unit of Pharmacotherapy- -Epidemiology and Pharmacoeconomics PTE2- Groningen Research Institute of Pharmacy, Groningen, The Netherlands. University of Groningen, Department of Pharmaceutical Technology and Biopharmacy, Groningen, The Netherlands",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.123",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Prefilled Syringes", "Cyclic Olefin Polymer (COP) Syringe"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Netherlands"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "New formulation of norepinephrine solution in prefilled cyclic olefin sterilised syringes",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A56.2",
    "authors": "K Beld, S Van Berkel, R Wijnsma, K Taxis, E Frijlink",
    "institution": "ISALA Hospital, Clinical Pharmacy, Zwolle, The Netherlands. University of Groningen, Unit of Pharmacotherapy- -Epidemiology and Pharmacoeconomics Pte2- Groningen Research Institute Of Pharmac, Groningen, The Netherlands. University of Groningen, Department of Pharmaceutical Technology and Biopharmacy, Groningen, The Netherlands",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.124",
    "filters": {
      "actSubs": ["Norepinephrine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Prefilled Syringes", "Cyclic Olefin Polymer (COP) Syringe"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography with Diode-Array Detection (HPLC-DAD)"],
      "studyLength": [],
      "country": ["Netherlands"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": ["incompatibilities"],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Paraffin oil-based emulsion: influence of gum arabic and the mixing rate on emulsion stability",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A56.3",
    "authors": "M Benabbes, M Alami Chentoufi, L Abdelkader",
    "institution": "Faculty of Medicine and Pharmacy- Mohammed V University of Rabat, Team of Formulation and Quality Control of Health Products- Faculty of Medicine and Pharmacy, Rabat, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.125",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["The Hydrophilic-Lipophilic Balance (HLB)"],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Formulation and stability study of extemporaneous oral liquid dosage forms containing flecainide acetate 2 mg/ml for paediatric use",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A57.1",
    "authors": "A Casiraghi, S Loiacono, S Bordignon, R Puzziferri, F Cilurzo, P Minghetti",
    "institution": "University of Milan, Department of Pharmaceutical Sciences- Specialisation School in Pharmacy, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.126",
    "filters": {
      "actSubs": ["Flecainide acetate"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["High Performance Liquid Chromatography (HPLC)"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Study of stability of two liquid formulations of omeprazole elaborated in the pharmaceutical service",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A57.2",
    "authors": "E Conesa Nicolás, AM Chica Marchal, AC Viney, S Nuñez Bracamonte, C Juez Santamaría, A Lloret Llorca, B Fernández-Lobato, CN García Matillas, M Martinez Penella",
    "institution": "Hospital General Universitario Santa Lucía, Servicio de Farmacia, Cartagena- Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.127",
    "filters": {
      "actSubs": ["Omeprazole"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Evaluation of the effectiveness and satisfaction of the master suspension formula for mucositis elaborated in a tertiary hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A58.1",
    "authors": "E Conesa Nicolás, AM Chica Marchal, AC Viney, S Nuñez Bracamonte, A Lloret Llorca, C Juez Santamaría, CN García Matillas, MS Garcia Simón, MDM Sanchez Catalicio",
    "institution": "Hospital General Universitario Santa Lucía, Servicio de Farmacia, Cartagena- Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.128",
    "filters": {
      "actSubs": ["Nystatin", "Methylprednisolone", "Mepivacaine", "Gentamicin"],
      "indication": ["Mucositis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Oral mucoadhesive dexamethasone 0.1% (m/m) gel: a strategy for motor inhibitors mucositis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A58.2",
    "authors": "AF Cosme Silva, A Castro, A Ferreira, H Luna Pais, V Rodrigues, JP Cruz, A Duarte, S Simões, C Eleuterio, AJ Almeida, J Marto",
    "institution": "Hospital de Santa Maria, Pharmacy and Paediatrics, Lisbon, Portugal. iMed Ulisboa, Pharmaceutics, Lisbon, Portugal. Hospital de Santa Maria, Pharmacy, Lisbon, Portugal. Hospital de Santa Maria, Oncology, Lisbon, Portugal. Hospital de Santa Maria, Pharmacy- Head of Department, Lisbon, Portugal. Faculdade de Farmácia da Universidade de Lisboa, Microbiology, Lisbon, Portugal. Faculdade de Farmácia da Universidade de Lisboa, Faculdade de Farmácia da Universidade de Lisboa, Lisbon, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.129",
    "filters": {
      "actSubs": ["Dexamethasone"],
      "indication": ["Mucositis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["5 months - 1 year"],
      "country": ["Portugal"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Mobile applications related to parenteral nutrition: qualitative and quantitative analysis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A59.1",
    "authors": "JT de Pourcq, JA Montero Delgado, M Gomis Pastor, C Fraile Clemente, FJ Merino Alonso",
    "institution": "Hospital de la Santa Creu I Sant Pau, Pharmacy Service, Barcelona, Spain. Hospital Universitario Nuestra Señora de Candelaria, Pharmacy Service, Santa Cruz de Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.130",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Mobile Application Rating Scale (MARS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": ["mobileVR"],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Application of hazard vulnerability analysis to evaluate potential risks of pharmacy compounding",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A59.2",
    "authors": "R Giammona, P Polidori",
    "institution": "IRCCS ISMETT, Clinical Pharmacy, Palermo, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.131",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Hazard Vulnerability Analysis"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Impact of ophthalmological preparations in the pharmacy service of a reference hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A60.1",
    "authors": "I Salar Valverde, N Manresa Ramon, M Gil Candel, M Onteniente Candela, C Pastor Mondejar, C Caballero Requejo, C Iniesta Navalon, M Garcia Coronel, E Urbieta Sanz",
    "institution": "Hospital General Universitario Reina Sofia, Hospital Pharmacy, Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.132",
    "filters": {
      "actSubs": ["Cyclosporine", "Vancomycin", "Ceftazidime", "Cefuroxime", "Aflibercept", "Bevacizumab"],
      "indication": [],
      "statedClass": ["Ophthalmological Medicines"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Chemical disinfectants vs sterile water and composite fibre: the effect of cleaning methods on microbial contamination in a class a pharmaceutical compounding environment",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A60.2",
    "authors": "E Gleditsch",
    "institution": "Sykehusapotekene HF – Oslo Hospital Pharmacy, Manufacturing, Oslo, Norway",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.133",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Norway"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "New formulations for the treatment of anti-neoplastic and radiotherapy-induced mucosites",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A61.1",
    "authors": "G Borciani, F Gradellini, C Polidori, S Manzini, G Sommese, L Fares",
    "institution": "Azienda Unità Sanitaria Locale – IRCCS di Reggio Emilia, Hospital Pharmacy, Reggio Emilia, Italy. University of Camerino, Pharmacology, Camerino, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.134",
    "filters": {
      "actSubs": ["Lidocaine hydrochloride", "Methylprednisolone", "Misoprostole", "Benzydamine", "Doxepin"],
      "indication": ["Mucositis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Added value from an information and communication technology- assisted intervention in a total parenteral unit of a paediatric hospital pharmacy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A61.2",
    "authors": "K Perdikouri, L Kouri, K Nikou, G Pegkas, D Gennimata",
    "institution": "Spiliopoulio Hospital, Hospital Pharmacy, Athens, Greece. Paediatric Hospital ‘Aglaia Kyriakou’, Hospital Pharmacy, Athens, Greece. General Hospital of Chest Diseases ‘Sotiria’, Hospital Pharmacy, Athens, Greece. Korgialeneio-Benakio Red Cross General Hospital, Hospital Pharmacy, Athens, Greece",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.135",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Greece"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Cytotoxic agents: skin tests for the diagnosis of drug hypersensitivity",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A61.3",
    "authors": "P Legendre, AC Bonnaure, R Bellay, MA Lester, PN Boivin",
    "institution": "CHU Rennes, Pharmacie, Rennes, France. CH Guillaume Regnier, Pharmacie, Rennes, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.136",
    "filters": {
      "actSubs": ["Docetaxel", "Pertuzumab", "Trastuzumab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Performance analysis of a fully automated oncology pharmacy production: a 2018 update",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A62.1",
    "authors": "S Leoni, MS de Meo, A Ortenzi, S Guglielmi, LL Borgiani, M Federici, D Paolucci, A Marinozzi",
    "institution": "Ospedali Riuniti Ancona, Hospital Pharmacy, Ancona, Italy. Loccioni Group, Humancare, Ancona, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.137",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Gravimetric Analysis", "Photographic Recognition"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Economic impact after the implementation of a risk matrix in the preparation of chemotherapy",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A62.2",
    "authors": "L López Esteban, M Hijazi-Vega, R Diez-Fernández, R Gardón-Pérez, MÁ Esteban-Pérez, I Bueno-Florido, A Cidoncha-Berlanga, M Labrador-Paniagua, T Molina-García",
    "institution": "Hospital Universitario de Getafe, Pharmacy Department, Getafe Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.138",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Risk Management Assessment Matrix"],
      "studyLength": ["Less than 3 months"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Robotic compounding: safety and productivity achievements in the preparation of hazardous drugs",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A63.1",
    "authors": "C Lopez-Cabezas, AM Marín, G Riu, C Codina, D Soy",
    "institution": "Hospital Clinic, Pharmacy, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.139",
    "filters": {
      "actSubs": ["Carboplatinum", "Cyclophosphamide", "Doxorubicin", "Epirubicin", "Florourasil (5-FU)", "Gemcitabine", "Irinotecan", "Oxaliplatinum", "Paclitaxel"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Failure Mode, Effects and Criticality Analysis (FMECA)", "Gravimetric Analysis"],
      "studyLength": ["5 months - 1 year"],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": ["automated"],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Use of extemporaneous oral suspensions of oxybutinin and prazosine in neonates",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A63.2",
    "authors": "R Claramunt García, CL Muñoz Cid, I Caba Porras, AM López-López, M Merino Almazán, Y Jimenez López, E Perez Cano, JF Marín Pozo",
    "institution": "Complejo Hospitalario de Jaén, Servicio de Farmacia, Jaén, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.140",
    "filters": {
      "actSubs": ["Oxybutinin", "Prazosine"],
      "indication": ["Primary Bladder Neck Obstruction"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Paediatrics"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Hot-melt ram extrusion 3D printing: a smart method for compounding orodispersible films in hospital pharmacies",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A64.1",
    "authors": "P Minghetti, UM Musazzi, F Selmin, GM Khalid, S Franzé, F Cilurzo",
    "institution": "University of Milan, Department of Pharmaceutical Sciences, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.141",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": ["Printing3D"],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Optimisation of intracameral cefuroxime consumption in the prevention of postoperative endophtalmitis",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A64.2",
    "authors": "J Poquet Jornet, JM del Moral-Sanchez, FJ Carrera-Hueso, C Cuesta-Grueso, A Munilla-Das",
    "institution": "Hospital of Denia, Pharmacy Department, Denia Alicante, Spain. Hospital DR. Moliner, Pharmacy Department, Serra Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.142",
    "filters": {
      "actSubs": ["Cefuroxime"],
      "indication": ["Endophtalmitis"],
      "statedClass": [],
      "typeOfMedical": ["Prefilled Syringes"],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Galenic preparation of 40% dextrose gel: new approach to management of neonatal hypoglycaemia",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A65.2",
    "authors": "M Rivano, C Veneziano, G Longobardo, M Albrecht",
    "institution": "IRCCS Ospedale San Raffaele, Pharmacy, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.144",
    "filters": {
      "actSubs": ["Dextrose"],
      "indication": ["Hypoglycaemia"],
      "statedClass": [],
      "typeOfMedical": ["Enteral Feeding Syringes"],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Newborn Intensive Care"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["5 months - 1 year"],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Feedback from lean management in a sterilisation unit",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A65.3",
    "authors": "H Roux, J Cantoni, MP Ponrouch, B Thaunay, A Giraudo, A Nguyen, A Jalabert",
    "institution": "Service de Stérilisation Centrale, Centre Hospitalier Universitaire de Montpellier, Montpellier, France. Service de Pharmacie, Centre Hospitalier de Montpellier, Montpellier, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.145",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Sterilisation Unit"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Kanban Board"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Orodispersible films – an interesting dosage form!",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A66.1",
    "authors": "S Sauer, L Kohl, L Veitinger, V Zink, T Hoppe-Tichy",
    "institution": "University Hospital Heidelberg, Pharmacy Department, Heidelberg, Germany",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.146",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Germany"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "PT-smell test: a novel hospital compounding and its clinical validation to diagnose olfactory dysfunction",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A66.2",
    "authors": "C Tovar Chaves, J Marto, M Santos, F Duarte-Ramos, R Bronze, L Antunes, A Alcobia, H Ribeiro",
    "institution": "Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal. Research Institute for Medicine and Pharmaceutical Science iMED.ULisboa, Faculdade de Farmácia- Universidade de Lisboa, Lisbon, Portugal. Hospital Garcia de Orta- E.P.E., Serviço de Otorrinolaringologia, Almada, Portugal. Faculdade de Farmácia da Universidade de Lisboa, Departamento de Sócio-Farmácia, Lisbon, Portugal. IBET, Apartado 12- 2781–901, Oeiras, Portugal. Hospital Garcia de Orta- E.P.E., Serviços Farmacêuticos, Almada, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.147",
    "filters": {
      "actSubs": [],
      "indication": ["Olfactory Dysfunction"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Fragrance Identification", "Barcelona Smell Test"],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Experience with the new direct acting antiviral agents in a third level hospital in 2018",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A47.3",
    "authors": "S Nuñez Bracamonte, MH García Lagunar, E Conesa Nicolás, A Lloret Llorca, C Juez Santamaría, CN García Matillas, I Fernández Martínez, JM Montoya Egea",
    "institution": "Hospital General Universitario Santa Lucía, Farmacia Hospitalaria, Cartagena, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.102",
    "filters": {
      "actSubs": ["Glecaprevir / Pibrentasvir", "Glecaprevir", "Pibrentasvir", "Elbasvir / Grazoprevir", "Elbasvir", "Grazoprevir", "Sofosbuvir / Velpatasvir", "Sofosbuvir", "Velpatasvir", "Ribavirin", "Ledipasvir / Sofosbuvir", "Ledipasvir", "Sofosbuvir / Velpatasvir / Voxilaprevir", "Voxilaprevir"],
      "indication": ["Hepatitis C (Chronic)"],
      "statedClass": ["Direct Acting Antivirals"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Anticholinergic burden in constipated patient admitted to an emergency department",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A48.1",
    "authors": "A Plaza Diaz, J Ruiz Ramos, A Juanes Borrego, M Blazquez Andion, L Lopez Vinardell, MA Mangues Bafalluy",
    "institution": "Hospital Sant Pau, Pharmacy, Barcelona, Spain. Hospital Sant Pau, Emergency Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.103",
    "filters": {
      "actSubs": [],
      "indication": ["Constipation", "Intestinal Obstruction"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Anticholinergic Burden Index", "STATA"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Liraglutide in chronic intestinal failure: overview and case report",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A48.2",
    "authors": "M Scaldaferri, E Castellana, M Ippolito, FD Merlo, U Aimasso, A De Francesco, F Cattel",
    "institution": "AOU Citta’ Della Salute E Della Scienza Di Torino, Pharmacy, Turin, Italy. AOU Citta’ Della Salute E Della Scienza Di Torino, Internal Medicine 3 U, Turin, Italy. AOU Citta’ Della Salute E Della Scienza Di Torino, Dietetics and Clinical Nutrition, Turin, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.104",
    "filters": {
      "actSubs": ["Liraglutide"],
      "indication": ["Short Bowel Syndrome with Intestinal Failure (SBS-IF)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Evaluation of the use of hydrocortisone, vitamin C and thiamine for the treatment of septic shock",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A49.1",
    "authors": "M Martín Cerezuela, E Sancho Ferrando, I Beltran Garcia, M Centelles Oria, E Villarreal Tello, M Gordon Sahuquillo, A Castellanos Ortega, P Ramirez Galleymore, JL Poveda Andres",
    "institution": "Hospital Universitario Y Politécnico La Fe, Pharmacy, Valencia, Spain. Hospital Universitario Y Politécnico La Fe, Icu, Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.105",
    "filters": {
      "actSubs": ["Hydrocortisone", "Thiamine", "Vitamin C"],
      "indication": ["Septic Shock"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Cohort Study", "Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["STATA"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Risk factors for persistence and tolerance of cow’s milk allergy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A49.2",
    "authors": "JM Giraldez Montero, G Duran Piñeiro, I Varela Rey, R Leis Trabazo, I Zarra Ferro",
    "institution": "Complejo Hospitalario Universitario De Santiago De Compostela, Pharmacy Department, Santiago De Compostela, Spain. Complejo Hospitalario Universitario De Santiago De Compostela, Paediatric Department, Santiago De Compostela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.106",
    "filters": {
      "actSubs": [],
      "indication": ["Cow's Milk Protein Allergy"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Gastroenterology", "Nutrition Unit"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Logistic Regression Analysis"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Use of ammonium tetrathiomolybdate in Wilson disease",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A50.1",
    "authors": "M Pomares Bernabeu, A Gonzalez Fernandez, M Ibañez Carrillo, AC Murcia Lopez, C Matoses Chirivella, A Navarro Ruiz",
    "institution": "Hospital General Universitario De Elche, Pharmacy, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.107",
    "filters": {
      "actSubs": ["Ammonium tetrathiomolybdate", "Trientine", "Zinc"],
      "indication": ["Wilson Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": ["orphan"],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Pharmaceutical care as a means of prevention against drug iatrogenesis: case of oral anticoagulants",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A50.2",
    "authors": "D Andre, C Chatain, MC Chaumais, A Rieutord, S Roy",
    "institution": "Antoine Béclère, 92140 Clamart, Clamart, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.108",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Oral Anticoagulants"],
      "typeOfMedical": [],
      "studyDesign": ["Interventional Study", "Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["5 months - 1 year"],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Risk factors associated with readmission to the emergency department in patients with previous gastrointestinal haemorrhage secondary to oral anticoagulant therapy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A51.1",
    "authors": "L López Vinardell, J Ruiz Ramos, A Juanes Borrego, M Puig-Campmany, MA Mangues Bafalluy",
    "institution": "Hospital De La Santa Creu I Sant Pau, Pharmacy, Barcelona, Spain. Hospital De La Santa Creu I Sant Pau, Emergency Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.109",
    "filters": {
      "actSubs": [],
      "indication": ["Gastrointestinal Haemorrhage", "Chronic Renal Failure", "Coagulation Disorder"],
      "statedClass": ["Direct Oral Anticoagulants", "Vitamin K Antagonists"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Multivariate Analysis"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Duration of dual antiplatelet therapy in coronary artery disease: is pharmacist intervention necessary to improve patient safety?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A51.2",
    "authors": "A Revuelta Amallo, M Alonso Diez, M Alvarez Lavin, E Ruiz De Velasco Artaza, J Fernandez Uria, A Aguirrezabal Arredondo",
    "institution": "Hospital Universitario De Basurto, Pharmacy, Bilbao, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.110",
    "filters": {
      "actSubs": [],
      "indication": ["Coronary Artery Disease", "Acute Coronary Syndrome"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["PRECISE-DAPT Score"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Safety and efficacy of low molecular weight heparins in patients with portal vein thrombosis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A52.1",
    "authors": "M Scaldaferri, E Rolle, C Zurlo, E Castellana, GM Saracco, F Cattel",
    "institution": "Citta’ Della Salute E Della Scienza Di Torino, Pharmacy, Turin, Italy. Citta’ Della Salute E Della Scienza Di Torino, Gastroenterology, Turin, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.111",
    "filters": {
      "actSubs": ["Nadroparin", "Enoxaparin", "Parnaparin"],
      "indication": ["Portal Vein Thrombosis", "Liver Cirrhosis", "Portal Hypertension", "Congestive Gastropathy", "Hepatocarcinoma", "Cavernoma", "Thrombocytopenia"],
      "statedClass": ["Low Molecular Weight Heparins"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Prescription analysis of direct acting oral anticoagulants",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A52.2",
    "authors": "I Soto, B Rubio, M Mañes, J Solis, B Bertran De Lis, EP Gómez, E Maroto, MI Bernias, I Sollano, I Morona, C Moriel",
    "institution": "Hospital Universitario De Móstoles, Hospital Pharmacy, Móstoles, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.112",
    "filters": {
      "actSubs": ["Apixaban", "Rivaroxaban", "Dabigatran", "Acenocoumarol"],
      "indication": ["Atrial Fibrillation", "Deep Vein Thrombosis", "Pulmonary Thromboembolism", "Gastritis"],
      "statedClass": ["Direct Oral Anticoagulants"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Longitudinal Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Cardiology", "Internal Medicine", "Geriatrics"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["5 months - 1 year"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Audit of oral anticoagulant prescribing; what has changed in 4 years?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A52.3",
    "authors": "J Tuthill, M Kieran, P Ging, C Meegan",
    "institution": "Mater Misericordiae University Hospital, Pharmacy Department, Dublin, Ireland",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.113",
    "filters": {
      "actSubs": ["Warfarin", "Apixaban", "Edoxaban", "Dabigatran", "Rivaroxaban"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Ireland"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": []
    }
  },
  {
    "title": "Effect of 2 mg intravenous phytonadione treatment on international normalised ratio in the hospitalised adult",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A53.1",
    "authors": "N Ramon, M Rosado Ancin, A Santaolalla Sanchez, C Valdazo Martin, A Larrabeiti Echevarria, JJ Garcia Albás, R Hernanz Chaves, C Martinez",
    "institution": "Hua, Service of Pharmacy, Vitoria-Gasteiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.114",
    "filters": {
      "actSubs": ["Phytonadione"],
      "indication": ["Elevated International Normalised Ratio"],
      "statedClass": ["Vitamin K Antagonists"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["STATA", "Pearson Correlation Coefficient"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Clinical and assisted impact of ischaemic ictus in patients treated with oral anticoagulants",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A53.2",
    "authors": "J Ruiz1, A Juanes Borrego, L López Vinardell, A Plaza Diaz, M Puig Campmany, MA Mangues Bafalluy",
    "institution": "Hospital Santa Creu I Sant Pau, Pharmacy, Barcelona, Spain. Hospital Santa Creu I Sant Pau, Emergency Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.115",
    "filters": {
      "actSubs": [],
      "indication": ["Atrial Fibrillation", "Stroke (Thromboembolic)", "Stroke (Cardioembolic)"],
      "statedClass": ["Oral Anticoagulants", "Vitamin K Antagonists", "Direct Oral Anticoagulants"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Modified Rankin Scale", "National Institutes of Health Stroke Scale"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Situational analysis of postoperative iron supplementation prescriptions in a plastic surgery department",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A54.1",
    "authors": "S Cesbron, P Gendre, P Nizet, C Letort, JF Huon, N Serandour, J Moquard, E Corbineau, AS Fanuel Remoue",
    "institution": "University Hospital, Pharmacy, Nantes, France. University Hospital, Plastic Surgery Department, Nantes, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.116",
    "filters": {
      "actSubs": ["Iron", "Ferric carboxymaltose", "Ferrous fumarate", "Ferrous sulphate"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Plastic Surgery"],
      "numPatients": [],
      "numPrescriptions": ["51 - 100"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": ["preopMedication"],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": []
    }
  },
  {
    "title": "Inappropriate use of human albumin in a teaching hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A54.2",
    "authors": "A Ben Cheikh Brahim, A Abbassi, R Khaireddine, E Bokri, H Dridi, Z Ouahchi",
    "institution": "Charles Nicolle Hospital of Tunis-Tunisia, Pharmacy, Tunis, Tunisia. ",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.117",
    "filters": {
      "actSubs": ["Human albumin"],
      "indication": ["Albuminaemia", "Nephrotic Syndrome"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Gastroenterology", "Paediatrics"],
      "numPatients": [],
      "numPrescriptions": ["101 - 500"],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Tunisia"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Efficacy and safety of tolvaptan in the treatment of polycystic kidney disease",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A55.1",
    "authors": "L Majuelos Aicart, L Lopez Bouzo, RM Damas Fuentes, C Otero Villalustre, L Oliva Hernandez, V Quesada Marques, DF Fernandez Vera",
    "institution": "Pharmacist, Hospital Pharmacy, Las Palmas De Gran Canaria, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.118",
    "filters": {
      "actSubs": ["Tolvaptan"],
      "indication": ["Polycystic Kidney Disease (Autosomal Dominant)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["STATA"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Efficacy of urea in the treatment of hyponatraemia in syndrome of inappropriate antidiuretic hormone secretion",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A55.2",
    "authors": "CY Perez, I Plasencia García, MÁ Ocaña Gómez, A Ferrer Machín, K Álvarez Tosco, J Merino Alonso, L Díaz Díaz, I González García, R Mesa Expósito, E Tévar Alfonso, M Vera Cabrera",
    "institution": "Hospital Universitario Nuestra Señora De La Candelaria, Farmacia Hospitalaria, San Cristobal De La Laguna, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.119",
    "filters": {
      "actSubs": ["Urea"],
      "indication": ["Hyponatraemia", "Inappropriate Antidiuretic Hormone Secretion"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Quasi-Experimental Design"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Shapiro–Wilk Test", "Analysis of Variance (ANOVA)", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Alirocumab and evolocumab: effectiveness after 3 years of follow-up in a real world setting",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A55.3",
    "authors": "C Alonso Martinez, P Sanchez-Sanchez, M Larrosa-Garcia, S Garcia-Garcia, M Miarons-Font, M Gomez-Domingo, I Cardona-Pascual, J Vidal-Otero, M Gorgas-Torner, C Alerany Pardo",
    "institution": "Vall D’hebron University Hospital, Pharmacy Service, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.120",
    "filters": {
      "actSubs": ["Alirocumab", "Evolocumab", "Atorvastatin", "Rosuvastatin", "Fluvastatin", "Pitavastatin", "Ezetimibe"],
      "indication": [],
      "statedClass": ["PCSK9 Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Use, efficacy and adherence to treatment with PCKS9 inhibitors in real clinical practice",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A56.1",
    "authors": "R Claramunt García, CL Muñoz Cid, A Sánchez Ruiz, AM López, E Pérez Cano, Y Jimenez López, J Jerez Rojas",
    "institution": "Hospital Universitario De Jaén, Pharmacy, Jaén, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.121",
    "filters": {
      "actSubs": ["Evolocumab", "Alirocumab"],
      "indication": ["Hypercholesterolaemia", "Cardiovascular Disease"],
      "statedClass": ["PCSK9 Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Medication Possession Ratio"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Alirocumab and evolocumab: results in clinical practice",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A56.2",
    "authors": "M Domínguez Bachiller, MI Barcia Martin, AM Gomez Pedrero, M Perez Encinas",
    "institution": "Hospital Universitario Fundación Alcorcon, Hospital Pharmacy, Alcorcon, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.122",
    "filters": {
      "actSubs": ["Alirocumab", "Evolocumab", "Ezetimibe"],
      "indication": ["Hyperlipidaemia"],
      "statedClass": ["PCSK9 Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Framingham Risk Score"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "PCSK9 inhibitors: evaluation of effectiveness in our centre in relation to the official clinical endpoints",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A57.1",
    "authors": "G Polito, F Ferrante, M Folcarelli, S Crescenzi",
    "institution": "Ospedale ‘F. Spaziani’, UO Farmacia, Frosinone, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.123",
    "filters": {
      "actSubs": ["Evolocumab", "Alirocumab"],
      "indication": ["Dyslipidaemia"],
      "statedClass": ["PCSK9 Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Cohort Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Long term efficacy, safety and adherence to alirocumab in patients with dyslipidaemia from a tertiary hospital cohort",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A57.2",
    "authors": "A Rodriguez, C Lopez, E González-Colominas, S Luque, L Recasens, J Pedro-Botet, A Oliveras, R Gonzalez, L Tarason, S Grau",
    "institution": "Hospital Del Mar, Pharmacy, Barcelona, Spain. Hospital Del Mar, Cardiology, Barcelona, Spain. Hospital Del Mar, Endocrinology, Barcelona, Spain. Hospital Del Mar, Nephrology, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.124",
    "filters": {
      "actSubs": ["Alirocumab"],
      "indication": ["Dyslipidaemia"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Common Terminology Criteria for Adverse Events", "Medication Possession Ratio"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Effectiveness of anti-interleukin-17 drugs in psoriasis in clinical practice",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A58.1",
    "authors": "A Retamero Delgado, C Seguí Solanes, V Charques Trallero, S Mendiola Garcia, N Rudi Sola, D Ferrandez Martí",
    "institution": "Consorci Sanitari De L’anoia, Pharmacy, Igualada, Spain. Hospital General De Granollers, Pharmacy, Granollers, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.125",
    "filters": {
      "actSubs": ["Secukinumab", "Ixekizumab", "Methotrexate", "Acitretin", "Ciclosporin"],
      "indication": ["Psoriasis"],
      "statedClass": ["Anti-Interleukin-17 Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Psoriasis Area and Severity Index (PASI)", "Dermatology Life Quality Index", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Dupilumab in the treatment of moderate to severe atopic dermatitis: case reports",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A58.2",
    "authors": "C Palomo-Palomo, MM Romero Alonso, D Guerra Estevez, M Barrera Ledesma, J Estaire Gutierrez",
    "institution": "Hospital Infanta Elena, Hospital Pharmacy, Huelva, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.126",
    "filters": {
      "actSubs": ["Dupilumab", "Cyclosporine", "Methotrexate"],
      "indication": ["Atopic Dermatitis"],
      "statedClass": ["Glucocorticoids", "Antihistamines"],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Eczema Area and Severity Index"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Dalbavancin off-label use: effectiveness and safety",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A59.1",
    "authors": "M Arrieta, JM Caro-Teller, S Ortiz-Pérez, C Rosas-Espinoza, MD Canales-Siguero, F Martínez De La Torre, JM Ferrari-Piquero",
    "institution": "Hospital Universitario 12 De Octubre, Pharmacy, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.127",
    "filters": {
      "actSubs": ["Dalbavancin"],
      "indication": ["Bacteraemia", "Endocarditis", "Osteomyelitis", "Septic Arthritis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Antibiotic therapy reassessment and its documentation: can virtual tools improve practices?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A59.2",
    "authors": "M Bonsergent, C Humbert, L Escaut, D Osman, A Barrail-Tran",
    "institution": "Chu Bicêtre, Pharmacy, 94270 Kremlin-Bicêtre, France. Chu Bicêtre, Infectious Diseases, 94270 Kremlin-Bicêtre, France. Chu Bicêtre, Medical Reanimation, 94270 Kremlin-Bicêtre, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.128",
    "filters": {
      "actSubs": ["Amoxicillin / Clavulanic acid"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": ["mobileVR"],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Experience of ceftaroline use in a third level hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A60.1",
    "authors": "D Canales, JM Caro Teller, F Martínez De La Torre, M Arrieta Loitegui, C Rosas, S Ortiz Pérez, JM Ferrari Piquero",
    "institution": "Hospital 12 De Octubre, Servicio De Farmacia, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.129",
    "filters": {
      "actSubs": ["Ceftaroline"],
      "indication": ["Bacteraemia", "Complicated Skin and Skin Structure Infections", "Pneumonia (Community Acquired)", "Catheter Associated Infections", "Endocarditis", "Pneumonia (Hospital Acquired)", "Osteomyelitis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Preliminary results of an antimicrobial stewardship programme in an oncology department",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A60.2",
    "authors": "C Castillo-Martin, A Martínez-Suarez, P Retamar-Gentil, S Sandoval-Fernandez Del Castillo, M Murillo-Izquierdo",
    "institution": "Hospital Universitario Virgen Macarena, Pharmacy, Seville, Spain. Hospital Universitario Virgen Macarena, Infectious Diseases, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.130",
    "filters": {
      "actSubs": ["Piperacillin / Tazobactam", "Amoxicillin / Clavulanic acid", "Ceftriaxone", "Levofloxacin", "Fluconazole"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Oncology"],
      "numPatients": [],
      "numPrescriptions": ["51 - 100"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": []
    }
  },
  {
    "title": "Incidence and risk factors for prosthetic joint infection within 90 days after hemiarthroplasty for femoral neck fractures in the elderly",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A61.1",
    "authors": "P Declercq, L Vanden Broeck, L Moons, I Du Bois, D Scherrenberg, I Spriet, A Sermon, WJ Metsemakers",
    "institution": "University Hospitals Leuven, Pharmaceutical and Pharmacological Sciences, Leuven, Belgium. University Hospitals Leuven, Department of Traumatology, Leuven, Belgium",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.131",
    "filters": {
      "actSubs": ["Cefazolin", "Clindamycin"],
      "indication": ["Prosthetic Joint Infection", "Femoral Neck Fractures"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["501 - 1000"],
      "numPrescriptions": [],
      "criteriaMethod": ["Cox Proportional Hazards Regression Analysis"],
      "studyLength": [],
      "country": ["Belgium"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": ["antibioticProphylaxis"],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Audit of antibiotic prophylaxis practice in visceral surgery in an African country",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A61.2",
    "authors": "DA Fiogbe, AM Dohou, CL Yehouenou, FMD Dossou, F Van Bambeke, O Dalleur",
    "institution": "Louvain Drug Research Institute Ldri-Université Catholique De Louvain Uclouvain, Clinical Pharmacy Research Group Clip, Brussels, Belgium. Université D’abomey Calavi Uac, Faculté Des Sciences De La Santé Fss, Cotonou, Benin. Centre National Hospitalier Et Universitaire De Pneumo-Phtisiologie De Cotonou, Laboratoire De Référence Des Mycobactéries Lrm, Cotonou, Benin. Centre Hospitalo-Universitaire Départementale Ouémé Plateau, Chirurgie, Porto-Novo, Benin. Louvain Drug Research Institute Ldri-Université Catholique De Louvain Uclouvain, Pharmacologie Cellulaire Et Moléculaire, Brussels, Belgium. Université Catholique De Louvain Uclouvain, Pharmacie-Clinique Universitaire Saint-Luc, Brussels, Belgium",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.132",
    "filters": {
      "actSubs": ["Ceftriaxone"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Visceral Surgery"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": ["3 months - 5 months"],
      "country": ["Belgium", "Benin"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": ["antibioticProphylaxis"],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": ["shortages"],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Antibiotic prescription through motivated request: clinical pharmacy tool to improve appropriateness and limit resistant bacterial strains. A follow-up after a year of monitoring in a local hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A62.1",
    "authors": "L Gambitta, S Campbell Davies, E Galfrascoli, E Calzavara, V Curci",
    "institution": "Asst Fatebenefratelli-Sacco-Fatebenefratelli and Ophthalmic Hospital, Hospital Pharmacy Operative Unit, Milan, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.133",
    "filters": {
      "actSubs": ["Ceftolozane / Tazobactam"],
      "indication": ["Urinary Tract Infection", "Respiratory Tract Infection", "Sepsis", "Surgical Site Infection"],
      "statedClass": ["Carbapenems"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": []
    }
  },
  {
    "title": "Off-label use of nebulised aztreonam lysine in patients with chronic gram negative bacterial lung colonisation",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A62.2",
    "authors": "S Garcia Garcia, I Cardona Pascual, E Revilla López, M Larrosa García, C Alonso Martinez, J Vidal Otero, C Alerany Pardo, L Cantos Gil, P Granollers Rabal, MR Gomez Domingo, JB Montoro Ronsano",
    "institution": "Vall D’hebron University Hospital, Hospital Pharmacy Department, Barcelona, Spain. Vall D’hebron University Hospital, Pneumology Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.134",
    "filters": {
      "actSubs": ["Aztreonam", "Tobramycin", "Colistin"],
      "indication": ["Cystic Fibrosis", "Bronchiectasis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Analysis of Variance (ANOVA)", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Is it possible to rationalise antibiotic use among hospitalised patients by clinical pharmacist activity?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A63.1",
    "authors": "Z Haleder, H Takács, G Soós",
    "institution": "Semmelweis University, University Pharmacy Department of Pharmacy Administration, Budapest, Hungary. Semmelweis University, Department of Dermatology-Venereology and Dermatooncology, Budapest, Hungary",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.135",
    "filters": {
      "actSubs": ["Ceftriaxone", "Piperacillin / Tazobactam", "Metronidazole", "Clarithromycin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Hungary"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": []
    }
  },
  {
    "title": "Clinical pharmacokinetics of vancomycin in neutropenic patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A63.2",
    "authors": "M Hijazi Vega, F Fernández-Fraga, I Gumiel-Baena, ME Martínez-Núñez, T Molina-García",
    "institution": "Hospital Universitario De Getafe Madrid, Pharmacy, Getafe, Spain. Hospital Universitario Puerta De Hierro Madrid, Pharmacy, Majadahonda, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.136",
    "filters": {
      "actSubs": ["Vancomycin"],
      "indication": ["Neutropenia"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Cockcroft–Gault Creatinine Clearance"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Pharmaceutical interventions in a small hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A64.1",
    "authors": "L Jimenez, E Lobo-Leon, C Puivecino-Moreno, R Gazquez-Perez, A Varas-Perez",
    "institution": "Hospital San Juan Grande, Pharmacy Hospital, Jerez De La Frontera Cadiz, Spain. Hospital San Juan Grande, Pharmacy Hospital, Cadiz, Spain. Hospital Sas Jerez, Pharmacy Hospital, Cadiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.137",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["5 months - 1 year"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Clinical outcome in paediatric intensive care unit patients treated with vancomycin",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A64.2",
    "authors": "A Khangtragool, K Sunkonkit, A Lucksiri, S Seetaboot",
    "institution": "Division of Pharmacy, Faculty of Medicine-Chiang Mai University, Chiang Mai, Thailand. Division of Pulmonary and Critical Care, Department of Paediatrics-Faculty of Medicine-Chiang Mai University, Chiang Mai, Thailand. Department of Pharmaceutical Care, Faculty of Pharmacy-Chiang Mai University, Chiang Mai, Thailand",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.138",
    "filters": {
      "actSubs": ["Vancomycin"],
      "indication": ["Septic Shock"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Paediatric Intensive Care"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Pediatric Index of Mortality (PIM) 2 Score"],
      "studyLength": [],
      "country": ["Thailand"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Stability to high temperatures of the antimicrobials used in outpatient parenteral antimicrobial therapy programmes",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A65.1",
    "authors": "M Mejias Trueba, L Herrera Hidalgo, JL Pérez Blanco, MV Gil Navarro, LE López Cortés, JM Carmona Caballero, R Luque Márquez",
    "institution": "Hospital Universitario Virgen Del Rocío, Hospital Pharmacy, Sevilla, Spain. Instituto De Biomedicina De Sevilla Ibis, Clinical Unit of Infectious Diseases-Microbiology and Preventive Medicine, Sevilla, Spain. Hospital Universitario Virgen Del Rocío, Pharmacy, Sevilla, Spain. Hospital Universitario Virgen Del Rocío, Clinical Unit of Infectious Diseases-Microbiology and Preventive Medicine, Sevilla, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.139",
    "filters": {
      "actSubs": ["Acyclovir", "Cefazolin", "Gentamicin", "Voriconazole", "Aztreonam", "Ampicillin", "Cefepime", "Ceftazidime", "Ceftriaxone", "Clindamycin", "Daptomycin", "Meropenem", "Piperacillin / Tazobactam", "Penicillin G", "Tobramycin", "Vancomycin", "Amphotericin", "Cloxacillin", "Ertapenem", "Foscarnet", "Fluconazole", "Ganciclovir", "Sulbactam", "Teicoplanin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Nosocomial infection by multiresistant pathogens in kidney transplant patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A65.2",
    "authors": "MJ Morales Lara, R Tamayo Bermejo, A Luna Higuera",
    "institution": "Hospital Regional Universitario Carlos Haya, Pharmacy, Malaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.140",
    "filters": {
      "actSubs": ["Basiliximab", "Mycophenolate", "Tacrolimus", "Thymoglobulin", "Ceftazidime", "Ciprofloxacin", "Ceftriaxone", "Meropenem", "Levofloxacin", "Piperacillin / Tazobactam", "Ceftazidime / Avibactam"],
      "indication": ["Nosocomial Infection", "Urinary Infection"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Adequacy of antibiotic prescriptions in a nursing home",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A66.1",
    "authors": "MR Cantudo Cuenca, BM Muñoz Cejudo, L Dani Ben Abdel-Lah, MA Mora Mora, JE Martínez De La Plata",
    "institution": "Hospital San Agustín Área De Gestión Sanitaria Norte De Jaén, Pharmacy, Linares, Spain. Agencia Pública Empresarial Sanitaria Hospital De Poniente, Pharmacy, El Ejido, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.141",
    "filters": {
      "actSubs": ["Amoxicillin / Clavulanic acid", "Fosfomycin", "Cloxacillin"],
      "indication": ["Urinary Tract Infection", "Skin and Soft Tissue Infection", "Respiratory Tract Infection (Lower)"],
      "statedClass": ["Quinolones", "Cephalosporins"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Charlson Comorbidity Index"],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": ["antibioticProphylaxis"],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": []
    }
  },
  {
    "title": "Pharmacist led antimicrobial stewardship programme",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A66.2",
    "authors": "MR Cantudo Cuenca, L Dani Ben Abdel-Lah, JE Martínez De La Plata, BM Muñoz Cejudo, M Mora Mora",
    "institution": "Hospital San Agustín Área De Gestión Sanitaria Norte De Jaén, Pharmacy, Linares, Spain. Agencia Pública Empresarial Sanitaria Hospital De Poniente, Pharmacy, Linares, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.142",
    "filters": {
      "actSubs": ["Cloxacillin", "Cefazolin"],
      "indication": [],
      "statedClass": ["Carbapenems", "Quinolones", "Antifungals (Systemic)", "Anti-MRSA (Methicillin-Resistant Staphylococcus aureus) Agents"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": ["antibioticProphylaxis"],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Pharmacist’s mission in infection management: evaluation of improvement actions",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A67.1",
    "authors": "C Muziotti, L Dol, MF Texier, S Chadapaud",
    "institution": "Centre Hospitalier D’hyeres, Hospital Pharmacy, Hyeres, France. Centre Hospitalier D’hyeres, Operational Hygiene Team, Hyeres, France. Centre Hospitalier D’hyeres, Infectious Disease Service, Hyeres, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.143",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Effectiveness of a new internal protocol for dosage of vancomycin in neonates",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A67.2",
    "authors": "M Ibáñez Carrillo, G Miralles Andreu, S Gutierrez Palomo, AM Sánchez García, AC Murcia López, A Navarro Ruiz",
    "institution": "Hospital General Universitario De Elche, Servicio De Farmacia, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.144",
    "filters": {
      "actSubs": ["Vancomycin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "The routine use of antibiotics after insertion of a cardiac implantable electronic device (CIED): evidence and current practice",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A68.1",
    "authors": "S Omran, O Mukhtar, S Mousa",
    "institution": "King Salman Armed Forces Hospital-Nwafh, Adult Intensive Care Unit, Tabuk, Saudi Arabia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.145",
    "filters": {
      "actSubs": [],
      "indication": ["Postoperative Infection", "Complete Heart Block", "Bacteraemia"],
      "statedClass": [],
      "typeOfMedical": ["Cardiac Implantable Electronic Device", "Permanent Pacemaker"],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Fisher’s Exact Test"],
      "studyLength": [],
      "country": ["Saudi Arabia"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Cost effectiveness analysis of meropenem dose optimisation in critical patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A68.2",
    "authors": "AI Idoate, A Aldaz, I Aquerreta, A Ortega",
    "institution": "Clinica Universidad De Navarra, Pharmacy, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.146",
    "filters": {
      "actSubs": ["Meropenem"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Propensity Score Matching"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Monitoring the prescription of new antibiotics: the work of the antimicrobial stewardship team in a third level hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A68.3",
    "authors": "E Sánchez-Yáñez, M Gómez Delgado, JL Ortiz Latorre, MR Mora-Santiago, I Moya-Carmona",
    "institution": "Hospital Universitario Virgen De La Victoria, Servicio De Farmacia, Málaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.147",
    "filters": {
      "actSubs": ["Ceftaroline", "Ceftolozane / Tazobactam", "Ceftazidime / Avibactam", "Dalbavancin", "Tedizolid", "Isavuconazole"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["10 - 50"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": []
    }
  },
  {
    "title": "Assessing the impact of antimicrobial stewardship programmes in hospitals: the role of pharmacists",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A69.1",
    "authors": "M Jaume Gaya, R Pérez Senoff, MS Sanz Parras, JM Saurina Gomila, A Rey Ferrin, Á García Álvarez, J Martinez Sotelo, PJ Siquier Homar, F Fernandez Cortes, A Vanrell Ballestero, M Pinteño Blanco",
    "institution": "Hospital Comarcal D’inca, Clinical Pharmacy, Inca, Spain. Hospital Comarcal D’inca, Intensive Care, Inca, Spain. Hospital Comarcal D’inca, Infectious Disease, Inca, Spain. Hospital Comarcal D’inca, Clinical Microbiology, Inca, Spain. Primary Care, Clinical Pharmacy, Inca, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.148",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["2 years - 5 years"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Beta-lactam antibiotics in critical ill patients: are we dosing our patients correctly?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A69.2",
    "authors": "M Núñez-Núñez, R Morón-Romero, R Álvarez-Sánchez, J García Villanova, N Chueca, S Portillo-Haro, E Yuste-Ossorio, J Cabeza-Barrera",
    "institution": "Farmacia Hospital San Cecilio, Pharmacy, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.149",
    "filters": {
      "actSubs": ["Meropenem", "Piperacillin"],
      "indication": [],
      "statedClass": ["Beta-Lactam Antibiotics"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Underdosing with high dose piperacillin/tazobactam administered via continuous infusion in outpatient parenteral antimicrobial therapy: a stability or viscosity problem?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A70.1",
    "authors": "C Quintens, I Spriet",
    "institution": "University Hospitals Leuven, Hospital Pharmacy, Leuven, Belgium",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.150",
    "filters": {
      "actSubs": ["Piperacillin / Tazobactam"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": ["Elastomeric Infusion Pumps"],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Spectrophotometry"],
      "studyLength": [],
      "country": ["Belgium"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": ["medicalDevices"],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Conformity of antibiotic therapy duration in patients with febrile neutropenia, hospitalised in the haematology department of a university hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A70.2",
    "authors": "M Ravey, S Robert, S Henard, B Demore",
    "institution": "Chru De Nancy, Pharmacie À Usage Intérieur, Vandoeuvre Les Nancy, France. Chru De Nancy, Maladies Infectieuses Et Tropicales, Vandoeuvre Les Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.151",
    "filters": {
      "actSubs": ["Cefepime", "Piperacillin / Tazobactam"],
      "indication": ["Neutropenia (Febrile)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Haematology"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Antibiotics in the emergency department: is it possible to improve prescriptions for infectious respiratory diseases in ambulatory patients?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A71.1",
    "authors": "P Ruiz Briones, R García Sánchez, C Ortega Navarro, MÁ Amor García, F García Moreno, A Melgarejo Ortuño, S García Sánchez, Á Narrillos Moraza, A Herranz Alonso, M Sanjurjo Saez",
    "institution": "Hospital General Universitario Gregorio Marañón, Pharmacy Department, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.152",
    "filters": {
      "actSubs": [],
      "indication": ["Respiratory Infection"],
      "statedClass": ["Antibiotics", "Quinolones", "Antibiotics (High Spectrum)"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Evaluation of piperacillin/tazobactam dosage in septic patients attending the emergency department",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A71.2",
    "authors": "J Ruiz, A Juanes Borrego, L López Vinardell, A Plaza Diaz, MA Mangues Bafalluy, M Puig Campmany",
    "institution": "Hospital Santa Creu I Sant Pau, Pharmacy, Barcelona, Spain. Hospital Santa Creu I Sant Pau, Emergency Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.153",
    "filters": {
      "actSubs": ["Piperacillin / Tazobactam"],
      "indication": ["Sepsis", "Bacteraemia (Gram Negative)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Simulation Study"],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Monte Carlo Simulation"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Antimicrobial stewardship programme in an intensive care unit",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A72.1",
    "authors": "E Sánchez Yañez, M Valera-Rubio, I Moya-Carmona, MR Mora-Santiago, C Pérez-López",
    "institution": "Hospital Clinico Virgen De La Victoria, Pharmacy Department, Malaga, Spain. Hospital Clinico Virgen De La Victoria, Infectious Disease, Malaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.154",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Carbapenems", "Antifungals"],
      "typeOfMedical": [],
      "studyDesign": ["Interventional Study", "Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["1 year - 2 years"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "A multidisciplinary and educational approach to antimicrobial stewardship programmes in the emergency department",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A72.2",
    "authors": "I Plo Seco, L Moreno Nuñez, S Sanz Márquez, E Zhan Zhou, J Valverde Canovas, Francisco, E Pérez Fernández, M Pérez Encinas",
    "institution": "Hospital Universitario Fundacion Alcorcón, Hospital Pharmacy, Alcorcon, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.155",
    "filters": {
      "actSubs": ["Meropenem", "Levofloxacin", "Amoxicillin / Clavulanic acid"],
      "indication": ["Pneumonia (Community Acquired)", "Respiratory Tract Infection", "Urinary Tract Infection"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Interventional Study"],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Evaluation of use, effectiveness and safety of isavuconazol",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A73.1",
    "authors": "CA Alonso Peralta, CM Valencia Soto, A Illaro Uranga, RM Gonzalez Franco, B Rogado Vegas, J Casanova Vázquez, P Del Rio Ortega, M Rioja Carrera, I Aragon Gracia, L Perez-Periañez Orillo, M Valero Domínguez",
    "institution": "Hospital Universitario Marqués De Valdecilla, Farmacia Hospitalaria, Santander, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.156",
    "filters": {
      "actSubs": ["Isavuconazole", "Voriconazole"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Proper use of antifungals: implementation of operational multidisciplinary teams dedicated to antifungals",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A73.2",
    "authors": "P Audureau, F Meyer, A Charmillon, S Henard, B Demore",
    "institution": "University Hospital Nancy-Brabois Adults Hospital, Pharmacy Department, Vandoeuvre-Lès-Nancy, France. University Hospital Nancy-Brabois Adults Hospital, Infectious and Tropical Diseases Department, Vandoeuvre-Lès-Nancy, France. Lorraine University, Ea 4360 Apemac, Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.157",
    "filters": {
      "actSubs": ["Caspofungin", "Posaconazole"],
      "indication": ["Candidiasis (Invasive)", "Aspergillosis (Pulmonary)"],
      "statedClass": ["Antifungals"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Haematology"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": ["501 - 1000"],
      "criteriaMethod": [],
      "studyLength": ["5 months - 1 year"],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": []
    }
  },
  {
    "title": "Therapeutic drug monitoring of voriconazole",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A74.1",
    "authors": "S Ruiz Boy, N Socoro-Yuste, C Bastida, D Soy-Muner",
    "institution": "Hospital Clínic, Pharmacy, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.158",
    "filters": {
      "actSubs": ["Voriconazole"],
      "indication": ["Invasive Fungal Infection", "Candidaemia"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Management of the hospitalised patient with flu",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A74.2",
    "authors": "M Mañes Sevilla, B Santiago-Gallego, I Soto-Baselga, C Moriel-Sánchez",
    "institution": "Hospital Universitario Mostoles, Pharmacy Department, Móstoles Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.159",
    "filters": {
      "actSubs": ["Oseltamivir", "Levofloxacin", "Ceftriaxone", "Amoxicillin / Clavulanic acid"],
      "indication": ["Influenza (Flu)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine", "Pneumology"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": []
    }
  },
  {
    "title": "Strategy for change in antiretroviral therapy: looking for better results",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A75.1",
    "authors": "P Barriga, P Pérez, S Arnaiz, C Caba, P Tena, JJ Duque, JA Sánchez, AM Dobrito, MR Garrido, LC Fernández",
    "institution": "Complejo Hospitalario Universitario De Cáceres, Hospital Pharmacy, Cáceres, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.160",
    "filters": {
      "actSubs": ["Emtricitabine", "Tenofovir disoproxil", "Rilpivirine", "Tenofovir alafenamide"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Prescription analysis of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in a third level hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A75.2",
    "authors": "A Caraffa, A Colicchio, L Gasperoni, G Selvetti, I Tommasini, E Zuccarini, M Mancini",
    "institution": "Azienda Ospedaliera Ospedali Riuniti Marche Nord, Uoc Farmacia, Pesaro, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.161",
    "filters": {
      "actSubs": ["Tenofovir disoproxil", "Tenofovir alafenamide", "Emtricitabine", "Elvitegravir", "Cobicistat", "Rilpivirine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["More than 1000"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": []
    }
  },
  {
    "title": "Adherence to antiretroviral treatment as a function of the complexity of the treatment",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A76.1",
    "authors": "J Romero, A Soria Martin, J Garcia Marin, M Fages, JR Avila Alvarez",
    "institution": "Hospital Punta De Europa, Pharmacy, Cadiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.162",
    "filters": {
      "actSubs": ["Emtricitabine", "Tenofovir disoproxil", "Efavirenz"],
      "indication": ["HIV"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Chi-Square (χ2) Test"],
      "studyLength": ["5 months - 1 year"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Patients with darunavir/cobicistat/emtricitabine/tenofovir alafenamide treatment in a third level hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A76.2",
    "authors": "R Gracia, JM Vinuesa, I Sanjoaquin, T Salvador, MDP Pardo, MA Alcácera, A Apesteguia, MJ Crusells, S Letona, M Gimeno-Gracia",
    "institution": "Hospital Clinico Universitario Lozano Blesa, Farmacia Hospitalaria, Zaragoza, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.163",
    "filters": {
      "actSubs": ["Darunavir / Cobicistat / Emtricitabine / Tenofovir alafenamide", "Darunavir", "Cobicistat", "Emtricitabine", "Tenofovir alafenamide"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["HIVTSQ - HIV Treatment Satisfaction Questionnaire"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Use of oseltamivir in the treatment of influenza A",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A76.3",
    "authors": "A Murgadella Sancho, B Gracia Garcia, L Losa Lopez, A Puebla Villaescusa, O Carrascosa Piquer, MT Barrera Puigdollers, N San Juan Martínez",
    "institution": "Hospital Moisès Broggi, Pharmacy, Sant Joan Despí, Spain. Hospital Dos De Maig, Pharmacy, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.164",
    "filters": {
      "actSubs": ["Oseltamivir"],
      "indication": ["Influenza A"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Adherence to antiretroviral treatment in patients with HIV",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A77.1",
    "authors": "C Notario Dongil, A Perez Fácila, B Proy Vega, MM Alañón Pardo, P Araque Arroyo, JC Valenzuela Gámez",
    "institution": "Hospital General La Mancha Centro, Servicio De Farmacia, Alcazar De San Juan, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.165",
    "filters": {
      "actSubs": [],
      "indication": ["HIV"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Switching to equivalent alternatives: antiretroviral optimisation strategy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A77.2",
    "authors": "B Proy Vega",
    "institution": "Hospital La Mancha Centro, Hospitalary Pharmacy, Alcazar De San Juan Ciudad Real, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.166",
    "filters": {
      "actSubs": ["Dolutegravir", "Abacavir", "Lamivudine", "Lamivudine / Abacavir", "Abacavir / Dolutegravir / Lamivudine", "Emtricitabine", "Tenofovir disoproxil", "Rilpivirine", "Emtricitabine / Tenofovir disoproxil / Rilpivirine", "Emtricitabine / Tenofovir disoproxil"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Changing from cobicistat to a ritonavir boosted regimen in HIV positive patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A78.1",
    "authors": "L Quesada-Muñoz, M Rodríguez Marín, M Vélez-Díaz-Pallarés, B Montero Llorente, T Gramage Caro, MÁ Rodríguez Sagrado, N Vicente Oliveros, S Sanz Merino, MT Bermejo Vicedo",
    "institution": "Ramón Y Cajal Hospital, Pharmacy, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.167",
    "filters": {
      "actSubs": ["Cobicistat", "Ritonavir", "Calcifediol", "Atorvastatin", "Omeprazole"],
      "indication": ["HIV"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Analysis of usage of direct acting antivirals for the treatment of hepatitis C",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A78.2",
    "authors": "MÁ Roch Ventura, J Del Estal Jiménez, A Sanjuan Belda, M Mendoza Aguilera, PA López Broseta, E Esteve Pitarch, M Martín Marqués, S Jornet Montaña, M Vuelta Arce, L Canadell Vilarrasa",
    "institution": "Hospital Universitari Joan Xxiii, Pharmacy, Tarragona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.168",
    "filters": {
      "actSubs": ["Glecaprevir / Pibrentasvir", "Glecaprevir", "Pibrentasvir", "Sofosbuvir / Velpatasvir", "Sofosbuvir", "Velpatasvir", "Elbasvir / Grazoprevir", "Grazoprevir", "Elbasvir", "Ombitasvir / Paritaprevir / Ritonavir", "Ombitasvir", "Paritaprevir", "Ritonavir", "Dasabuvir", "Ledipasvir / Sofosbuvir", "Ledipasvir", "Sofosbuvir / Velpatasvir / Voxilaprevir", "Voxilaprevir"],
      "indication": ["Hepatitis C"],
      "statedClass": ["Direct Acting Antivirals"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Effectiveness of dolutegravir and lamivudine therapy in a two drug regimen in a third level hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A79.1",
    "authors": "C Fernández Zamora, T Rodríguez Martínez, MA Meroño Saura, S Clavijos Bautista, J Plaza Aniorte, P Pacheco López, MÁ Carvajal Sánchez, J Ibáñez Caturla, MD Nájera Pérez",
    "institution": "Hospital Morales Meseguer, Farmacia Hospitalaria, Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.169",
    "filters": {
      "actSubs": ["Dolutegravir", "Lamivudine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Evaluation of palivizumab as prophylaxis against respiratory syncytial virus infection",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A79.2",
    "authors": "F Fernandez Fraga, P Lopez Mendez, A Lopez Garcia, N Ibañez Heras, T Molina Garcia",
    "institution": "Hospital Universitario De Getafe, Farmacia, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.170",
    "filters": {
      "actSubs": ["Palivizumab"],
      "indication": ["Respiratory Syncytial Virus Infection", "Respiratory Tract Infection"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Analysis of the use of non-specific intravenous immunoglobulins in a tertiary hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A80.1",
    "authors": "Z Rodríguez Fernández, E Martínez Álvarez, X Casas Fernández, A Vélez Blanco, N Álvarez Nuñez, JJ Ortiz De Urbina González",
    "institution": "León University Hospital, Hospital Pharmacy, León, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.171",
    "filters": {
      "actSubs": [],
      "indication": ["Immunodeficiency - Common Variable", "Immunodeficiency - Secondary", "Idiopathic Thrombocytopenic Purpura", "Polyneuropathy", "Myasthenia Gravis"],
      "statedClass": ["Intravenous Immunoglobulins (IVIg) - Non-Specific"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": []
    }
  },
  {
    "title": "Analysis of effectiveness: use of pertuzumab and trastuzumab in neoadjuvant treatment in patients with HER2 positive breast cancer and its correlation with plasma levels of trastuzumab",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A80.2",
    "authors": "R Álvarez Ambite, F Gutierrez Nicolas, I Ceballos Lezna, IJ Expósito Afonso, J González García, R Ramos Díaz, J Cruz Jurado, GJ Nazco Casariego",
    "institution": "Hospital Universitario De Canarias, Oncología Médica, Santa Cruz De Tenerife, Spain. Hospital Universitario De Canarias, Farmacia Hospitarlaria, Santa Cruz De Tenerife, Spain. Hospital Universitario De Canarias, Oncología Medica, Santa Cruz De Tenerife, Spain. Hospital Universitario De Canarias, Anatomia Patológica, Santa Cruz De Tenerife, Spain. Hospital Universitario De Canarias, Farmacia Hospitalaria, Santa Cruz De Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.172",
    "filters": {
      "actSubs": ["Pertuzumab", "Trastuzumab", "Adriamycin", "Cyclophosphamide"],
      "indication": ["Breast Cancer (HER2 Positive)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["ELISA Immunoassay"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Comparison of immune checkpoint inhibitors (nivolumab, pembrolizumab, atézolizumab and durvalumab) in the treatment of non-small cell lung cancer: tolerance and financial impact",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A81.1",
    "authors": "F Badibouidi, L Dupont, M Benchaabane, S Loutski",
    "institution": "Ghpso, Pharmacy, Creil, France. Ghpso, Oncology, Creil, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.173",
    "filters": {
      "actSubs": ["Nivolumab", "Pembrolizumab", "Atezolizumab", "Durvalumab"],
      "indication": ["Non-Small Cell Lung Cancer", "Pneumonitis"],
      "statedClass": ["Immune Checkpoint Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["1 year - 2 years"],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Effectiveness and safety of platin/permetrexed combination in non-small cell lung cancer",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A81.2",
    "authors": "EM Barreiro Fernandez, C Martinez-Diaz, FJ Salmeron-Navas, M Dominguez-Cantero, S Fenix-Caballero",
    "institution": "Hospital Universitario Puerto Real, Servicio De Farmacia, Cadiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.174",
    "filters": {
      "actSubs": ["Platin", "Pemetrexed", "Cisplatinum", "Carboplatinum"],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Kaplan-Meier Method", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Cyclin dependent kinase 4/6 inhibitors in breast cancer: potential drug interactions",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A81.3",
    "authors": "MI Bernias Domínguez, M Mañes Sevilla, PM Bernias Domínguez, MJ Vazquez Castillo, C Moriel Sánchez",
    "institution": "Hospital Universitario De Móstoles, Hospital Pharmacy, Madrid, Spain. Fremap, Medicine, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.175",
    "filters": {
      "actSubs": ["Palbociclib", "Ribociclib"],
      "indication": ["Breast Cancer"],
      "statedClass": ["Cyclin-Dependent Kinases 4/6 Inhibitors", "Statins", "Proton-Pump Inhibitors", "Antidepressants", "Pyrazolones"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Ibrutinib associated atrial fibrillation: incidence and management in the real life clinical setting",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A82.1",
    "authors": "S Blanco-Dorado, A Mosquera-Torre, E López-Montero, M Touris-Lores, B Bernardez Ferran, I Zarra-Ferro",
    "institution": "Complejo Hospitalario Universitario De Santiago De Compostela, Pharmacy Department, Santiago De Compostela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.176",
    "filters": {
      "actSubs": ["Ibrutinib", "Apixaban", "Rivaroxaban", "Amiodarone"],
      "indication": ["Atrial Fibrillation", "Arrhythmia"],
      "statedClass": ["Low Molecular Weight Heparins", "Beta-Blockers"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Indirect comparison between pembrolizumab monotherapy and pembrolizumab chemotherapy regimens in squamous lung cancer",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A82.2",
    "authors": "MDP Briceño Casado, MD Gil-Sierra, S Fenix-Caballero, M Dominguez-Cantero, EJ Alegre-Del Rey",
    "institution": "Hospital Universitario Puerto Real, Hospital Pharmacy, Cadiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.177",
    "filters": {
      "actSubs": ["Pembrolizumab"],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Bucher's Method"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Detection and communication of concomitant use of capecitabine and proton pump inhibitors",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A83.1",
    "authors": "AB Guisado Gil, IM Carrión Madroñal, E Sánchez Gómez, MD Santos Rubio",
    "institution": "Hospital Juan Ramón Jiménez, Ugc Farmacia, Huelva, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.178",
    "filters": {
      "actSubs": ["Capecitabine", "Omeprazole", "Pantoprazole", "Esomeprazole", "Rabeprazole"],
      "indication": ["Colorectal Cancer", "Gastric Cancer", "Oesophageal Cancer", "Breast Cancer", "Pancreatic Cancer"],
      "statedClass": ["Proton-Pump Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Effectiveness and safety of eribulin for advanced breast cancer treatment",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A83.2",
    "authors": "I Cavada Carranza, M Carrasco Gomariz, M Moreno Garcia, R Diez Fernandez, T Molina Garcia",
    "institution": "Hospital Universitario De Getafe, Pharmacy Department, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.179",
    "filters": {
      "actSubs": ["Eribulin"],
      "indication": ["Breast Cancer (Advanced)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Sequencing of ibrutinib, idelalisib and venetoclax in chronic lymphocytic leukaemia: experience in a tertiary hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A84.1",
    "authors": "R García-Fumero, C Alarcón-Payer, A Jiménez-Morales, MDM García-Valdés, JM Puerta-Puerta, R Claramunt García",
    "institution": "Hospital Universitario Virgen De Las Nieves, Pharmacy, Granada, Spain. Hospital Universitario De Jaén, Pharmacy, Jaén, Spain. Hospital Universitario Virgen De Las Nieves, Haematology, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.180",
    "filters": {
      "actSubs": ["Ibrutinib", "Idelalisib", "Venetoclax"],
      "indication": ["Leukaemia (Chronic Lymphocytic)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": []
    }
  },
  {
    "title": "Real life tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukaemia",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A84.2",
    "authors": "C Alarcon-Payer1, JM Puerta Puerta2, A Jiménez Morales3, R Claramunt García, F Horno Ureña",
    "institution": "Hospital Universitario De Jaén, Servicio De Farmacia, Jaén, Spain. Hospital Universitario Virgen De Las Nieves, Servicio De Haematología, Granada, Spain. Hospital Universitario Virgen De Las Nieves, Servicio De Farmacia, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.181",
    "filters": {
      "actSubs": ["Imatinib", "Nilotinib", "Dasatinib"],
      "indication": ["Leukaemia (Chronic Myeloid)"],
      "statedClass": ["Tyrosine Kinase Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Real-Time Polymerase Chain Reaction"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Gefitinib in non-small cell lung cancer: effectiveness and safety",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A85.1",
    "authors": "JC Del Río Valencia, A Henares López, R Tamayo Bermejo, I Muñoz Castillo",
    "institution": "Hospital Regional Universitario Malaga, Servicio De Farmacia, Malaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.182",
    "filters": {
      "actSubs": ["Gefitinib"],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Response Evaluation Criteria In Solid Tumours (RECIST)", "Kaplan-Meier Method"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Risk of myelotoxicity in non-cancer patients treated with chemotherapy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A85.2",
    "authors": "R Diez Fernandez, I Cavana Carranza, M Carrasco Gomariz, M Moreno Garcia, T Molina Garcia",
    "institution": "Hospital Universitario Getafe, Pharmacy, Madrid, Spain. Hospital Universitario De Getafe, Pharmacy, Getafe, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.183",
    "filters": {
      "actSubs": ["Cyclophosphamide"],
      "indication": ["Myelotoxicity", "Systemic Lupus Erythematosus", "Neutropenia", "Thrombocytopenia"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Common Terminology Criteria for Adverse Events"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Safety and tolerability of palbociclib in clinical practice in a tertiary hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A86.1",
    "authors": "J Fernández Fradejas, L Quesada-Muñoz, M Vélez-Díaz-Pallarés, E Vida Navas, A Cortés Salgado, A Cabello Bravo, T Bermejo Vicedo",
    "institution": "Hospital Universitario Ramón Y Cajal, Pharmacy, Madrid, Spain. Hospital Universitario Ramón Y Cajal, Oncology, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.184",
    "filters": {
      "actSubs": ["Palbociclib", "Fulvestrant"],
      "indication": [],
      "statedClass": ["Aromatase Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Cohort Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Common Terminology Criteria for Adverse Events", "Eastern Cooperative Oncology Group (ECOG) Performance Status"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Anthracycline dosage in paediatric obese patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A86.2",
    "authors": "B Fernandez Garcia, C Fraile Rodriguez, X Abasolo Tamayo, I Herrero Corell, M Serrano Alonso, MÁ García-Del-Barrio",
    "institution": "Clinica Universidad De Navarra, Pharmacy, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.185",
    "filters": {
      "actSubs": ["Daunorubicin", "Doxorubicin", "Epirubicin", "Idarubicin"],
      "indication": [],
      "statedClass": ["Anthracyclines"],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Improved access to chemotherapeutic treatment in patients with multiple myeloma",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A87.1",
    "authors": "EG Fernández López, MM Viña Romero, J Merino Alonso, JA De Leon Gil, I Gonzalez Perera, JA Martin Conde",
    "institution": "Hospital Nuestra Señora De Candelaria, Hospital Pharmacy, Santa Cruz De Tenerife, Spain. Santa Cruz De Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.186",
    "filters": {
      "actSubs": ["Bortezomib", "Thalidomide", "Prednisone", "Melphalan", "Dexamethasone", "Daratumumab", "Lenalidomide"],
      "indication": ["Multiple Myeloma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Imatinib dose optimisation through therapeutic monitoring in chronic myeloid leukaemia as part of pharmaceutical care",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A87.2",
    "authors": "C Fernandez Oliveira, E Fernández Gabriel, M Outeda Macías, MS Noya Pereira, I Martín Herranz",
    "institution": "Complexo Hospitalario Universitario A Coruña, Pharmacy Service, A Coruna, Spain. Complexo Hospitalario Universitario A Coruña, Haematology Service, A Coruna, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.187",
    "filters": {
      "actSubs": ["Imatinib"],
      "indication": ["Leukaemia (Chronic Myeloid)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Optimisation of resources in the use of immunotherapy: nivolumab and pembrolizumab weight based dosing instead of flat dose",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A88.1",
    "authors": "I Lomares Manzano, MJ Martinez Bautista, A Ganfornina Andrades, MV Manzano Martin",
    "institution": "Hospital Universitario Puerta Del Mar, Servicio De Farmacia Hospitalaria, Cádiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.188",
    "filters": {
      "actSubs": ["Nivolumab", "Pembrolizumab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": ["flatDoses"],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Checkpoint inhibitors in non-microcytic lung cancer: results in common clinical practice",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A88.2",
    "authors": "A Magallon Martinez, MJ Agustín Ferrández, A Pinilla Rello, A Escolano Pueyo, O Pereira Blanco, L Cazorla Poderoso, M Perez Moreno, A Casajús Navasal, R Abaz Sazatornil",
    "institution": "Universitary Miguel Servet Hospital, Hospital Pharmacy, Zaragoza, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.189",
    "filters": {
      "actSubs": ["Nivolumab", "Pembrolizumab", "Atezolizumab", "Pemetrexed", "Carboplatinum"],
      "indication": ["Non-Small Cell Lung Cancer", "Adenocarcinoma", "Squamous Cell Carcinoma", "Large Cell Carcinoma"],
      "statedClass": ["Immune Checkpoint Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Eastern Cooperative Oncology Group (ECOG) Performance Status", "Kaplan-Meier Method"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Comparative effectiveness of nintedanib plus docetaxel versus docetaxel monotherapy in adenocarcinoma non-small cell lung cancer",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A89.1",
    "authors": "M Merino Almanzan, JM Duarte Perez, JF Marin Pozo, R Claramunt Garcia, CL Muñoz Cid, I Caba Porras",
    "institution": "Complejo Hospitalario Jaen, Hospital Pharmacy, Jaén, Spain. University of Granada, Pharmacology, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.190",
    "filters": {
      "actSubs": ["Nintedanib", "Docetaxel"],
      "indication": ["Adenocarcinoma", "Non-Small Cell Lung Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Kaplan-Meier Method", "Cox Proportional Hazards Regression Analysis", "Eastern Cooperative Oncology Group (ECOG) Performance Status"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Efficacy and safety of erlotinib in non-small cell lung cancer",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A89.2",
    "authors": "E Monteagudo Santolaya, M Prieto Castello, L Cebrián Lara, R Colom Moreno, A Sánchez Alcaraz",
    "institution": "Hospital Universitario De La Ribera, Clinical Pharmacy, Alzira, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.191",
    "filters": {
      "actSubs": ["Erlotinib"],
      "indication": ["Non-Small Cell Lung Cancer (EGFR-Mutated)", "Adenocarcinoma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Karnofsky Performance Status Scale"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Evaluation of aggressiveness of cancer care near the end of life in patients with pancreatic cancer",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A89.3",
    "authors": "S Martínez-Pérez, M Llinares-Esquerdo, G Miralles-Andreu, S Gutierrez-Palomo, A Garcia-Monsalve, A Navarro Ruiz",
    "institution": "Hospital General Universitario De Elche, Pharmacy, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.192",
    "filters": {
      "actSubs": [],
      "indication": ["Pancreatic Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Oncology", "Intensive Care", "Palliative Care"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Eastern Cooperative Oncology Group (ECOG) Performance Status"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Evaluation of aggressiveness of cancer care near the end of life in patients with metastatic non-microcytic lung cancer",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A90.1",
    "authors": "M Llinares-Esquerdo, S Martínez-Pérez, M Pomares-Bernabeu, IP Jiménez-Pulido, L Sorian-Irigaray, A Navarro Ruiz",
    "institution": "Hospital General Universitario De Elche, Pharmacy, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.193",
    "filters": {
      "actSubs": [],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Palliative Care", "Intensive Care"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Eastern Cooperative Oncology Group (ECOG) Performance Status"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Effectiveness of dexamethasone mouthwash 0.1 mg/mL for prevention of everolimus related stomatitis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A90.2",
    "authors": "S Martínez-Pérez, M Llinares-Esquerdo, S Gutierrez-Palomo, IP Jimenez-Pulido, A Garcia-Monsalve, A Navarro Ruiz",
    "institution": "Hospital General Universitario De Elche, Pharmacy, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.194",
    "filters": {
      "actSubs": ["Dexamethasone", "Everolimus", "Exemestane"],
      "indication": ["Stomatitis", "Breast Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Characterisation of potential drug–drug interactions in oncological patients treated with oral anticancer drugs",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A91.1",
    "authors": "M Pomares Bernabeu, G Miralles Andreu, S Martinez Perez, A Garcia Monsalve, C Matoses Chirivella, A Navarro Ruiz",
    "institution": "Hospital General Universitario De Elche, Pharmacy, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.195",
    "filters": {
      "actSubs": ["Allopurinol"],
      "indication": [],
      "statedClass": ["Corticosteroids", "Proton-Pump Inhibitors", "Antiplatelets", "Oral Anticoagulants"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"]
    }
  },
  {
    "title": "Reviewing the latest clinical research for treating advanced non-small cell lung cancer: selection of randomised controlled trials published in 2018",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A91.2",
    "authors": "R García-Fumero, C Fernández-López, J Expósito-Hernández, S Portillo-Haro, MÁ Calleja-Hernández",
    "institution": "Hospital Universitario Virgen De Las Nieves, Department of Pharmacy, Granada, Spain. Biosanitary Institute of Granada Ibs Granada, Sas-Universidad De Granada, Granada, Spain. Catalan Institute of Oncology, Department of Pharmacy, Barcelona, Spain. Hospital Universitario Virgen De Las Nieves, Department of Oncology, Granada, Spain. Hospital Universitario San Cecilio, Department of Pharmacy, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.196",
    "filters": {
      "actSubs": ["Alectinib", "Crizotinib", "Osimertinib", "Pembrolizumab", "Anlotinib", "Dulanermin", "Atezolizumab"],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": ["Epidermal Growth Factor Receptor (EGFR) Inhibitors", "Anaplastic Lymphoma Kinase (ALK) Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Evaluation of clinical pharmacy services in a haematology outpatient setting",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A92.1",
    "authors": "R Gavira Moreno, V Vázquez Vela, P Gomez Germá, C Puivecino Moreno, A Varas Pérez, JF Sierra Sánchez",
    "institution": "Area De Gestion Sanitaria Norte De Cadiz-Hospital De Jerez, Pharmacy, Jerez De La Frontera, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.197",
    "filters": {
      "actSubs": ["Lenalidomide", "Ibrutinib"],
      "indication": ["Multiple Myeloma", "Leukaemia (Chronic Lymphocytic)", "Leukaemia (Chronic Myeloid)"],
      "statedClass": ["Statins"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Haematology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["1 year - 2 years"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"]
    }
  },
  {
    "title": "Secondline treatment of metastatic non-small cell lung cancer with immune checkpoint inhibitors",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A92.2",
    "authors": "FJ Salmeron Navas, C Martinez-Diaz, EM Barreiro-Fernandez, M Dominguez Cantero, S Fenix-Caballero",
    "institution": "Hospital Universitario Puerto Real, Servicio De Farmacia, Cadiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.198",
    "filters": {
      "actSubs": ["Atezolizumab", "Nivolumab", "Pembrolizumab"],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": ["Immune Checkpoint Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Kaplan-Meier Method"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Indirect treatment comparisons of ibrutinib–obinotuzumab versus venetoclax–obinotuzumab in naive chronic lymphocytic leukaemia",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A93.1",
    "authors": "P Selvi, O Montero-Perez, S Portilo-Haro",
    "institution": "Hospital Minas De Riotinto, Pharmacy, Riotinto, Spain. Hospital Juan Ramón Jiménez, Pharmacy, Huelva, Spain. Hospital Parque Tecnologico De La Salud, Pharmacy, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.199",
    "filters": {
      "actSubs": ["Ibrutinib", "Obinotuzumab", "Venetoclax", "Chlorambucil"],
      "indication": ["Leukaemia (Chronic Lymphocytic)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Real world evidence of pembrolizumab as monotherapy in non-small cell lung cancer: effectiveness and safety study",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A93.2",
    "authors": "R Tamayo Bermejo, JC Del Río Valencia, B Mora Rodríguez, I Muñoz Castillo",
    "institution": "Hospital Regional Universitario De Málaga, Pharmacy, Málaga, Spain. Vithas Hospital Xanit Internacional, Pharmacy, Málaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.200",
    "filters": {
      "actSubs": ["Pembrolizumab"],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Response Evaluation Criteria In Solid Tumours (RECIST)", "Kaplan-Meier Method"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Anthracycline dosing in obese adult patients: a systematic review",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A94.1",
    "authors": "B Tapia, A Casas, B Torroba, C Fraile, A Gutierrez, B Fernandez, M Serrano-Alonso, MA García Del Barrio",
    "institution": "Clinica Universidad De Navarra, Hospital Pharmacy, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.201",
    "filters": {
      "actSubs": ["Doxorubicin", "Epirubicin", "Idarubicin", "Daunorubicin"],
      "indication": [],
      "statedClass": ["Anthracyclines"],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Trifluridine–tipiracil for metastatic colorectal cancer: real world data experience",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A94.2",
    "authors": "M Tonelli, M Scaldaferri, S Bustreo, L Fanchini, G Ritorto, P Racca, F Cattel",
    "institution": "AOU Citta’ Della Salute E Della Scienza Di Torino, Pharmacy, Turin, Italy. AOU Citta’ Della Salute E Della Scienza Di Torino, Colorectal Cancer Unit, Turin, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.202",
    "filters": {
      "actSubs": ["Trifluridine / Tipiracil", "Trifluridine", "Tipiracil", "Raltitrexed", "Regorafenib", "Mitomycin C"],
      "indication": ["Colorectal Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Influence of palbociclib toxicity in real world clinical practice",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A95.1",
    "authors": "L Ulacia Epelde, D Tejada Marín, P Aldave Cobos, G Pinilla Lebrero, A Rodríguez Esquíroz, JA Illodo Becerra, J Polo Garcia, M Calvo Arbeloa, R Juanbeltz Zurbano, N Larrea Goñi, JJ Elizondo Armendariz",
    "institution": "Complejo Hospitalario De Navarra, Farmacia, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.203",
    "filters": {
      "actSubs": ["Palbociclib"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Is there a role for the pharmacist in screening for metabolic syndrome?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A95.2",
    "authors": "R Aladawi, K Prabhu, D Stewart, C Ryan, H Abdelaziz, M El Edrisi, M Izham, M Steinhoff, A Jochebeth, S Kuttikrishnan, SU Khan, M Young, M Steinhoff, A Tonna",
    "institution": "Hamad Medical Corporation-Doha-Qatar, Pharmacy-Clinical Pharmacy, Doha, Qatar. Hamad Medical Corporation-Doha-Qatar, Interim Translational Research Institute Itri, Doha, Qatar. Qatar University, Academic Quality, Doha, Qatar. Trinity College Dublin, The School of Pharmacy and Pharmaceutical Sciences, Dublin, Ireland. Hamad Medical Corporation-Doha-Qatar, Internal Medicine, Doha, Qatar. Qatar University, Medical and Health Sciences Office, Doha, Qatar. Hamad Medical Corporation-Doha-Qatar, Metabolic Institute, Doha, Qatar. Hamad Medical Corporation-Doha-Qatar, I Interim Translational Research Institute Itri, Doha, Qatar. Robert Gordon University, Pharmacy and Life Sciences, Aberdeen, UK",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.204",
    "filters": {
      "actSubs": [],
      "indication": ["Metabolic Syndrome"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Longitudinal Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Qatar", "Ireland", "United Kingdom"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Switching oral antiandrogenic treatment in patients with castrate metastatic prostate cancer: an analysis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A96.1",
    "authors": "C Valdazo Martín, JJ García Albás, MÁ Andrés Moralejo, H Ayerra Pérez, M Rosado Ancín, A Santaolalla Sánchez, N Ramón Rigau, A Larrabeiti Echevarria, C Martínez Martínez",
    "institution": "Hospital Universitario Araba, Hospital Pharmacy, Vitoria-Gasteiz, Spain. Hospital Universitario Araba, Urology, Vitoria-Gasteiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.205",
    "filters": {
      "actSubs": ["Abiraterone", "Enzalutamide", "Prednisone"],
      "indication": ["Prostate Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"]
    }
  },
  {
    "title": "Tolerance profile to antithymocyte immunoglobulin treatment and its relation to infectious parameters in paediatric patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A96.2",
    "authors": "A Ferrada Gascó, G Gómez Silva, E Martínez Chillaron, I Beltran García, P Escobar Cava, C Fuentes Socorro, JM Fernández Navarro, JL Poveda Andrés",
    "institution": "Hospital Universitari I Politècnic La Fe, Farmacia, Valencia, Spain. Hospital Clínico Universitario, Oncohematología Pediatrica, Santiago De Compostela, Spain. Hospital Universitari I Politècnic La Fe, Pediatria, Valencia, Spain. Hospital Universitari I Politècnic La Fe, Unidad De Trasplante Pediatrico, Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.206",
    "filters": {
      "actSubs": ["Antithymocyte Globulin (Rabbit)"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Analysis of the prescription and safe drug administration of ocrelizumab",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A97.1",
    "authors": "JI García Soler, V Arocas Casañ, L Menendez Naranjo, E Gonzalez Lozano, A Laorden Carrasco, M Diaz Ramon, JA Cano Molina, C Ramirez Roig, M Valderrey Pulido, S Vicente Sánchez",
    "institution": "Hospital Clinico Universitario Virgen De La Arrixaca, Pharmacy Service, Murcia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.207",
    "filters": {
      "actSubs": ["Ocrelizumab"],
      "indication": ["Multiple Sclerosis (Primary Progressive)"],
      "statedClass": ["Disease Modifying Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Common Terminology Criteria for Adverse Events"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": []
    }
  },
  {
    "title": "Impact of a tool in the electronic clinical history for the optimisation of biologic drugs in rheumatology",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A97.2",
    "authors": "M Mañes Sevilla, EP Gómez-Caballero, B Bertran De Lis-Bartolome, I Soto Baselga, C Moriel-Sánchez",
    "institution": "Hospital Universitario Mostoles, Pharmacy Department, Móstoles Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.208",
    "filters": {
      "actSubs": ["Etanercept", "Infliximab", "Adalimumab", "Certolizumab", "Golimumab", "Tocilizumab", "Abatacept", "Secukinumab", "Baricitinib", "Tofacitinib", "Ustekinumab"],
      "indication": [],
      "statedClass": ["Biologicals"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Rheumatology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "A review of infliximab biosimilar to biosimilar switch: Remsima to Flixabi",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A98.1",
    "authors": "R O’neill, S Singh, R Luber",
    "institution": "Guy’s and St Thomas’s NHS Foundation Trust, Pharmacy, London, UK. Guy’s and St Thomas’s NHS Foundation Trust, Gastroenterology, London, UK",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.209",
    "filters": {
      "actSubs": ["Infliximab"],
      "indication": ["Inflammatory Bowel Disease"],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["United Kingdom"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Analysis of changes in disease modifying treatment in the management of patients with multiple sclerosis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A98.2",
    "authors": "A Arancón Pardo, C Sobrino Jiménez, E Rodríguez Martín, C Bilbao Gómez-Martino, E Villamañán Bueno, I Jiménez-Nácher, F Moreno Ramos, MÁ González Fernández, M Moreno Palomino, M García-Trevijano, A Herrero Ambrosio",
    "institution": "Hospital Universitario La Paz, Pharmacy Department, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.210",
    "filters": {
      "actSubs": ["Interferon Beta-1a", "Teriflunomide", "Dimethylfumarate", "Natalizumab"],
      "indication": ["Multiple Sclerosis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Vedolizumab: outcomes and therapeutic drug monitoring in inflammatory bowel disease",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A99.1",
    "authors": "O Ballesta-López, M Centelles-Oria, A Ferrada-Gascó, T Palanques-Pastor, I Beltrán-García, R Iglesias-Gómez, MR Marqués-Miñana, P Nos-Mateu, JL Poveda-Andrés",
    "institution": "Hospital Universitario Y Politécnico La Fe, Pharmacy, Valencia, Spain. Hospital Universitario Y Politécnico La Fe, Gastroenterology, Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.211",
    "filters": {
      "actSubs": ["Vedolizumab"],
      "indication": ["Inflammatory Bowel Disease", "Ulcerative Colitis", "Crohn’s Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["The Mayo Score for Ulcerative Colitis", "Harvey-Bradshaw Index (HBI) for Crohn's Disease", "Enzyme Immunoassay"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": []
    }
  },
  {
    "title": "Clinical and economic impact of infliximab biosimilar Inflectra in rheumatoid arthritis, psoriatic arthropathy and ankylosing spondylitis naïve and switched patients: 5 years of follow-up",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A99.2",
    "authors": "J Borras, A Gracia-Pérez, A Valcuende Rosique, MDe Castera, JD Rosique, FJ Abad",
    "institution": "Hospital Sagunto, Pharmacy Service, Sagunto, Spain. Hospital De Sagunto, Rheumatology Section, Sagunto, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.212",
    "filters": {
      "actSubs": ["Infliximab"],
      "indication": ["Rheumatoid Arthritis", "Psoriatic Arthropathy", "Ankylosing Spondylitis"],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Adherence to adalimumab, golimumab and ustekinumab therapy in inflammatory bowel disease",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A100.1",
    "authors": "M Calvo Arbeloa, A Arrondo Velasco, A Rodriguez Esquiroz, J Polo García, G Pinilla Lebrero, D Tejada Marín, J Elizondo Armendáriz, M Sarobe Carricas",
    "institution": "Complejo Hospitalario De Navarra, Pharmacy Department, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.213",
    "filters": {
      "actSubs": ["Adalimumab", "Golimumab", "Ustekinumab"],
      "indication": ["Inflammatory Bowel Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Observational Transversal Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Morisky – Green Questionnaire", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Inotuzumab–ozogamizin for the treatment of relapse B precursor acute lymphoblastic leukaemia in an adult patient: a case report",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A100.2",
    "authors": "JC Del Río Valencia, C Ortega De La Cruz, T Chinchilla Alarcón, I Muñoz Castillo",
    "institution": "Hospital Regional Universitario Malaga, Servicio De Farmacia, Malaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.214",
    "filters": {
      "actSubs": ["Inotuzumab / Ozogamicin"],
      "indication": ["Leukaemia (Acute Lymphoblastic)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series", "Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Beliefs about medication and quality of life in multiple sclerosis patients treated with natalizumab",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A100.3",
    "authors": "L Carrasco Piernavieja, M Dominguez Bachiller, MI Barcia Martín, E Zhan Zhou, AM Martín De Rosales Cabrera, L Borrega Canelo, M Perez Encinas",
    "institution": "Hospital Universitario Fundación Alcorcón, Hospital Pharmacy, Alcorcón, Spain. Hospital Universitario Fundación Alcorcón, Neurology, Alcorcón, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.215",
    "filters": {
      "actSubs": ["Natalizumab"],
      "indication": ["Multiple Sclerosis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Expanded Disability Status Scale", "EuroQol-5D", "Visual Analogue Scale", "Statistical Package for the Social Sciences (SPSS)", "Multivariate Analysis"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Therapeutic drug monitoring of etanercept biosimilar in psoriatic patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A101.1",
    "authors": "L Elberdin Pazos, RM Fernández Torres, E Blanco Castro, M Outeda Macias, C Fernandez Oliveira, E Fonseca Capdevila, I Martin Herranz",
    "institution": "Complexo Hospitalario Universitario De A Coruña Chuac-Sergas, Instituto De Investigación Biomédica De A Coruña Inibic, Universidade Da Coruña Udc-Spain, Department of Pharmacy, A Coruña, Spain. Complexo Hospitalario Universitario De A Coruña Chuac-Sergas, Instituto De Investigación Biomédica De A Coruña Inibic, Universidade Da Coruña Udc-Spain., Department of Dermatology, A Coruña, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.216",
    "filters": {
      "actSubs": ["Etanercept", "Methotrexate", "Ciclosporin"],
      "indication": ["Psoriasis (Moderate to Severe Plaque)"],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["ELISA Immunoassay", "Psoriasis Area and Severity Index (PASI)", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Ten years of expertise in ustekinumab use for the treatment of moderate to severe plaque psoriasis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A101.2",
    "authors": "S Esteban-Casado, C Esteban Alba, I Cañamares Orbis, P Tejedor Prado, E Izquierdo Garcia, A Such Díaz, EA Alvaro Alonso, A Lazaro Cebas, A Santiago Perez, I Escobar Rodriguez",
    "institution": "Hospital Universitario Infanta Leonor, Pharmacy, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.217",
    "filters": {
      "actSubs": ["Ustekinumab"],
      "indication": ["Psoriasis (Moderate to Severe Plaque)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Psoriasis Area and Severity Index (PASI)", "Kaplan-Meier Method"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Case report: usefulness of therapeutic drug monitoring of vedolizumab in managing acute graft versus host disease",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A102.1",
    "authors": "R Fernandez Caballero, N Martin-Gutierrez, G Sanchez-Hernandez, S Jimenez-Cabrera, A Navarro-Bailón, B Rey-Búa, M Martin-Gil, D Peña-Lorenzo, L Pedraza-Nieto, MJ Otero-López",
    "institution": "University Hospital of Salamanca, Pharmacy Service, Salamanca, Spain. University Hospital of Salamanca, Haematology Service, Salamanca, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.218",
    "filters": {
      "actSubs": ["Vedolizumab"],
      "indication": ["Graft Versus Host Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Bayesian Population Pharmacokinetic Approach"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Real clinical impact of drug–drug interactions of immunosuppressants in transplant patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A102.2",
    "authors": "AI Gago-Sanchez, M Cardenas, MD Aumente, P Font, JR Del Prado, MA Calleja",
    "institution": "Reina Sofia Universitary Hospitalimibic/University, Pharmacy, Cordoba, Spain. Reina Sofia Universitary Hospitalimibic/University, Rheumatology, Cordoba, Spain. Macarena Universitary Hospital, Pharmacy, Sevilla, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.219",
    "filters": {
      "actSubs": ["Tacrolimus", "Nifedipine"],
      "indication": [],
      "statedClass": ["Immune-Suppressors", "Antifungal Azoles"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": ["1 year - 2 years"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"]
    }
  },
  {
    "title": "‘Real world’ experience of tofacitinib and baricitinib in the treatment of rheumatoid arthritis: effectiveness and safety evaluation",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A103",
    "authors": "S Garcia Garcia, I Cardona Pascual, M Larrosa Garcia, JB Montoro Ronsano, R Caparros Ruiz, C Alonso Martinez, J Vidal Otero, S Gamarra Calvo, MR Gomez Domingo, C Alerany Pardo",
    "institution": "Vall D’hebron University Hospital, Hospital Pharmacy Department, Barcelona, Spain. Vall D’hebron University Hospital, Rheumatology Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.220",
    "filters": {
      "actSubs": ["Tofacitinib", "Baricitinib", "Methotrexate", "Leflunomide", "Hydroxychloroquine", "Sulfasalazine"],
      "indication": ["Rheumatoid Arthritis"],
      "statedClass": ["Janus Kinase Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Disease Activity Score-28 for Rheumatoid Arthritis with ESR (DAS28-ESR)", "Analysis of Variance (ANOVA)", "Chi-Square (χ2) Test", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Ten year analysis of the use of infliximab in ulcerative colitis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A104.1",
    "authors": "G Gonzalez De La Fuente, F Gutierrez Nicolas, J Gonzalez Garcia, B Del Rosario Garcia, L Cantarelli, J Ramos Rodriguez, GJ Nazco Casariego",
    "institution": "Hospital Universitario De Canarias, Pharmacy, La Laguna, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.221",
    "filters": {
      "actSubs": ["Infliximab"],
      "indication": ["Ulcerative Colitis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Evaluation of cost and efficacy of eculizumab in complement mediated thrombotic microangiopathy in the clinical setting",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A104.2",
    "authors": "M Larrosa García, P Sanchez-Sancho, BJ Montoro Ronsano, N Ramos Terrada, C Alerany Pardo, S Garcia Garcia",
    "institution": "Vall D´Hebron University Hospital, Clinical Pharmacy, Barcelona, Spain. Vall D´Hebron University Hospital, Clinical Nephrology, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.222",
    "filters": {
      "actSubs": ["Eculizumab"],
      "indication": ["Complement-Mediated Thrombotic Microangiopathy"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["Less than 10"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Potential optimisation of treatment with ustekinumab in Crohn’s disease",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A105.1",
    "authors": "M Llinares-Esquerdo, S Martínez-Pérez, G Miralles-Andreu, M Pomares-Bernabeu, IP Jiménez-Pulido, A Navarro Ruiz",
    "institution": "Hospital General Universitario De Elche, Pharmacy, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.223",
    "filters": {
      "actSubs": ["Ustekinumab"],
      "indication": ["Crohn’s Disease"],
      "statedClass": ["Biologicals"],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": ["Digestive Medicine"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": []
    }
  },
  {
    "title": "Evaluation of adherence to oral disease modifying therapies in patients with relapsing–remitting multiple sclerosis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A105.2",
    "authors": "MP Ortega-Garcia, M Zaragozá-González, I Toledo-Guasp, P Pérez-Villalón, P Blasco-Segura",
    "institution": "Consorcio Hospital General Universitario De Valencia, Service of Pharmacy, Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.224",
    "filters": {
      "actSubs": ["Fingolimod", "Teriflunomide", "Dimethylfumarate"],
      "indication": ["Multiple Sclerosis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Adherence to selective immunosuppressive drug treatments in patients with inflammatory immune mediated diseases",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A106.1",
    "authors": "PA López Broseta, J Del Estal Jiménez, MÁ Roch Ventura, A Sanjuan Belda, S Jornet Montaña, M Martín Marqués, M Mendoza Aguilera, E Esteve Pitarch, M Vuelta Arce, L Canadell Vilarrasa",
    "institution": "Hospital Universitari Joan Xxiii, Pharmacy, Tarragona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.225",
    "filters": {
      "actSubs": ["Adalimumab", "Etanercept"],
      "indication": ["Immune-Mediated Inflammatory Disease", "Rheumatoid Arthritis", "Psoriatic Arthropathy", "Psoriasis", "Crohn’s Disease", "Ulcerative Colitis", "Spondyloarthropathy"],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Medication Possession Ratio", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Acceptance of pharmacokinetic recommendations for everolimus in renal transplant patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A106.2",
    "authors": "A Rochina, S Gutiérrez, A González, A García, L Soriano, A Navarro",
    "institution": "Hospital General Universitario Elche, Hospital Pharmacist, Elche, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.226",
    "filters": {
      "actSubs": ["Everolimus"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Nephrology"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": ["personalized"],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "A population pharmacokinetic model of adalimumab in a cohort of paediatric patients with inflammatory bowel disease: a preliminary analysis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A106.3",
    "authors": "M Miarons Font, JG Sánchez Hernandez, JS Pérez Blanco, S Clemente Bautista, N Rebollo Diaz, O Segarra Cantón, MJ Cabañas Poy, R Torres Peral, MQ Gorgas, MJ Otero",
    "institution": "Hospital Universitario Vall D’hebron, Pharmacy Department, Barcelona, Spain. Complejo Asistencial Universitario De Salamanca, Pharmacy Department, Salamanca, Spain. University of Salamanca, Department of Pharmaceutical Sciences, Salamanca, Spain. Hospital Universitario Vall D’hebron, Paediatric Gastroenterology Unit, Barcelona, Spain. Complejo Asistencial Universitario De Salamanca, Paediatric Gastroenterology Unit, Salamanca, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.227",
    "filters": {
      "actSubs": ["Adalimumab"],
      "indication": ["Inflammatory Bowel Disease", "Ulcerative Colitis", "Crohn’s Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["First-Order Conditional Estimation with Interaction (FOCEI)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Economic impact of intensification regimens in inflammatory bowel disease",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A107",
    "authors": "L Ulacia Epelde, A Arrondo Velasco, J Polo Garcia, G Pinilla Lebrero, JA Illodo Becerra, M Calvo Arbeloa, A Rodríguez Esquíroz, D Tejada Marín, P Aldave Cobos, MT Sarobe Carricas, JJ Elizondo Armendariz",
    "institution": "Complejo Hospitalario De Navarra, Farmacia, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.228",
    "filters": {
      "actSubs": ["Adalimumab", "Golimumab", "Ustekinumab", "Vedolizumab", "Infliximab"],
      "indication": ["Inflammatory Bowel Disease"],
      "statedClass": ["Biologicals"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["501 - 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Liver transplant and diabetes mellitus",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A108.1",
    "authors": "M Vera Cabrera, I Plasencia García, A Ferrer Machín, I Gonzalez García, T Betancor García, L Díaz Díaz, R Mesa Exposito, S Hernandez Rojas, K Alvarez Tosco, C Perez Martin, J Merino Alonso",
    "institution": "Hospital Nuestra Señora La Candelaria, Hospital Pharmacy, Santa Cruz of Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.229",
    "filters": {
      "actSubs": [],
      "indication": ["Diabetes Mellitus"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Pilot study to survey the attitude, supplement use and storage conditions of drug products among patients receiving biological therapy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A108.2",
    "authors": "RG Vida, A Somogyi-Végh, M Mayer, D Kiss, N Schaadt, R Rajj, B Molnár, L Botz",
    "institution": "University of Pécs Faculty of Pharmacy, Department of Pharmaceutics and Central Clinical Pharmacy, Pécs, Hungary",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.230",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Biologicals"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Hungary"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "One in a million: a TNF receptor-1 associated syndrome resistant to anti-TNF-alpha therapy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A108.3",
    "authors": "BC Sánchez Lerma, MÁ Pérez Cruz, Y Hernández Gago, MP González Joyanes, AL García Silva, MA Velaz Suarez",
    "institution": "Hospital Pharmacist, Hospital Pharmacy Department. Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas De Gran Canaria, Spain. Hospital Pharmacist, Hospital Pharmacy, Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas De Gran Canaria, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.231",
    "filters": {
      "actSubs": ["Etanercept", "Anakinra", "Prednisone"],
      "indication": ["Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS)"],
      "statedClass": ["Tumor Necrosis Factor (TNF) Inhibitors", "Glucocorticoids"],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": ["orphan"],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Effectiveness of nusinersen in paediatric patients SMA1 and SMA2",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A109.1",
    "authors": "GB Ortenzi, G Palmas, E Andresciani, AMF Garzone, MA Berardi, S Siliquini, L Porfiri, MS Demeo, S Guglielmi, C Polidori, A Pompilio",
    "institution": "AO Ospedali Riunti Di Ancona, Sod Farmacia, Ancona, Italy. AO Ospedali Riuniti Ancona, Sod Clinica Pediatrica, Ancona, Italy. Università Degli Studi Di Camerino, Scuola Di Scienze Del Farmaco E Dei Prodotti Della Salute’ Facoltà Di Farmacia, Camerino, Italy. AO Ospedaliriunti Ancona, Sod Neuropsichiatria Infantile, Ancona, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.232",
    "filters": {
      "actSubs": ["Nusinersen"],
      "indication": ["5q-Spinal Muscular Atrophy (SMA)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND)", "Hammersmith Infant Neurological Examination (HINE)", "Hammersmith Functional Motor Scale-Expanded (HFMSE)"],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": ["orphan"],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Indirect treatment comparison of anti-calcitonin gene related peptide pathway antibodies in chronic migraine",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A109.2",
    "authors": "MDP Briceño Casado, S Fenix-Caballero, MD Gil-Sierra, M Dominguez Cantero, EJ Alegre-Del Rey",
    "institution": "Hospital Universitario Puerto Real, Hospital Pharmacy, Cadiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.233",
    "filters": {
      "actSubs": ["Erenumab", "Fremanezumab", "Glacanezumab", "Eptinezumab"],
      "indication": ["Migraine"],
      "statedClass": ["CGRP Receptor Antagonists"],
      "typeOfMedical": [],
      "studyDesign": ["Meta-Analysis"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Bucher's Method"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Is paracetamol a real alternative in the management of patent ductus arteriosus in preterm infants?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A110",
    "authors": "AA Garcia Robles, R Iglesias Gómez, P Pérez Huertas, A Parra Llorca, B Torres García, A Gimeno Navarro, M Vento Torres, JL Poveda Andrés, M Aguar Carrascosa",
    "institution": "Hospital Universitari I Politècnic La Fe, Pharmacy-Neonatology, Valencia, Spain. Hospital Universitari I Politècnic La Fe, Pharmacy, Valencia, Spain. Hospital Universitari I Politècnic La Fe, Neonatology, Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.234",
    "filters": {
      "actSubs": ["Paracetamol", "Ibuprofen"],
      "indication": ["Patent Ductus Arteriosus"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Cohort Study"],
      "setting": ["Hospital"],
      "ward": ["Neonatal Intensive Care"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": ["orphan"],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Prevalence analysis of patients treated with triptans at risk of developing medication overuse headache and development of a prescription optimisation strategy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A111.1",
    "authors": "MT Brieva Herrero, E Marquez-Fernández, N Sánchez-Devicente",
    "institution": "Hospital Antequera, Hospital Pharmacist, Antequera, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.235",
    "filters": {
      "actSubs": [],
      "indication": ["Medication Overdose Headache"],
      "statedClass": ["Triptans"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": ["deprescribing"],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Perphenazine and propranolol poisoning: a case report",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A111.2",
    "authors": "CA Alonso Peralta, T Gimenez Poderós, D Gómez, RM González Franco, B Rogado Vegas, J Casanova Vázquez, M Rioja Carrera, P Del Rio Ortega, L Perez-Periañez Orrillo, I Aragon Gracia, M Valero Domínguez",
    "institution": "Hospital Universitario Marqués De Valdecilla, Farmacia Hospitalaria, Santander, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.236",
    "filters": {
      "actSubs": ["Perphenazine", "Propranolol", "Dobutamine", "Glucagon", "Naloxone"],
      "indication": [],
      "statedClass": ["Benzodiazepines"],
      "typeOfMedical": [],
      "studyDesign": ["Case Reports / Series"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Glasgow Coma Scale"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"]
    }
  },
  {
    "title": "Dexmedetomidine treatment for the sedation of preterm neonates",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A112.1",
    "authors": "R Escrig-Fernández, AA Garcia Robles, O Ballesta-López, MJ Company-Albir, A Gimeno-Navarro, JL Poveda-Andrés, I Izquierdo-Macián",
    "institution": "Hospital Universitario Y Politécnico La Fe, Neonatology, Valencia, Spain. Hospital Universitario Y Politécnico La Fe, Neonatology/Pharmacy, Valencia, Spain. Hospital Universitario Y Politécnico La Fe, Pharmacy, Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.237",
    "filters": {
      "actSubs": ["Dexmedetomidine", "Fentanyl"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Neonatal Intensive Care"],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Review of 3 month prescriptions containing drugs inducing QT prolongation and torsade de pointe",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A112.2",
    "authors": "A Cappe, S Membre, M Moussour, M Compagnon, D Pons",
    "institution": "Ch Philippe Pinel, Pharmacy, Amiens, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.238",
    "filters": {
      "actSubs": ["Escitalopram", "Hydroxyzine", "Domperidone"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["501 - 1000"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": []
    }
  },
  {
    "title": "An observational retrospective study on treatment adherence of long acting injectable antipsychotics",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A113.1",
    "authors": "AM Fernández Varela, LM Martínez Agulleiro, B Salazar Laya, D Núñez Arias, I Rodríguez Penín",
    "institution": "Hospital Arquitecto Marcide, Farmacia Hospitalaria, Ferrol-A Coruña, Spain. Hospital Arquitecto Marcide, Psiquiatría, Ferrol-A Coruña, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.239",
    "filters": {
      "actSubs": [],
      "indication": ["Schizophrenia", "Delusional Disorder", "Personality Disorder"],
      "statedClass": ["Long Acting Injectable Antipsychotics"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Psychotropic drug usage in octogenarian and nonagenarian complex chronic patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A113.2",
    "authors": "A Perez Contel, S Ortonobes Roig, N Soler Blanco, G Diestre Ortin, P Miralles-Albors, S Fernández-Molina, A Barragán Muñoz, M Gómez-Valent",
    "institution": "Consorci Corporacio Sanitaria Parc Tauli, Pharmacy, Sabadell, Spain. Consorci Corporacio Sanitaria Parc Tauli, Psychogeriatrics, Sabadell, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.240",
    "filters": {
      "actSubs": ["Trazodone", "Sertraline", "Quetiapine", "Risperidone", "Gabapentin"],
      "indication": [],
      "statedClass": ["Hypnotics", "Benzodiazepines", "Antidepressants", "Neuroleptics", "Mood Stabilisers"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Acute Geriatric Unit"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Pfeiffer Test", "Mann-Whitney U Test", "STATA"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": []
    }
  },
  {
    "title": "Current status of clinical trials for Alzheimer’s disease",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A113.3",
    "authors": "A Rodriguez, ME Navarrete-Rouco, P Acin, M Ponce, M Jorques, O Ferrandez-Quirante, M Espona",
    "institution": "Hospital Del Mar, Pharmacy, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.241",
    "filters": {
      "actSubs": [],
      "indication": ["Alzheimer’s Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Descriptive Study", "Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Neuropsychology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": ["clinicalTrials"],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Effectiveness of immunotherapy in severe uncontrolled asthma",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A114.1",
    "authors": "M Bitlloch Obiols, L Perez Cordon, J Delgado Rodriguez, A Sanchez Ulayar, V Aguilera Jimenez, M Pujal Herranz, T Gurrera Roig, D Lopez Faixo, C Agusti Maragall, L Campins Bernadas",
    "institution": "Hospital De Mataró, Pharmacy, Mataró, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.242",
    "filters": {
      "actSubs": ["Omalizumab", "Mepolizumab", "Reslizumab", "Benralizumab"],
      "indication": ["Asthma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Effectiveness and safety of anti-IL-5 biologic agents in severe eosinophilic asthma",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A114.2",
    "authors": "M Calvo Arbeloa, G Pinilla Lebrero, E Lacalle Fabo, J Polo García, L Ulacia Epelde, J Illodo Becerra, D Fresán Restituto, P Aldave Cobos, J Elizondo Armendáriz, M Sarobe Carricas",
    "institution": "Complejo Hospitalario De Navarra, Pharmacy Department, Pamplona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.243",
    "filters": {
      "actSubs": ["Mepolizumab", "Reslizumab", "Benralizumab"],
      "indication": ["Asthma"],
      "statedClass": ["Anti-Interleukin-5 Monoclonal Antibodies"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Asthma Control Test"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Treatment of asthma and chronic obstruction pulmonary disease: are our hospital nurses and physicians ready to treat and educate inpatients?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A115.1",
    "authors": "R Guimaraes, PF Rogliano, L Durand, N Bouzou, S Saad, S Le Poole",
    "institution": "Ch Rives De Seine, Pharmacy, Neuilly-Sur-Seine, France. Ch Rives De Seine, Internal Medicine, Neuilly-Sur-Seine, France. Ch Rives De Seine, Geriatrics, Neuilly-Sur-Seine, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.244",
    "filters": {
      "actSubs": [],
      "indication": ["Asthma", "Chronic Obstruction Pulmonary Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Safety and effectiveness of reduced dose omalizumab for chronic idiopathic urticaria",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A115.2",
    "authors": "M Alonso Moreno, M Soriano Martinez, B Fernandez Rubio, M Mejias Trueba",
    "institution": "Hospital Universitario Virgen Del Rocío, Farmacia, Sevilla, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.245",
    "filters": {
      "actSubs": ["Omalizumab", "Ciclosporin", "Montelukast"],
      "indication": ["Chronic Idiopathic Urticaria"],
      "statedClass": ["Antihistamines"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Allergy", "Dermatology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Urticaria Activity Score (UAS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Evaluation of a pharmaceutical care programme for patients being treated with omalizumab",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A116.1",
    "authors": "R Mesa Expósito, I Plasencia Garcia, MA Ocaña Gomez, A De Leon Gil, E Tevar Alonso, A Ferrer Machin, M Vera Cabrera, KI Alvarez Tosco, CY Perez Martin, JA Martin Conde, FJ Merino Alonso",
    "institution": "Hospital Nuestra Señora De La Candelaria, Pharmacy, Santa Cruz De Tenerife, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.246",
    "filters": {
      "actSubs": ["Omalizumab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": ["selfMedication"],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Effectiveness and safety of omalizumab in the treatment of severe uncontrolled asthma",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A116.2",
    "authors": "L Portillo Horcajada, C Garcia Yubero, B Garcia De Santiago, E Lopez Aspiroz, E Garcia Martin, Y Larrubia Marfil, JP Barro Ordovas, J Llorente Gutierrez, A Martinez Hernandez",
    "institution": "University Hospital Infanta Sofía, Pharmacy Department, San Sebastián De Los Reyes, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.247",
    "filters": {
      "actSubs": ["Omalizumab"],
      "indication": ["Asthma"],
      "statedClass": ["Corticosteroids"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Asthma Control Test"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Therapeutic positioning and use of intravitreal ranibizumab and aflibercept",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A117.1",
    "authors": "S García Sánchez, A Ribed-Sánchez, I Herrero-Durán, MJ Aparicio Hernández-Lastras, A Melgarejo-Ortuño, FJ García-Moreno, MÁ Amor-García, P Ruiz-Briones, Á Narrillos-Moraza, A Herranz-Alonso, M Sanjurjo-Sáez",
    "institution": "ospital General Universitario Gregorio Marañón, Pharmacy, Madrid, Spain. Hospital General Universitario Gregorio Marañón, Ophthalmology, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.248",
    "filters": {
      "actSubs": ["Ranibizumab", "Aflibercept", "Bevacizumab"],
      "indication": ["Age Related Macular Degeneration", "Diabetic Macular Oedema"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Clinical evaluation and satisfaction of patients treated with PRGF-Endoret (plasma rich in growth factors)",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A117.2",
    "authors": "S Gea Navarrete, M Montero Hernández, M Belló Crespo, L Rubio Alonso, Á Santiuste Román, E Soler Company",
    "institution": "Hospital Arnau De Vilanova-Llíria, Pharmacy, Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.249",
    "filters": {
      "actSubs": ["Plasma Rich In Growth Factors"],
      "indication": ["Keratitis", "Corneal Ulcer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Initial therapy for neovascular age related macular degeneration: are the guidelines met in clinical practice?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A118.1",
    "authors": "M Hernando Verdugo, E Queipo García, A Pariente Junquera, MI López Gálvez, MT Sánchez Sánchez",
    "institution": "Hospital Clinico Universitario De Valladolid, Pharmacy, Valladolid, Spain. Hospital Clinico Universitario De Valladolid, Ophthalmology, Valladolid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.250",
    "filters": {
      "actSubs": ["Ranibizumab", "Bevacizumab", "Aflibercept"],
      "indication": ["Age Related Macular Degeneration"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Ophthalmology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Assessment of burden of disease in terms of health related quality of life in patients with multiple myeloma not eligible for autologous stem cell transplantation",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A118.2",
    "authors": "O Delgado Sanchez, A Domingo, J De La Rubia, A García, A López, C Seguí, L Rumi, A Mengual, G Lostaunau, MV Mateos",
    "institution": "Hospital Son Espases, Pharmacy Department, Palma De Mallorca, Spain. Hospital General De Granollers, Haematology, Granollers, Spain. Hospital Dr Peset, Haematology, Valencia, Spain. Hospital Arnau De Vilanova De Lleida, Haematology, Lleida, Spain. Hospital Arnau De Vilanova De Valencia, Haematology, Valencia, Spain. Hospital General De Granollers, Pharmacy Department, Granollers, Spain. Hospital Arnau De Vilanova De Lleida, Clinical Trials Unit, Lleida, Spain. Hospital Arnau De Vilanova De Valencia, Pharmacy Department, Valencia, Spain. Celgene Slu, Medical Affairs, Madrid, Spain. Hospital Universitario Salamanca, Haematology, Salamanca, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.251",
    "filters": {
      "actSubs": ["Lenalidomide", "Bortezomib"],
      "indication": ["Multiple Myeloma", "Dyspnoea"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["EuroQol-5D"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "The impact of an integrated electronic medical record on therapeutic drug monitoring",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A119.1",
    "authors": "P Firman",
    "institution": "Royal Brisbane and Women’s Hospital, Pharmacy Department, Royal Brisbane Hospital, Australia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.252",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["10 - 50"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Australia"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": ["softwareAided"],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Analysis of pharmaceutical interventions in the exchange of therapeutic equivalents",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A119.2",
    "authors": "S Nuñez Bracamonte, MC González Pérez-Crespo, E Conesa Nicolás, C Juez Santamaría, A Lloret Llorca, CN García Matillas, I Fernández Martínez, JM Montoya Egea",
    "institution": "Hospital General Universitario Santa Lucía, Farmacia Hospitalaria, Cartagena, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.253",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Intensification in biological treatment in ulcerative colitis",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A120.1",
    "authors": "A Pintado, R Asensi Diez, A Linares, I Muñoz Castillo",
    "institution": "Hospital Regional Universitario Malaga, Farmacia Hospitalaria, Malaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.254",
    "filters": {
      "actSubs": ["Infliximab", "Adalimumab", "Vedolizumab", "Ustekinumab", "Tofacitinib"],
      "indication": ["Ulcerative Colitis"],
      "statedClass": ["Biologicals"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Potentially inappropriate medication for elderly hospitalised patients in a trauma and orthopaedic surgery department",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A120.2",
    "authors": "MM Alañon Pardo, MT Gómez Lluch, MC Conde García, B Proy Vega, ML Moreno Perulero, JC Valenzuela Gámez",
    "institution": "Hospital General La Mancha-Centro, Pharmacy, Alcázar De San Juan, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.255",
    "filters": {
      "actSubs": [],
      "indication": ["Hip Fracture", "Osteoporosis"],
      "statedClass": ["Proton-Pump Inhibitors", "Benzodiazepines"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Traumatology", "Orthopaedic Surgery"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["STOPP/START Criteria", "Binary Logistic Regression Analysis"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Real life experience of home care administration of 5-azacitidine and domiciliary management of patients with myelodysplastic syndrome",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A121.1",
    "authors": "C Alarcon-Payer, I Elósegui Horno, JE Martínez De La Plata, CL Muñoz Cid, A Jiménez Morales",
    "institution": "Hospital Universitario De Jaén, Servicio De Farmacia, Jaén, Spain. Hospital San Agustín, Servicio De Farmacia, Linares, Spain. Hospital De Poniente-El Ejido, Servicio De Farmacia, Almería, Spain. Hospital Universitario Virgen De Las Nieves, Servicio De Farmacia, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.256",
    "filters": {
      "actSubs": ["5-azacitidine"],
      "indication": ["Myelodysplastic Syndrome"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["2 years - 5 years"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": ["homeCare"],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Analysis of the effectiveness and safety of daratumumab in monotherapy in adult patients with relapsed refractory multiple myeloma",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A121.2",
    "authors": "C Alarcon-Payer, AM López López, F Gómez-De Rueda, R Claramunt García, MJ Barbero Hernández, A Jiménez Morales",
    "institution": "Hospital Universitario De Jaén, Servicio De Farmacia, Jaén, Spain. Hospital Universitario Virgen De Las Nieves, Servicio De Farmacia, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.257",
    "filters": {
      "actSubs": ["Daratumumab", "Montelukast"],
      "indication": ["Multiple Myeloma"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["2 years - 5 years"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Intravenous biosimilar prescribing trends in a third level Spanish hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A121.3",
    "authors": "JM Vinuesa Hernando, R Gracia Piquer, R Fresquet Molina, FJ Campos Montellano, M Galindo Allueva, MJ Nebot Villacampa, M Arenere Mendoza, I Varela Martínez, T Salvador Gómez, MA Alcacera Lopez",
    "institution": "Hospital Clínico Universitario Lozano Blesa, Pharmacy, Zaragoza, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.258",
    "filters": {
      "actSubs": ["Infliximab", "Rituximab", "Trastuzumab"],
      "indication": ["Rheumatoid Arthritis", "Inflammatory Bowel Disease", "Hematologic Malignancy", "Systemic Lupus Erythematosus", "Breast Cancer", "Gastric Cancer"],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": []
    }
  },
  {
    "title": "Prescribing trends of adalimumab and etanercept biosimilar drugs in a third level hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A122.1",
    "authors": "JM Vinuesa Hernando, R Gracia Piquer, FJ Campos Montellano, R Fresquet Molina, M Galindo Allueva, O Horna Oreja, A Frutos Perez-Surio, MA Alcacera Lopez, T Salvador Gómez, M Gimeno Gracia",
    "institution": "Hospital Clínico Universitario Lozano Blesa, Pharmacy, Zaragoza, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.259",
    "filters": {
      "actSubs": ["Adalimumab", "Etanercept"],
      "indication": ["Spondyloarthropathy", "Rheumatoid Arthritis", "Psoriatic Arthropathy", "Psoriasis", "Inflammatory Bowel Disease"],
      "statedClass": ["Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["501 - 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": []
    }
  },
  {
    "title": "Management of community acquired pneumonia at a tertiary care teaching hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A122.2",
    "authors": "M Alomar, A Mayet, A Alsuwayegh, N Alkhayyat, D Almuqbel",
    "institution": "Clinical Pharmacist Specialist-Internal Medicine, Clinical Pharmacy, Riyadh, Saudi Arabia. King Saud University Medical City, Clinical Pharmacy, Riyadh, Saudi Arabia",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.260",
    "filters": {
      "actSubs": [],
      "indication": ["Pneumonia (Community Acquired)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Saudi Arabia"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Management of drugs in patients with swallowing difficulties in a public residential care home: role of the hospital pharmacist",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A123.1",
    "authors": "N Ferreras López, MA González, N Álvarez Núñez, D López Suarez, E Martínez Álvarez, Z Rodríguez Fernández, B Matilla Fernández, JJ Ortiz De Urbina, C Guindel Jiménez",
    "institution": "Complejo Asistencial Univeristario De León, Hospital Pharmacy, León, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.261",
    "filters": {
      "actSubs": [],
      "indication": ["Dysphagia"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Longitudinal Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Pharmacist interventions in a hospital at home unit",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A123.2",
    "authors": "A Brito, A Simoes, A Alcobia",
    "institution": "Hospital Garcia De Orta, Pharmacy, Almada, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.262",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": ["homeCare"],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": ["deprescribing"],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Pharmaceutical interventions in drugs provided to the outpatient hospital pharmacy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A124.1",
    "authors": "A Brito, A Fernandes, L Lourenço, S Domingos, A Alcobia",
    "institution": "Hospital Garcia De Orta, Pharmacy, Almada, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.263",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Longitudinal Study"],
      "setting": ["Hospital"],
      "ward": ["Infectious Disease", "Oncology", "Gastroenterology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Clinical pharmacist residence in an intensive care unit: scope and relevance",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A124.2",
    "authors": "T Cabeças, J Cardoso, R Oliveira, M Pereira",
    "institution": "Cuf Infante Santo, Pharmacy, Lisboa, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.264",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "A safe handling hazardous drugs strategy to improve the safety of health professionals: reducing exposure by medical prescription review in nursing homes",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A124.3",
    "authors": "I Cañamares Orbis, F Apolo Carvajal, M Gonzalez Martinez, E Capilla Santamaria, N Martinez Casanova, I Mayorga Bajo, B Caliz Hernandez, MT Llanos Garcia, A Escudero Brocal, H Hernandez Ovejero, A Aranguren Oyarzabal",
    "institution": "Servicio Madrileño De Salud, Subdirección General De Farmacia Y Productos Sanitarios, Consejería De Sanidad., Madrid, Spain. Consejería De Políticas Sociales-Familias-Igualdad Y Natalidad, Agencia Madrileña De Atencion Social, Madrid, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.265",
    "filters": {
      "actSubs": ["Risperidone", "Acenocoumarol", "Valproic acid", "Clonazepam", "Spironolactone", "Carbamazepine", "Paroxetine"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Analysis of antibiotic consumption in a nursing home",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A125.1",
    "authors": "R Sánchez Del Moral, AB Guisado Gil, ÁMVillalba Moreno, IM Carrión Madroñal",
    "institution": "Hospital Juan Ramón Jiménez, Ugc Farmacia, Huelva, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.266",
    "filters": {
      "actSubs": ["Amoxicillin / Clavulanic acid", "Fosfomycin"],
      "indication": [],
      "statedClass": ["Quinolones"],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["1 year - 2 years"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": ["stewardship"],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": []
    }
  },
  {
    "title": "Analysis of the maintenance rate of long acting injectable antipsychotic treatment in outpatients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A125.2",
    "authors": "A Castro Balado, E Echarri-Arrieta, L García-Quintanilla, FJ Martínez-Bahamonde, EJ Bandín-Vilar, I Varela-Rey, M Busto-Iglesias, I Zarra-Ferro",
    "institution": "Complejo Hospitalario Universitario De Santiago De Compostela, Hospital Pharmacist Service, Santiago De Compostela, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.267",
    "filters": {
      "actSubs": ["Aripiprazole", "Paliperidone"],
      "indication": ["Schizophrenia", "Substance Related Disorders", "Intellectual Disability", "Personality Disorder"],
      "statedClass": ["Long Acting Injectable Antipsychotics"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Evaluation of pharmaceutical interventions: improvement plans",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A126.1",
    "authors": "L Martinez-Dueñas Lopez-Marin, T Vilchez Medina, R Claramunt García, CL Muñoz Cid, AM Lopez, Y Jimenez Lopez, E Perez Cano, N Garcia Gomez",
    "institution": "Hospital Universitario De Jaén, Pharmacy, Jaén, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.268",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine", "Pneumology", "Neurology", "Cardiology", "Digestive Medicine", "Oncology", "Infectious Disease", "Traumatology", "Psychiatry"],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": ["compliance"],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"]
    }
  },
  {
    "title": "Development of a Belgian classification system for clinical pharmacy activities",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A126.2",
    "authors": "S Verheyen, S Wuyts, H Collier, PJ Cortoos",
    "institution": "Uz Brussel, Pharmacy, Brussels, Belgium",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.269",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Fleiss' Kappa"],
      "studyLength": [],
      "country": ["Belgium"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Effect of abiraterone versus enzalutamide on prostate specific antigen levels in metastatic castration resistant prostate cancer",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A127.1",
    "authors": "B Del Rosario García, F Gutiérrez Nicolás, GA González De La Fuente, L Cantarelli, R Ramos Díaz, R García Marrero, A Plata Bello, GJ Nazco Casariego",
    "institution": "Complejo Hospitalario Universitario De Canarias, Pharmacy, San Cristóbal De La Laguna, Spain. Complejo Hospitalario Universitario De Canarias, Oncology, San Cristóbal De La Laguna, Spain. Complejo Hospitalario Universitario De Canarias, Urology, San Cristóbal De La Laguna, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.270",
    "filters": {
      "actSubs": ["Abiraterone", "Enzalutamide"],
      "indication": ["Prostate Cancer (Metastatic Castration Resistant)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Student's T-test", "Gleason Grading System"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Analysis and evaluation of pharmaceutical interventions performed in the emergency department of a tertiary hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A127.2",
    "authors": "I Plo Seco, S Álvarez Atienza, M Domínguez Bachiller, J Martínez Simón, Javier, S Sanz Márquez, M Renilla Sánchez, Esther, M Pérez Encinas",
    "institution": "Hospital Universitario Fundacion Alcorcón, Hospital Pharmacy, Alcorcon, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.271",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Interventional Study"],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": ["highRisk"],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": ["renal"],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Pharmacists at the health centre",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A128.1",
    "authors": "A Falk, M Dahl",
    "institution": "Region Kronoberg, Drug Department, Växjö, Sweden",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.272",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["5 months - 1 year"],
      "country": ["Sweden"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Off-label use of intralesional cidofovir in recurrent respiratory papillomatosis: a case report",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A128.2",
    "authors": "A Ganfornina Andrades, MDC Jiménez De-Juan, A Salguero Olid, MJ Fernández Anguita",
    "institution": "Puerta Del Mar University Hospital, Pharmacy, Cádiz, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.273",
    "filters": {
      "actSubs": ["Cidofovir"],
      "indication": ["Papillomatosis (Recurrent Respiratory)"],
      "statedClass": [],
      "typeOfMedical": ["Luer-Lock Syringes"],
      "studyDesign": ["Case Reports / Series", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": ["compounding"],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": ["orphan"],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Role of the pharmacist in the multidisciplinary management of osteomyelitis: from medication reconciliation to support in clinical decision making",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A129.1",
    "authors": "P Gendre, P Nizet, S Cesbron, J Mocquard, JF Huon, N Serandour, E Corbineau",
    "institution": "University Hospital, Pharmacy, Nantes, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.274",
    "filters": {
      "actSubs": [],
      "indication": ["Osteomyelitis"],
      "statedClass": ["Antibiotics (Systemic)"],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Orthopaedic Surgery"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"]
    }
  },
  {
    "title": "Facilitators and barriers to performing comprehensive medication reviews and follow-up in older hospitalised patients by multiprofessional ward teams including a clinical pharmacist",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A129.2",
    "authors": "T Kempen, A Kälvemark, M Sawires, D Stewart, U Gillespie",
    "institution": "Uppsala University Hospital, Hospital Pharmacy Department, Uppsala, Sweden. Uppsala University, Department of Medical Sciences, Uppsala, Sweden. Uppsala University, Department of Pharmaceutical Biosciences, Uppsala, Sweden. Qatar University, Qatar University Health -College of Pharmacy, Doha, Qatar",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.275",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine", "Geriatrics"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Consolidated Framework for Implementation Research"],
      "studyLength": [],
      "country": ["Sweden", "Qatar"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Evolution of antimicrobial consumption in a trauma intensive care unit using defined daily doses per 100 occupied bed days",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A130.1",
    "authors": "L Gómez-Ganda, P Lalueza-Broto, ÁG Arévalo-Bernabé, A Rey-Pérez, J Baena-Caparrós, L Domenech-Moral, M Baguena-Martínez",
    "institution": "Vall D’hebron University Hospital, Pharmacy Service, Barcelona, Spain. Vall D’hebron University Hospital, Trauma Intensive Care Service, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.276",
    "filters": {
      "actSubs": ["Amoxicillin / Clavulanic acid", "Piperacillin / Tazobactam", "Meropenem", "Daptomycin", "Linezolid", "Fluconazole", "Ceftolozane / Tazobactam"],
      "indication": ["Trauma"],
      "statedClass": ["Penicillins", "Cephalosporins", "Quinolones", "Carbapenems", "Aminoglycosides", "Glycopeptides", "Antifungals"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Trauma Intensive Care"],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": ["resistance"],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Electrolyte disturbances in premature infants with intrauterine growth restriction receiving parenteral nutrition",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A130.2",
    "authors": "L Gómez-Ganda1, CJ Parramón-Teixidó1, B Garcia-Palop1, M Linés-Palazón2, F Castillo-Salinas2, A Blanco-Grau3, JB Montoro-Ronsano1, S Clemente-Bautista1",
    "institution": "Vall D’hebron University Hospital, Pharmacy Service, Barcelona, Spain. Vall D’hebron University Hospital, Neonatology Service, Barcelona, Spain. Vall D’hebron University Hospital, Clinical Laboratory, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.277",
    "filters": {
      "actSubs": [],
      "indication": ["Intrauterine Growth Restriction", "Hypophosphataemia", "Hypercalcaemia"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": ["Neonatal Intensive Care"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Logistic Regression Analysis", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": ["neonatology"],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Comparative study of patient profiles and initial antiretroviral treatment in 2014 versus 2018",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A131.1",
    "authors": "T Gonzalez Furelos, A Casas Martínez, I Rodríguez Penín",
    "institution": "Xerencia Xestión Integrada Ferrol, Pharmacy Service, Ferrol, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.278",
    "filters": {
      "actSubs": ["Tenofovir disoproxil", "Emtricitabine", "Emtricitabine / Tenofovir disoproxil", "Abacavir", "Lamivudine", "Lamivudine / Abacavir", "Efavirenz", "Rilpivirine", "Darunavir", "Ritonavir", "Darunavir / Ritonavir", "Raltegravir", "Tenofovir alafenamide", "Cobicistat", "Dolutegravir", "Elvitegravir"],
      "indication": [],
      "statedClass": ["Nucleoside Reverse Transcriptase Inhibitors", "Non-Nucleoside Reverse Transcriptase Inhibitors", "Protease Inhibitors", "Integrase Inhibitor"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study", "Descriptive Study", "Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": ["safetyProfile"],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": []
    }
  },
  {
    "title": "Transcription of supportive medication for inpatient chemotherapy by designated oncology ward pharmacists",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A131.2",
    "authors": "C Imaz, E Smith, A Fox, D Wright, L Carson",
    "institution": "University Hospital Southampton NHS Foundation, Pharmacy, Southampton, UK. University Hospital Southampton NHS Foundation, Southampton Pharmacy Research Centre, Southampton, UK. Queen’s University Belfast, School of Pharmacy, Belfast, UK",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.279",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Oncology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Student's T-test", "Chi-Square (χ2) Test", "Welch's T-Test"],
      "studyLength": [],
      "country": ["United Kingdom"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "The wide review of polypharmacy in the frail older person",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A132.1",
    "authors": "C Kinahan, H Heery",
    "institution": "Portiuncula University Hospital, Pharmacy Department, Co Galway, Ireland. Portiuncula University Hospital, Pharmacy Department, Ballinasloe, Ireland",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.280",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Cohort Study"],
      "setting": ["Hospital", "Community Pharmacy"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["STOPP/START Criteria", "Medication Appropriateness Index", "PRISMA-7 Questionnaire"],
      "studyLength": ["Less than 3 months"],
      "country": ["Ireland"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": ["deprescribing"],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "From evidence based medicine to practice: gum chewing for postoperative recovery of gastrointestinal function after colorectal surgery with interprofessional teamwork",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A132.2",
    "authors": "YN Lin, CL Chuan, CS Tsai",
    "institution": "Tainan Municipal Hospital managed by Show Chwan Medical Care Corporation, Pharmacy, Tainan, Taiwan ROC. Tainan Municipal Hospital managed by Show Chwan Medical Care Corporation, Nutrition and Dietetics, Tainan, Taiwan ROC. Tainan Municipal Hospital managed by Show Chwan Medical Care Corporation, Internal Medicine, Tainan, Taiwan ROC",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.281",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["PICO (Patient, Intervention, Comparison And Outcome) - Procedure", "Analysis of Covariance (ANCOVA)"],
      "studyLength": [],
      "country": ["Taiwan"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Budgetary impact of biosimilar prescription in the treatment of rheumatic diseases",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A133.1",
    "authors": "A Linares, C Fernandez Cuerva, R Asensi Diez, I Muñoz Castillo",
    "institution": "Hru Carlos Haya, Pharmacy, Malaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.282",
    "filters": {
      "actSubs": ["Etanercept", "Adalimumab", "Golimumab", "Tocilizumab", "Infliximab", "Certolizumab", "Abatacept", "Ustekinumab", "Rituximab", "Anakinra"],
      "indication": ["Rheumatological Diseases"],
      "statedClass": ["Biologicals", "Biosimilars"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Rheumatology"],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Preliminary design of hospital telepharmacy",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A133.2",
    "authors": "K Nikou, V Papandreou, AA Volakaki, SA Koufopoulou, C Allagianni, D Makridaki",
    "institution": "General Hospital of Chest Diseases ‘Sotiria’, Pharmacy, Athens, Greece. Evangelismos Hospital, Pharmacy, Athens, Greece. Panarkadiko Hospital, Pharmacy, Tripoli, Greece. Naxos Hospital, Pharmacy, Naxos, Greece. General Hospital of Attica ‘Sismanoglio-Amalia Fleming’, Pharmacy, Athens, Greece",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.283",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Greece"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": ["youngPharma"],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Selection of a population pharmacokinetic model of adalimumab in patients with inflammatory bowel disease suitable for therapeutic drug monitoring",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A134.1",
    "authors": "P Mas-Serrano, R Nalda-Molina, A Ramón-López, S Marquez-Megías, M Díaz-González, J Selva, A Gutiérrez, C Colomer",
    "institution": "Hospital General Universitario De Alicante, Clinical Pharmacokinetic Unit-Pharmacy Department, Alicante, Spain. Miguel Hernández University, Division of Pharmacy and Pharmaceutics, Alicante, Spain. Hospital General Universitario De Alicante, Digestive Department, Alicante, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.284",
    "filters": {
      "actSubs": ["Adalimumab"],
      "indication": ["Inflammatory Bowel Disease"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Nonlinear Mixed Effects Modelling", "Bayesian Population Pharmacokinetic Approach"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Evaluation of a clinical pharmacy service on an inpatient ward in an acute hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A134.2",
    "authors": "C Mc Gann, B Love, J Carr, E Dolan, M O’Connor",
    "institution": "Connolly Hospital, Pharmacy Department, Blanchardstown, Ireland. Connolly Hospital, Medicine for the Elderly, Blanchardstown, Ireland",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.285",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Eadon Scoring Criteria"],
      "studyLength": ["Less than 3 months"],
      "country": ["Ireland"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Administration of oral anticancer drugs for patients with swallowing difficulties",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A135.1",
    "authors": "N Meca, A Manzaneque, G Castells, G Garreta, C Sebastián, I Parés, P Arcenillas, J Nicolás",
    "institution": "Hospital Universitari Mutua De Terrassa, Pharmacy, Terrassa, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.286",
    "filters": {
      "actSubs": ["Ruxolitinib", "Palbociclib", "Vismodegib", "Nilotinib", "Ibrutinib", "Sorafenib", "Vemurafenib", "Crizotinib", "Lenalidomide", "Imatinib", "Lenvatinib", "Sunitinib"],
      "indication": [],
      "statedClass": ["Oral Anticancer Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Description of pharmaceutical interventions in an intensive care unit",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A135.2",
    "authors": "M Muñoz Burgos, S Escalona Rodriguez, E Prado Mel, M Mejias Trueba",
    "institution": "Hospital Universitario Virgen Del Rocio, Hospital Pharmacy, Seville, Spain. Hospital Universitario Virgen Del Rocio, Intensive Medicine, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.287",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": ["drugMonitoring"],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Prognostic value of haematological inflammatory markers in patients with metastatic non-small cell lung cancer treated with pembrolizumab",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A136.1",
    "authors": "R Jimenez-Galan, L Abdel-Kader-Martin, M Mejias Trueba, MD Vega-Coca, S Flores-Moreno",
    "institution": "Hospital Universitario Virgen Del Rocío, Pharmacy, Seville, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.288",
    "filters": {
      "actSubs": ["Pembrolizumab"],
      "indication": ["Non-Small Cell Lung Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Ambispective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Kaplan-Meier Method", "Multivariate Analysis"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Pharmaceutical intervention to reduce the anticholinergic burden in older hospitalised patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A136.2",
    "authors": "M Mensa Vendrell, A Rizo Gómez, R Romero Dominguez, G Ballesteros Cabañas, M Barrantes González, D Soy Muner",
    "institution": "Hospital Plató, Pharmacy Department, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.289",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Anxiolytics", "Antidepressants", "Antipsychotics", "Opioids", "Antiepileptics"],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Drug Burden Index Score"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": ["deprescribing"],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": " Fall incidents in nursing home patients: development of a predictive clinical rule (finder)",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A137.1",
    "authors": "V Milosevic, B Winkens, B Oijen, K Hurkens, A Linkens, C Mestres-Gonzalvo, H Kuy",
    "institution": "Zuyderland Mc, Clinical Pharmacy and Toxicology, Sittard-Geleen, The Netherlands. Maastricht University, Methodology and Statistics, Maastricht, The Netherlands. Zuyderland Mc, Internal Medicine Section of Geriatric Medicine, Sittard-Geleen, The Netherlands. Mumc, Clinical Pharmacy and Toxicology, Maastricht, The Netherlands. Erasmus Mc, Clinical Pharmacy and Toxicology, Rotterdam, The Netherlands",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.290",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Cohort Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": ["Multiple Linear Regression Analysis"],
      "studyLength": [],
      "country": ["Netherlands"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Evaluation of a new clinical pharmacy service within a newly launched surgical admission process",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A137.2",
    "authors": "K Kreundl, K Koch, C Sablatschan, M Klems, K Kirchdorfer, R Lemmens, D Mueller",
    "institution": "University of Vienna, Department for Pharmacology and Toxicology, Vienna, Austria. Hanusch-Hospital, Pharmacy Department, Vienna, Austria",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.291",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": ["More than 1000"],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Austria"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": ["preopMedication"],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"]
    }
  },
  {
    "title": "Pharmaceutical interventions in a medication reconciliation programme on admission in surgical patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A138.1",
    "authors": "L Martinez-Dueñas Lopez-Marin, T Vilchez Medina, CL Muñoz Cid, R Claramunt García, AM Lopez Lopez, E Perez Cano, Y Jimenez Lopez, N Garcia Gomez",
    "institution": "Hospital Universitario De Jaén, Pharmacy, Jaén, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.292",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Observational Study"],
      "setting": ["Hospital"],
      "ward": ["General Surgery", "Urology"],
      "numPatients": ["501 - 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": ["geriatrics"],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": ["preopMedication"],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Estimating the survival prognosis of patients with advanced gastrointestinal malignancy on home parenteral nutrition: a retrospective, monocentre study",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A138.2",
    "authors": "J Neefs, I Spriet, L De Pourcq, P Declercq",
    "institution": "University Hospitals Leuven, Hospital Pharmacy, Leuven, Belgium",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.293",
    "filters": {
      "actSubs": [],
      "indication": ["Gastric Cancer"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Multivariate Logistic Regression Analysis", "Karnofsky Performance Status Scale", "Glasgow Prognostic Score"],
      "studyLength": [],
      "country": ["Belgium"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": ["homeCare"],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Measuring the impact of hospital pharmacist prescription reviewing in an oncology setting on the pharmacovigilance reporting in a comprehensive cancer centre",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A139.1",
    "authors": "E Omodeo Salè, D Pezzella, M Piccoli, M Milani, C Jemos, D Malengo, F Carrara, D Cimino",
    "institution": "Ieo-European Institute of Oncology Irccs-Milan, Clinical Pharmacy, Milano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.294",
    "filters": {
      "actSubs": ["Paclitaxel", "Cyclophosphamide", "Carboplatinum", "Epirubicin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": ["vigilance"],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "The underreporting rate as a pharmacovigilance process indicator in a comprehensive cancer centre",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A139.2",
    "authors": "E Omodeo Salè, D Pezzella, M Piccoli, M Milani, C Jemos, D Malengo, F Carrara, D Cimino",
    "institution": "Ieo-European Institute of Oncology Irccs-Milan, Clinical Pharmacy, Milano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.295",
    "filters": {
      "actSubs": ["Paclitaxel"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": ["vigilance"],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Pharmaceutical interventions in parenteral nutrition for critically ill patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A139.3",
    "authors": "M Gonzalez-Padilla, A Jurado-Romero, M Valera-Rubio, JL Ortiz Latorre, I Moya-Carmona",
    "institution": "Hospital Universitario Virgen De La Victoria, Servicio De Farmacia, Málaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.296",
    "filters": {
      "actSubs": [],
      "indication": ["Pancreatitis"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Intensive Care"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Stability of lipid emulsion in paediatric parenteral nutrition with high electrolytic load",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A140",
    "authors": "L Otero Millan, N Lago Rivero, JL Legido Soto, C Vázquez López, A Blanco Rodicio, G Piñeiro Corrales",
    "institution": "Hospital Álvaro Cunqueiro, Pharmacy, Vigo, Spain. University of Vigo, Applied Physics, Vigo, Spain. Hospital Álvaro Cunqueiro, Emergency, Vigo, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.297",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Aggregation Number", "Laser Diffraction Analysis", "Student's T-test"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": ["stability"],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Monitoring of off-label use: analysis of prescriptions in the pharmacy’s antiblastic drugs unit",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A141.1",
    "authors": "C Panciroli, L Cervi, D Mazza, L Cavallo, G Mangoni, F Corru’, M Dall’aglio, F Ruggiero, MLA Medaglia",
    "institution": "Asst Grande Ospedale Metropolitano Niguarda, SC Farmacia, Milano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.298",
    "filters": {
      "actSubs": ["Rituximab", "Mitomycin C", "5-azacitidine", "Bendamustine", "Cyclophosphamide", "Decitabine", "Brentuksimab vedotin", "Pembrolizumab"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Antiblastic Drugs Unit", "Haematology", "Nephrology", "Ophthalmology", "Oncology"],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Italy"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": ["offLabel"],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": ["habits"],
      "drugInteractions": []
    }
  },
  {
    "title": "Results of a medication reconciliation programme in complex chronic patients at hospital discharge",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A141.2",
    "authors": "L Perez Cordon, J Delgado Rodriguez, M Bitlloch Obiols, S Marin Rubio, C Agusti Maragall, D Lopez Faixo, A Sanchez Ulayar, L Campins Bernadas, T Gurrera Roig, M Miarons Font",
    "institution": "Hospital De Mataró, Pharmacy, Mataró, Spain. Hospital Universitari Dexeus, Pharmacy, Barcelona, Spain. Hospital Universitari Vall D’hebron, Pharmacy, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.299",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Pharmaceutical interventions in haemodialysis patients: a 2 year overview",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A142.1",
    "authors": "C Pinto, J Godinho, L Fernandes, P Vieira, AI Ferreira, I Sousa, C Vieira",
    "institution": "Nephrocare Portugal-SA, Pharmaceutical Services, Lisboa, Portugal",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.300",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Hypertensive Agents", "Vitamins", "Phosphate Binders"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Descriptive Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Portugal"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": ["renal"],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Differences in allelic frequencies of relevant pharmacogenetic polymorphisms may lead to local gene panel development",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A142.2",
    "authors": "X Díaz-Villamarín, AE Fernández-Gómez, P García-Navas, S Portillo-Haro, A Antúnez-Rodríguez, CL Dávila-Fajardo",
    "institution": "Hospital Universitario San Cecilio, Pharmacy, Granada, Spain. Pfizer-University of Granada-Junta De Andalucía Centre for Genomics and Oncological Research Genyo, Genomics Unit, Granada, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.301",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Laboratory Research"],
      "setting": ["Hospital", "Laboratory"],
      "ward": [],
      "numPatients": ["More than 1000"],
      "numPrescriptions": [],
      "criteriaMethod": ["Kompetitive Allele Specific PCR (KASP)", "Chi-Square (χ2) Test", "Fisher’s Exact Test"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Identification of hazardous drugs and process in a university hospital",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A143.1",
    "authors": "C Mora Herrera, C Cuadros Martinez, C Puivecino Moreno, V Vazquez Vela",
    "institution": "Hospital Universitario Jerez De La Frontera, Servicio De Farmacia Hospitalaria, Jerez De La Frontera, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.302",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Antineoplastic Drugs"],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": ["riskSafety"],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Nutritional risk evaluation in institutionalised elderly patients in a public nursing home",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A143.2",
    "authors": "C Puivecino Moreno, V Vazquez-Vela, A Varas-Perez, V Sanchez-Matamoros Piazza, C Mora Herrera",
    "institution": "Hospital Universitario Jerez De La Frontera, Pharmacy Service, Jerez De La Frontera-Cádiz, Spain. Hospital Universitario Jerez De La Frontera, Pharmacy Service, Jerez De La Frontera, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.303",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["51 - 100"],
      "numPrescriptions": [],
      "criteriaMethod": ["Mini Nutritional Assessment – Short Form (MNA-SF)"],
      "studyLength": ["Less than 3 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": ["endOfLife"],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Nurses: what do you think about a pharmaceutical presence in the emergency ward?",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A143.3",
    "authors": "N Ranjit, G Decreau-Gaillon, LM Joly",
    "institution": "Chru De Rouen, Pharmacy, Rouen, France. Chru De Rouen, Emergency Ward, Rouen, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.304",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["Emergency Department"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Medicine reconciliation at hospital discharge",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A144.1",
    "authors": "I Martinez Aguirre, A Revuelta Amallo, JA Domínguez Menéndez, U Blazquez Urtizberea, M Alonso Diez, E Fernández Díaz, A Aguirrezabal Arredondo",
    "institution": "Hospital De Basurto, Pharmacy Department, Bilbao, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.305",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study"],
      "setting": ["Hospital"],
      "ward": ["Internal Medicine", "Cardiology", "Oncology"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["3 months - 5 months"],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Assessment of the palatability of antibiotic oral suspensions: a literature review",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A144.2",
    "authors": "S Robert, YE Nisse, D Béatrice",
    "institution": "Chru Nancy, Pharmacy, Vandoeuvre Les Nancy, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.306",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": ["Antibiotic Oral Suspensions"],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Visual Analogue Scale"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": ["pediatrics"],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Impact of medication reconciliation in complex chronic patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A145.1",
    "authors": "C Rodriguez Bernuz, A Morales Triadó, L Vilaró Jaques, A Martín Val, RA Fernàndez Fernàndez, A Vilariño Seijas, S Cervero Corbella, C Oliveras Simón, C Quiñones Ribas",
    "institution": "Hospital Universitari Germans Trias I Pujol, Pharmacy, Badalona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.307",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["General Surgery", "Gastrointestinal Surgery", "Angiology", "Vascular Surgery", "Urology", "Nephrology", "Rheumatology"],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["STATA"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Treatment adequacy in domiciliary care programme patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A145.2",
    "authors": "C Salom, C Campabadal, I Muiño, C Carrillo, F Bejarano, N Marco, J Del Estal, MP Muniain, MÁ Roch, L Palacios, L Canadell",
    "institution": "Dap Camp De Tarragona-Ics, Pharmacy, Tarragona, Spain. Ap Camp De Tarragona-Ics, Eap Salou, Tarragona, Spain. Dap Camp De Tarragona-Ics, Computing, Tarragona, Spain. Hospital Joan Xxiii, Pharmacy, Tarragona, Spain. Dap Camp De Tarragona-Ics, Management, Tarragona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.308",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Longitudinal Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": ["homeCare"],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Nutritional support in oncology: a cross sectional study among cancer patients",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A146.1",
    "authors": "Y Samouh, A Benider, S Derfoufi",
    "institution": "Faculty of Medicine and Pharmacy-Hassan Ii University-Casablanca-Morocco, Laboratory of Drug Science-Biomedical Research and Biotechnology-Faculty of Medicine and Pharmacy-Hassan Ii University-Casablanca-Morocc, Casablanca, Morocco. Faculty of Medicine and Pharmacy-Hassan Ii University-Casablanca-Morocco, Mohammed Vi Centre for the Treatment of Cancers-Ibnrochd University Hospital Centre-Casablanca-Morocco, Casablanca, Morocco. Faculty of Medicine and Pharmacy-Hassan Ii University-Casablanca-Morocco, Pharmacy Unit of Ibn Rochd University Hospital Centre-Casablanca-Morocco, Casablanca, Morocco",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.309",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Cross-Sectional Study", "Observational Study", "Descriptive Study"],
      "setting": ["Hospital"],
      "ward": ["Oncology"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Morocco"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": ["nutrition"],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "An exploration into a pharmacist-led medicines reconciliation service in an acute hospital setting",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A146.2",
    "authors": "C Shine, M Kieran, C Meegan",
    "institution": "Mater Misericordiae University Hospital, Pharmacy Department, Dublin 7, Ireland. MMUH, Pharmacy, Dublin, Ireland. Mater Misericordiae University Hospital, Pharmacy, Dublin, Ireland",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.310",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Ireland"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Pharmacists’ communication with foreign language speaking patients in a foreigner settlement area, Japan",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A147.1",
    "authors": "E Takahashi, Y Takahashi, H Sato, K Obayashi, Y Takechi, K Takahashi",
    "institution": "Takasaki University of Health and Welfare, Faculty of Pharmacy, Takasaki-Gunma, Japan. Pharma Mirai Co Ltd, Kyoso-Mirai Kakezuka Pharmacy, Isesaki-Gunma, Japan. Hoshino Pharmacy, Tsunatori Branch, Isesaki-Gunma, Japan. Gunma Pharmaceutical Association, Gunma Pharmaceutical Association, Maebashi-Gunma, Japan. Teikyo University Graduate School of Public Health, Department of Global Community Health, Itabashi-Tokyo, Japan",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.311",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Community Pharmacy"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Japan"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": ["institutional"],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Adherence and interactions in patients treated with abiraterone and enzalutamide",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A147.2",
    "authors": "MV Tarazona Casany, P Perez, E Monte, MJ Cuellar",
    "institution": "Hospital Pharmacy Hospital Universitario Y Politécnico La Fe Valencia Spain, Hospital Pharmacy, Valencia, Spain. Hospital Universitario Y Politécnico La Fe Valencia Spain, Hospital Pharmacy, Valencia, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.312",
    "filters": {
      "actSubs": ["Abiraterone", "Enzalutamide", "Amiodarone", "Enzalutamide", "Atorvastatin", "Simvastatin", "Omeprazole", "Esomeprazole"],
      "indication": ["Prostate Cancer (Metastatic Castration Resistant)"],
      "statedClass": ["Lipid Lowering Agents", "Proton-Pump Inhibitors"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Morisky – Green Questionnaire"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": ["oncology"],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": ["drugInteractions"]
    }
  },
  {
    "title": "Healthcare providers’ views of pharmacy team involvement in the preparation and administration of medicines on inpatients wards: an exploratory study",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A147.3",
    "authors": "EM Vella, A Cutajar, P Lewis",
    "institution": "The University of Manchester, School of Health Sciences, Manchester, UK. Mater Dei Hospital, Department of Pharmacy-Clinical Pharmacy Practice Unit, Msida, Malta",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.313",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": ["General Surgery", "Critical Care Unit", "Emergency Department"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Framework Analysis"],
      "studyLength": ["3 months - 5 months"],
      "country": ["United Kingdom", "Malta"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": ["prepareIV"],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": ["administrative"],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Patient perceptions of generic medicines 20 years after the right of substitution by pharmacists",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A148.1",
    "authors": "M Vergano, F Badibouidi",
    "institution": "Ghpso, Pharmacy, Creil, France",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.314",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["Computer Assisted Web Interviewing (CAWI)"],
      "studyLength": [],
      "country": ["France"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Improving intravenous to oral switch by identifying and tackling barriers perceived by physicians and nurses",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A148.2",
    "authors": "S Von Winckelmann, E Boey, V Verheyen",
    "institution": "Imelda Hospital, Hospital Pharmacy, Bonheiden, Belgium",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.315",
    "filters": {
      "actSubs": ["Acetaminophen"],
      "indication": [],
      "statedClass": ["Antibiotics"],
      "typeOfMedical": [],
      "studyDesign": ["Interventional Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": ["Orthopaedics", "Geriatrics"],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Belgium"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "The impact of clinical pharmacist driven interventions on patient safety in hospitalised patients: preliminary results of a point prevalence study",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A149.1",
    "authors": "S Wilkes, R Zaal, A Abdulla, N Hunfeld",
    "institution": "Erasmus Mc-University Medical Centre Rotterdam, Department of Hospital Pharmacy, Rotterdam, The Netherlands",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.316",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study", "Point Prevalence Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) Index"],
      "studyLength": [],
      "country": ["Netherlands"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": ["errors"],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Promotion of the quality of drug education for patients using nasogastric tube feeding before discharge",
    "url": "https://ejhp.bmj.com/content/27/Suppl_1/A149.2",
    "authors": "SC Yeh, YH Liang",
    "institution": "Taipei City Hospital, Pharmacy, Taipei City, Taiwan ROC",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.317",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["Less than 3 months"],
      "country": ["Taiwan"],
      "year": ["2020"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": ["homeCare"],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": ["education"],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "A comparative study of the satisfaction of clients with the services of an outpatient pharmacy in a tertiary hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A200.1",
    "authors": "AC Viney, CN García Matillas, S Núñez Bracamonte, E CONESA NICOLÁS, A Lloret Llorca, C Juez Santamaría, MC Mira Sirvent, IG Pérez Pérez, MS García Simón, MDM Sánchez Catalicio, MH García Lagunar",
    "institution": "Hospital General Universitario Santa Lucia de Cartagena, Servicio de Farmacia Hospitalaria, Cartagena, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.430",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Comparative Study", "Retrospective Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": ["outpatient"],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": ["patientIntervention"],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Binary logistic regression analysis to evaluate the influence of different basal factors on the effectiveness of ledipasvir/sofosbuvir",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A201.2",
    "authors": "JC del Río Valencia, R Asensi Diez, R Tamayo Bermejo, I Muñoz Castillo",
    "institution": "Hospital Regional Universitario Malaga, Servicio Farmacia, Malaga, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.433",
    "filters": {
      "actSubs": ["Ledipasvir / Sofosbuvir", "Ledipasvir", "Sofosbuvir"],
      "indication": ["Hepatitis C (Chronic)"],
      "statedClass": ["Direct Acting Antivirals"],
      "typeOfMedical": [],
      "studyDesign": ["Retrospective Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": ["Binary Logistic Regression Analysis", "Statistical Package for the Social Sciences (SPSS)"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": ["pharmacogenetics"],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Impact of a multidisciplinary team in reducing polypharmacy and treatment complexity in home care patients",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A186.1",
    "authors": "N Pagès-Puigdemont, M Rovira-Illamola, L Gené, I Garrell, L GUerrero, A Lascorz, E Martínez, M Ortega, A Silva, M Sans, D Soy",
    "institution": "Hospital Clínic, Pharmacy Department, Barcelona, Spain. Capsbe, Cap Comte Borrell, Barcelona, Spain",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.400",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Prospective Study", "Interventional Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["10 - 50"],
      "numPrescriptions": [],
      "criteriaMethod": ["Medication Regimen Complexity Index"],
      "studyLength": [],
      "country": ["Spain"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": ["homeCare"],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": ["deprescribing"],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": ["adherence"],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": [],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Pharmacy intervention and drug prescription regulations in a tertiary hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A196.2",
    "authors": "P Stathopoulou, V Papandreou, V Papadopoulou, G Chatzidimitriou, A Sakka, M Vlachou",
    "institution": "General Hospital ‘Evaggelismos’, Pharmacy Department, Athens, Greece",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.422",
    "filters": {
      "actSubs": ["Ferric carboxymaltose", "Human albumin"],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Observational Study"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": [],
      "country": ["Greece"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": ["deprescribing"],
      "prepareIV": [],
      "costAnalysis": ["costAnalysis"],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": ["intervention"],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": ["stock"],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": ["policiesAudits"],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Determining the necessary components of a pharmaceutical care complexity screening tool: an E-delphi study",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A161.2",
    "authors": "M Alshakrah, D Steinke, M Tully, S Williams, P Lewis",
    "institution": "University of Manchester, Division of Pharmacy and Optometry, Manchester, UK",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.346",
    "filters": {
      "actSubs": [],
      "indication": [],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": ["Systematic Review"],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": [],
      "numPrescriptions": [],
      "criteriaMethod": ["E-Delphi Method", "Likert Scale"],
      "studyLength": [],
      "country": ["United Kingdom"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": [],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": [],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": ["interview"],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": [],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": ["multidisciplinary"],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  },
  {
    "title": "Analysis of adverse reaction reports before and after the use of equivalent imatinib in a tertiary hospital",
    "url": "https://ejhp.bmj.com/content/26/Suppl_1/A196.1",
    "authors": "E Specogna, MT Chiarelli, C Naddeo, M Bettio, M Mazzucchelli, F Venturini",
    "institution": "Scuola di Specializzazione in Farmacia Ospedaliera – Universita’ Degli Studi di Milano, Dipartimento di Scienze Farmaceutiche, Milano, Italy. Fondazione Irccs ca’ Granda Ospedale Maggiore Policlinico, U.O.C. Farmacia, Milano, Italy",
    "DOI": "http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.421",
    "filters": {
      "actSubs": ["Imatinib"],
      "indication": ["Leukaemia (Chronic Myeloid)"],
      "statedClass": [],
      "typeOfMedical": [],
      "studyDesign": [],
      "setting": ["Hospital"],
      "ward": [],
      "numPatients": ["101 - 500"],
      "numPrescriptions": [],
      "criteriaMethod": [],
      "studyLength": ["5 months - 1 year"],
      "country": ["Italy"],
      "year": ["2019"],
      "journal": ["European Journal of Hospital Pharmacy (EJHP)"],
      "pediatrics": [],
      "geriatrics": [],
      "neonatology": [],
      "oncology": [],
      "pharmacogenetics": [],
      "pharmacoeconomy": [],
      "radiopharmaceuticals": [],
      "compounding": [],
      "medicalDevices": [],
      "personalized": [],
      "nutrition": [],
      "highRisk": [],
      "endOfLife": [],
      "selfMedication": [],
      "preopMedication": [],
      "outpatient": [],
      "enzymeSubstrate": [],
      "geneTherapy": [],
      "homeCare": [],
      "antibioticProphylaxis": [],
      "painManagement": [],
      "offLabel": [],
      "flatDoses": [],
      "switching": ["switching"],
      "deprescribing": [],
      "prepareIV": [],
      "costAnalysis": [],
      "riskSafety": [],
      "vigilance": ["vigilance"],
      "stability": [],
      "drugMonitoring": [],
      "safetyProfile": [],
      "intervention": [],
      "patientIntervention": [],
      "nursesReccomend": [],
      "telepharmacy": [],
      "interview": [],
      "selection": [],
      "stock": [],
      "automated": [],
      "coldChain": [],
      "softwareAided": [],
      "mobileVR": [],
      "Printing3D": [],
      "socialMedia": [],
      "shortages": [],
      "adverseEvents": ["adverseEvents"],
      "adherence": [],
      "resistance": [],
      "renal": [],
      "errors": [],
      "administrative": [],
      "stewardship": [],
      "policiesAudits": [],
      "multidisciplinary": [],
      "institutional": [],
      "recalls": [],
      "education": [],
      "clinicalTrials": [],
      "youngPharma": [],
      "nextStep": ["nextStep"],
      "compliance": [],
      "orphan": [],
      "delivery": [],
      "falsified": [],
      "incompatibilities": [],
      "habits": [],
      "drugInteractions": []
    }
  }
]